<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29213271</article-id>
<article-id pub-id-type="pmc">5702648</article-id>
<article-id pub-id-type="doi">10.3389/fimmu.2017.01613</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Visceral Inflammation and Immune Activation Stress the Brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Holzer</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<uri xlink:href="http://frontiersin.org/people/u/28027" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farzi</surname>
<given-names>Aitak</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/177882" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hassan</surname>
<given-names>Ahmed M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/173528" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zenz</surname>
<given-names>Geraldine</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/478490" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jačan</surname>
<given-names>Angela</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/480310" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reichmann</surname>
<given-names>Florian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/227346" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology, Medical University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff2"><sup>2</sup><institution>BioTechMed-Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff3"><sup>3</sup><institution>CBmed GmbH—Center for Biomarker Research in Medicine</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Willem Van Eden, Utrecht University, Netherlands</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Valerio Chiurchiù, Università Campus Bio-Medico, Italy; Christine Jansen, Utrecht University, Netherlands</p>
</fn>
<corresp content-type="corresp" id="cor1">*Correspondence: Peter Holzer, <email>peter.holzer@medunigraz.at</email></corresp>
<fn fn-type="other" id="fn001">
<p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1613</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Holzer, Farzi, Hassan, Zenz, Jačan and Reichmann.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Holzer, Farzi, Hassan, Zenz, Jačan and Reichmann</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Stress refers to a dynamic process in which the homeostasis of an organism is challenged, the outcome depending on the type, severity, and duration of stressors involved, the stress responses triggered, and the stress resilience of the organism. Importantly, the relationship between stress and the immune system is bidirectional, as not only stressors have an impact on immune function, but alterations in immune function themselves can elicit stress responses. Such bidirectional interactions have been prominently identified to occur in the gastrointestinal tract in which there is a close cross-talk between the gut microbiota and the local immune system, governed by the permeability of the intestinal mucosa. External stressors disturb the homeostasis between microbiota and gut, these disturbances being signaled to the brain <italic>via</italic> multiple communication pathways constituting the gut–brain axis, ultimately eliciting stress responses and perturbations of brain function. In view of these relationships, the present article sets out to highlight some of the interactions between peripheral immune activation, especially in the visceral system, and brain function, behavior, and stress coping. These issues are exemplified by the way through which the intestinal microbiota as well as microbe-associated molecular patterns including lipopolysaccharide communicate with the immune system and brain, and the mechanisms whereby overt inflammation in the GI tract impacts on emotional-affective behavior, pain sensitivity, and stress coping. The interactions between the peripheral immune system and the brain take place along the gut–brain axis, the major communication pathways of which comprise microbial metabolites, gut hormones, immune mediators, and sensory neurons. Through these signaling systems, several transmitter and neuropeptide systems within the brain are altered under conditions of peripheral immune stress, enabling adaptive processes related to stress coping and resilience to take place. These aspects of the impact of immune stress on molecular and behavioral processes in the brain have a bearing on several disturbances of mental health and highlight novel opportunities of therapeutic intervention.</p>
</abstract>
<kwd-group>
<kwd>gut–brain axis</kwd>
<kwd>gut microbiota</kwd>
<kwd>immune–brain axis</kwd>
<kwd>immune stress</kwd>
<kwd>intestinal inflammation</kwd>
<kwd>lipopolysaccharide</kwd>
<kwd>mental health</kwd>
<kwd>neuropeptide Y</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn01">Austrian Science Fund<named-content content-type="fundref-id">10.13039/501100002428</named-content></funding-source>
<award-id rid="cn01">P23097-B18, P25912-B23 and W1241-B18</award-id>
</award-group>
<award-group>
<funding-source id="cn02">Österreichische Forschungsförderungsgesellschaft<named-content content-type="fundref-id">10.13039/501100004955</named-content></funding-source>
<award-id rid="cn02">CBmed K1 Competence Centre</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="339"></ref-count>
<page-count count="26"></page-count>
<word-count count="23425"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>In a general context, stress is considered to be a dynamic process in which the physical and/or mental homeostasis of an organism is challenged, the outcome depending on the type, severity, and duration of stimuli (stressors) involved, the stress responses triggered and the stress susceptibility/resilience of the organism. Homeostatic disturbances can be triggered by both exogenous and endogenous stressors. There is abundant evidence that the immune system is involved in stress responses, given that both physical and psychosocial stressors have an impact on immune function. It needs to be emphasized, however, that the interaction between stress and immune system is a bidirectional process, implying that alterations in immune function themselves can elicit stress responses. Such bidirectional interactions have been identified to occur in the gastrointestinal (GI) tract in which there is a close cross-talk between the gut microbiota and the local immune system (<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B4">4</xref>), governed by the permeability of the GI mucosa. On the one hand, external stressors impact on the gut microbiota and its relationship with the GI mucosal, immune, endocrine, and nervous system. On the other hand, this disturbance of gut homeostasis is signaled to the central nervous system (CNS) <italic>via</italic> multiple communication pathways constituting the gut–brain axis, ultimately eliciting stress responses and perturbations of brain function (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>It has been known for some time that infection-related as well as infection-independent immunological stimuli can evoke stress responses as reflected by an increased activity of the hypothalamic–pituitary–adrenal (HPA) axis, resulting in enhanced plasma concentrations of adrenocorticotropic hormone (ACTH) and cortisol/corticosterone (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Pathogen-associated molecular patterns (PAMPs) such as bacterial lipopolysaccharide (LPS) have been extensively studied in their ability to stimulate the innate immune system <italic>via</italic> binding to toll-like receptor-4 (TLR4), cause the formation of proinflammatory cytokines, activate the HPA system (<xref ref-type="bibr" rid="B8">8</xref>–<xref ref-type="bibr" rid="B10">10</xref>), and alter brain function and behavior. Cytokines generated in response to, e.g., LPS trigger a complex behavioral response, encompassed in the terms “sickness behavior” or “illness response,” which comprise fever, anorexia, somnolence, decrease in locomotion, exploration and social interaction, hyperalgesia, and delayed depression-like behavior (<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B15">15</xref>). These cerebral effects are brought about by multiple signaling mechanisms: direct access of cytokines to the brain, activation of vagal afferent neurons, and neuroinflammatory processes in the brain (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Once acute sickness subsides, depression-like behavior may ensue, in which cytokine-induced HPA axis hyperactivity plays a particular role (<xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>Given the abundance of the gut microbiota (<xref ref-type="bibr" rid="B18">18</xref>), it is commonly assumed that a large part of the circulating levels of LPS and related PAMPs derive from bacteria in the GI tract (<xref ref-type="bibr" rid="B19">19</xref>) and that the effects of intraperitoneally (IP) administered LPS replicate primarily the reactions to increased translocation of LPS from the gut lumen under conditions of enhanced mucosal permeability. The intestinal mucosal barrier is subject to many influences that regulate its cellular and paracellular permeability, among which stress is an important factor. de Punder and Pruimboom (<xref ref-type="bibr" rid="B19">19</xref>) hypothesize that the stress-induced increase in mucosal permeability serves to meet the enhanced metabolic demand under conditions of stress. At the same time, a persistent increase in the translocation of LPS to the circulation is associated with pathologies such as chronic GI inflammation (<xref ref-type="bibr" rid="B20">20</xref>) and non-alcoholic fatty liver disease (<xref ref-type="bibr" rid="B21">21</xref>) but also with chronic fatigue syndrome (<xref ref-type="bibr" rid="B22">22</xref>), depression (<xref ref-type="bibr" rid="B23">23</xref>), and autism spectrum disorder (<xref ref-type="bibr" rid="B24">24</xref>). A minor part of circulating PAMPs may also derive from other microbe-colonized organs, such as oral cavity, respiratory system, and genitourinary tract as well as from food (<xref ref-type="bibr" rid="B19">19</xref>). It has, in addition, been argued that there are dormant bacterial reservoirs in the blood and certain tissues, including the brain, and that PAMP production in these reservoirs may contribute to chronic inflammatory disease (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>In view of these facts and conditions, the present article sets out to highlight some of the interactions between peripheral immune activation, especially in the visceral system, and brain function, behavior, and stress coping. These issues are exemplified by the way the intestinal microbiota and its metabolites communicate with the immune system and CNS, on the one hand, and the mechanisms whereby overt inflammation in the GI tract impacts on brain function, pain sensitivity, and stress coping, on the other hand. As the interactions between the peripheral immune system and the brain take place along the gut–brain axis, the major pathways of this communication system are also briefly dealt with. Furthermore, novel insights into the molecular signaling processes in the brain that occur under conditions of peripheral immune stress are discussed, and adaptive processes related to stress coping and resilience are considered. In concluding, these novel aspects of immune–brain interaction are put into perspective with disturbances of mental health that become manifest under conditions of stress and with emerging opportunities of therapeutic intervention.</p>
</sec>
<sec id="S2">
<title>Multiple Communication Pathways Along the Gut–Brain Axis</title>
<p>The communication network between GI microbiota, mucosa, endocrine system, immune system, and enteric nervous system, on the one hand, and the brain, on the other hand, uses at least five information carriers (Figure <xref ref-type="fig" rid="F1">1</xref>): gut microbiota-derived molecules, immune mediators, gut hormones, vagal afferent neurons, and spinal afferent neurons (<xref ref-type="bibr" rid="B5">5</xref>). As the interaction between gut and the brain is bidirectional, there are also at least four information carriers that signal from the CNS to the GI tract: parasympathetic efferent neurons, sympathetic efferent neurons, neuroendocrine factors involving the adrenal medulla, and neuroendocrine factors involving the adrenal cortex (<xref ref-type="bibr" rid="B5">5</xref>). Additional relays include the blood–brain barrier (BBB) and distinct brain circuits that process the information the CNS receives from the periphery.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Pathways involved in the behavioral disturbances associated with visceral immune activation and inflammation. There are multiple communication pathways between gut and brain: microbiota-derived signals, immune cell-derived signals, gut hormones, and vagal and spinal afferents. In the course of experimental colitis or microbe-evoked peripheral immune activation, signaling along these pathways is altered, ultimately influencing brain functions, such as anxiety, depression-like behavior, learning, and memory.</p>
</caption>
<graphic xlink:href="fimmu-08-01613-g001"></graphic>
</fig>
<p>It is important to note that these circulation-based (endocrine) and neuronal communication routes do not operate in isolation but are closely interrelated with each other. Microbial metabolites, microbe-associated molecular patterns (MAMPs), and PAMPs can act both on GI endocrine and/or immune cells and sensory neurons. This is exemplified by the short-chain fatty acids (SCFAs) comprising acetic, <italic>n</italic>-butyric, and propionic acid, which are generated from otherwise indigestible carbohydrate fibers through microbial fermentation. SCFAs are multi-target messengers that act on GI endocrine, mucosal, and immune cells as well as on brain microglia (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). SCFAs are important energy sources for the microbiota and mucosa, exert antiinflammatory effects through their action on macrophages, neutrophils, dendritic, and regulatory T cells, and have a fortifying influence on the GI epithelial barrier (<xref ref-type="bibr" rid="B27">27</xref>) as well as BBB (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>Most of the cellular effects of SCFAs are mediated by G protein-coupled receptors (GPRs), such as GPR41 (also known as FFAR3), GPR43 (also known as FFAR2), and GPR109A (also known as HCAR2) (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). This is also true for the impact SCFAs have on enteroendocrine cells in the GI mucosa. By stimulating GPR41 and GPR43 on L cells in the distal ileum and colon, SCFAs release the gut hormones peptide YY (PYY), glucagon-like peptide-1 (GLP-1), and GLP-2 (<xref ref-type="bibr" rid="B29">29</xref>–<xref ref-type="bibr" rid="B31">31</xref>). Through this route, enteroendocrine cells convey messages of the gut microbiota within the digestive system as well as to distant organs, including the brain. Following their release from L cells, PYY and GLP-1 inhibit gastric motility, improve glucose homeostasis, induce satiety (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B32">32</xref>), and alter behavior (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). It is likely that other appetite-regulating hormones, such as ghrelin, cholecystokinin, and leptin, are also under the influence of the gut microbiota (<xref ref-type="bibr" rid="B35">35</xref>–<xref ref-type="bibr" rid="B37">37</xref>). Gut hormone activity may be coupled with intestinal immune processes, as proinflammatory prostaglandins (PGs) acting <italic>via</italic> EP<sub>4</sub> receptors enhance the release of GLP-1, GLP-2, and PYY (<xref ref-type="bibr" rid="B38">38</xref>), and enteroendocrine cell activity is increased in Crohn’s disease affecting the small bowel (<xref ref-type="bibr" rid="B39">39</xref>). In addition, enteroendocrine cells may be involved in hormone-independent ways of gut–brain communication, given that misfolded α-synuclein could be transferred to the brain through direct connections between enteroendocrine cells and neural circuits, thus contributing to the pathogenesis of Parkinson’s disease (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>A number of gut hormones including PYY, GLP-1, and ghrelin signal to the brain to affect appetite and energy homeostasis but also impact on mood and emotional-affective behavior (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B32">32</xref>–<xref ref-type="bibr" rid="B34">34</xref>). This messaging is not only accomplished <italic>via</italic> a circulatory route but also through activation of vagal afferent neurons (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B41">41</xref>). The vagus nerve appears in fact to play a particular role in the signaling of microbial, endocrine, and immune signals to the brain, which is consistent with its predominant sensory nature, given that the vast majority (80–90%) of the axons in the vagus nerve are afferent nerve fibers (<xref ref-type="bibr" rid="B42">42</xref>–<xref ref-type="bibr" rid="B44">44</xref>). Vagal afferents are thought to tonically deliver information from visceral organs to the brain, this massive sensory input being relevant not only to the autonomic regulation of digestion and energy balance but also to interoception (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Also termed the “sixth sense” (<xref ref-type="bibr" rid="B45">45</xref>), interoception refers to the integrated sense of the physiological condition of the body (<xref ref-type="bibr" rid="B46">46</xref>) and the representation of the internal state in the brain (<xref ref-type="bibr" rid="B47">47</xref>). GI interoception includes a wide range of conscious sensations, such as pain, nausea, GI discomfort, GI tension, hunger, and thirst, as well as signaling processes that go virtually unnoticed although they impact on emotional-affective and cognitive processes (<xref ref-type="bibr" rid="B48">48</xref>–<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="S3">
<title>Immune Stress Signaling from the Gut to the Brain</title>
<sec id="S3-1">
<title>Immune Signaling <italic>via</italic> Microbial Factors</title>
<p>The gut microbiota is a rich source of potential messenger molecules: primary metabolites generated by microbial cells, MAMPs, and PAMPs shed from microbial cells, and secondary metabolites generated by microbial fermentation of food components or transformation of host molecules such as bile acids (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B51">51</xref>–<xref ref-type="bibr" rid="B55">55</xref>). Apart from the MAMPs and PAMPs, many of the other microbial metabolites, such as SCFAs, trimethylamine-<italic>N</italic>-oxide, p-cresol, aryl hydrocarbon receptor ligands, formyl peptides, flagellin, polyamines such as spermidine, 4-ethyl phenol sulfate (4-EPS), and polysaccharide A produced by <italic>Bacteroides fragilis</italic> (<xref ref-type="bibr" rid="B27">27</xref>), have an effect on the immune system, may influence sensory nerve activity or travel by the blood stream to distant organs including the brain (Table <xref ref-type="table" rid="T1">1</xref>). While we know many factors that govern the composition, diversity, and function of the gut microbiota, we still lack a full comprehension of the signaling systems that govern the homeostatic interaction between the gut microbiota and the local immune system as well as the resilience of this homeostatic cross-talk. In a wider perspective, a dysbalance in the micobiota–immune relationship represents itself a stress scenario which, if this “immune stress” is transmitted to the brain, will elicit a systemic stress response. As alluded to before, the intestinal mucosal barrier (<xref ref-type="bibr" rid="B27">27</xref>) plays an important role in the interaction between the gut microbiota and the intestinal immune system. Spadoni and colleagues (<xref ref-type="bibr" rid="B56">56</xref>) have recently characterized some of the structural and functional characteristics of the gut–vascular barrier in mice and humans that controls the translocation of microbial macromolecules into the bloodstream and denies entry of microbial cells. They identified Wnt/β-catenin signaling in gut endothelial cells as an important control mechanism which, when downregulated, may enable certain pathogenic bacteria such as <italic>Salmonella typhimurium</italic> to enter the bloodstream (<xref ref-type="bibr" rid="B56">56</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Effects of PAMPs and other microbial metabolites on emotional-affective and cognitive behavior.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">PAMP/metabolite</th>
<th align="left" colspan="1" rowspan="1" valign="top">Main receptor</th>
<th align="left" colspan="1" rowspan="1" valign="top">Dose</th>
<th align="left" colspan="1" rowspan="1" valign="top">Species (sex)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Behavioral effects</th>
<th align="left" colspan="1" rowspan="1" valign="top">Additional effects</th>
<th align="center" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MALP-2<break></break>FSL-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">TLR2/6</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 µg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wistar rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sickness behavior: anorexia, adipsia, hypoactivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypo- and hyperthermia, upregulated levels of proinflammatory cytokines in plasma</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B137">137</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pam3CSK4</td>
<td align="left" colspan="1" rowspan="1" valign="top">TLR2/1</td>
<td align="left" colspan="1" rowspan="1" valign="top">200 ng/2 μl in mice, 1 μg/3 μl in rats, ICV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice and rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sickness behavior: anorexia, hypoactivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypothalamic inflammation and microglia activation, increased POMC neuron activity, hyperthermia</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B138">138</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LTA</td>
<td align="left" colspan="1" rowspan="1" valign="top">TLR2</td>
<td align="left" colspan="1" rowspan="1" valign="top">20 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6N mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">No effect 3 h after LTA injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Upregulated levels of proinflammatory cytokines in plasma (proteins) and brain (mRNA), decreased expression of tight junction-associated proteins in the brain, increased circulating corticosterone levels</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B97">97</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5" valign="top">LPS</td>
<td align="left" colspan="1" rowspan="5" valign="top">TLR4</td>
<td align="left" colspan="1" rowspan="2" valign="top">0.83 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6 mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute sickness (6 h) and delayed depression (24 h)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Expression of acute (c-Fos) and chronic (ΔFosB) cellular reactivity markers</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B13">13</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Crl:CD1 mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Depression-like behavior prevented by minocycline or IDO antagonist 1-MT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enhanced kynurenine/tryptophan ratio in plasma and brain normalized by minocycline or 1-MT</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B191">191</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">0.8 ng/kg IV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy human volunteers (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anxiety, depressed mood, and decreased memory performance</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased circulating levels of IL-6, TNF-α, soluble TNF receptors, IL-1 receptor antagonist and cortisol, mild increase in rectal temperature</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B87">87</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">0.4 ng/kg IV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy human volunteers (male, female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anxiety, depressed mood, sickness symptoms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase in circulating proinflammatory cytokines and cortisol higher in females than males</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B90">90</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.0 ng/kg IV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Healthy human volunteers (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sickness symptoms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microglial activation throughout the brain, increased circulating levels of proinflammatory cytokines</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B91">91</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FK565, MDP, LPS</td>
<td align="left" colspan="1" rowspan="1" valign="top">NOD1, NOD2, TLR4</td>
<td align="left" colspan="1" rowspan="1" valign="top">3, 3, 0.1 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6 mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NOD agonists alone without effect, synergism with LPS in eliciting sickness</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypothermia, upregulated levels of proinflammatory cytokines in plasma (proteins) and brain (mRNA), increased circulating corticosterone levels</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B10">10</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">Poly I:C</td>
<td align="left" colspan="1" rowspan="3" valign="top">TLR3</td>
<td align="left" colspan="1" rowspan="1" valign="top">6 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sprague–Dawley rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced locomotor activity (6 h), anxiety-like behavior (24 h), reduced saccharin preference (24–72 h)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased body weight gain (24 h), molecular changes in frontal cortex and hippocampus: increased proinflammatory cytokine and IDO expression (mRNA, 6 h), reduced BDNF and TrkB expression (mRNA, 6, 24, 48 h), increased tryptophan (6, 24, 48 h), and kynurenine (24, 48 h) levels</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B174">174</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2, 6, 12 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6 mice (female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dose-dependent acute sickness observed in OFT (4, 8, 12 h) and burrowing (6, 10, 26 h)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Upregulation of proinflammatory cytokines in plasma (protein) and brain (mRNA), biphasic core body temperature change</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B96">96</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">12 mg/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficit in contextual memory consolidation (24 h)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Diminished BDNF mRNA expression (4 h)</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B176">176</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4-EPS</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">30 mg/kg IP for 3 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6N mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety and startle reflex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase in 4-EPS levels in response to maternal immune activation by Poly I:C</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B57">57</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">SCFAs</td>
<td align="left" colspan="1" rowspan="1" valign="top">GPR41</td>
<td align="left" colspan="1" rowspan="1" valign="top">25 mM sodium propionate, 40 mM sodium butyrate plus 67.5 mM sodium acetate in drinking water for 7 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top">BDF1 mice overexpressing α-synuclein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor deficits</td>
<td align="left" colspan="1" rowspan="1" valign="top">α-Synuclein-mediated neuroinflammation</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B82">82</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GPR43</td>
<td align="left" colspan="1" rowspan="1" valign="top">25 mM sodium propionate, 40 mM sodium butyrate plus 67.5 mM sodium acetate in drinking water for 4 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top">Germ-free C57BL/6 mice (male and female)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Normalization of microglia density, morphology and immaturity (altered in germ-free mice)</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B26">26</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">Sodium butyrate</td>
<td align="left" colspan="1" rowspan="1" valign="top">GPR41</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 g/kg by oral gavage for 3 days</td>
<td align="left" colspan="1" rowspan="1" valign="top">Germ-free C57BL/6J mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normalization of blood–brain barrier permeability which is enhanced in germ-free mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normalization of occludin expression in frontal cortex which is decreased in germ-free mice, increase of histone acetylation in brain lysates</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B28">28</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">GPR43</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.2 g/kg IP in single injection or for 4 weeks</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Antidepressant-like effect</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase of histone acetylation in hippocampus</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B83">83</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.2 g/kg IP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aged (24 months) Wistar rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rescue of aging-associated memory impairment</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B84">84</xref>)</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Propionic acid</td>
<td align="left" colspan="1" rowspan="1" valign="top">GPR41</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 µl of 0.26 M solution, ICV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adolescent (41 days) Long–Evans rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Restricted behavioral interest in a specific object, impaired social behavior, impaired reversal in T-maze task</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroinflammatory response</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GPR43</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 µl of 0.26 M solution ICV for 8 days</td>
<td align="left" colspan="1" rowspan="1" valign="top">Long-Evans rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase of locomotor activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Change in molecular phospholipid species in blood and brain</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B86">86</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>BDNF, brain-derived neurotrophic factor; 4-EPS, 4-ethyl phenol sulfate; FSL-1; fibroblast-stimulating lipopeptide-1; ICV, intracerebroventricular; IDO, indoleamine 2,3-dioxygenase; IL, interleukin; IP, intraperitoneal; IV, intravenous; LTA, lipoteichoic acid; LPS, lipopolysaccharide; MALP-2, macrophage-activating lipopeptide-2; MDP, muramyl dipeptide; 1-MT, 1-methyltryptophan; NOD, nucleotide-binding and oligomerization domain; OFT, open field test; PAMP, pathogen-associated molecular pattern; poly I:C, polyinosinic:polycytidylic acid; POMC, proopiomelanocortin; SCFA, short-chain fatty acid; TLR, Toll-like receptor; TNF, tumor necrosis factor; TrkB, tropomyosin-related kinase B</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Although the list of identified chemical messengers derived from the gut microbiota is steadily increasing, only a limited number of these molecules have been investigated in their effects on gut–brain and immune–brain signaling: PAMPs such as LPS, lipoteichoic acid (LTA), and peptidoglycan components, SCFAs and 4-EPS (Table <xref ref-type="table" rid="T1">1</xref>). The latter metabolite is markedly increased in a mouse model of autism spectrum disorder which is caused by maternal immune activation and characterized by enhanced gut permeability, altered microbial composition, altered serum metabolomic profile, and defects in communicative, stereotypic, anxiety-like, and sensorimotor behaviors (<xref ref-type="bibr" rid="B57">57</xref>). Some of these behavioral abnormalities are reproduced by 4-EPS, while treatment with the human commensal <italic>Bacteroides fragilis</italic> has a beneficial effect (<xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
<sec id="S3-2">
<title>Immune Signaling Across the Blood-Brain Barrier (BBB)</title>
<p>The BBB is an important checkpoint for the entry of molecules and cells into the brain and in this capacity shares many similarities with the gut–vascular barrier (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Both boundaries are built by a cellular layer that controls the movement of molecules and cells and closely interacts with neighboring immune and other cells that provide functional support to the barrier (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>). In the present context, it is particularly worth noting that SCFAs play not only a role in the gut epithelial barrier but also in the development and maintenance of the BBB. This implication has been disclosed in germ-free mice in which increased BBB permeability is associated with reduced expression of the tight junction proteins occludin and claudin-5 in frontal cortex, striatum, and hippocampus (<xref ref-type="bibr" rid="B28">28</xref>). A decrease in the expression of these tight junction proteins in the murine hippocampus, but not amygdala, prefrontal cortex, and hypothalamus, has likewise been found after antibiotic-induced disruption of the gut microbiota (<xref ref-type="bibr" rid="B54">54</xref>). Re-colonization of the intestine of germ-free adult mice with a normal gut microbiota normalizes BBB permeability and upregulates the expression of tight junction proteins, an effect that is reproduced by butyric acid (<xref ref-type="bibr" rid="B28">28</xref>). The microbial control of BBB development and function has very likely a bearing on gut–brain and particularly immune–brain signaling, because the transfer of immune-relevant factors (e.g., cytokines, chemokines, PGs) and even immune cells across the BBB depends on the functional status of the barrier and its regulatory mechanisms (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Given that the BBB is essential for brain development, function, and homeostasis, the control of BBB permeability is probably an important mechanism whereby the gut microbiota controls brain activity and behavior.</p>
</sec>
<sec id="S3-3">
<title>Immune Signaling <italic>via</italic> the Vagus Nerve</title>
<p>As alluded to before, immune signaling from the gut to the brain can also take a neuronal route, particularly <italic>via</italic> the vagus nerve. Microbial as well as immune factors appear to alter the excitability and activity of both enteric sensory as well as vagal afferent neurons, which appear to be connected with each other <italic>via</italic> junctions involving nicotinic acetylcholine receptors (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). One such factor is polysaccharide A derived from <italic>Bacteroides fragilis</italic> which stimulates sensory neurons of the myenteric plexus (<xref ref-type="bibr" rid="B62">62</xref>) while components of <italic>Lactobacillus rhamnosus</italic> (JB-1) have a similar stimulant effect on vagal afferent neurons (<xref ref-type="bibr" rid="B63">63</xref>). Such microbe-driven neuronal processes are likely to participate in the vagus nerve-dependent effects of probiotics on brain function and behavior (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>The role of the abdominal vagus in transmitting microbial and immune messages to the brainstem is related both to the proximity of vagal afferent nerve fibers to immunologically relevant structures in the abdominal cavity (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>) and to the sensitivity of these nerve fibers to messengers derived from the microbiota and immune system. It has been shown, for instance, that IP administered LPS is primarily transported to the liver where it induces the release of interleukin (IL)-1β from Kupffer cells (macrophage-like cells to screen blood and lymph) (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The cytokine, in turn, is thought to excite afferent nerve fibers in the hepatic branch of the vagus nerve or to enhance their afferent signaling (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B66">66</xref>). In addition, the abdominal vagus is associated with paraganglia and connective tissue containing macrophages and dendritic cells that respond to IP administration of LPS with synthesis of IL-1β (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>). The abdominal paraganglia of the vagus nerve contain glomus-like cells that have IL-1 receptors (<xref ref-type="bibr" rid="B69">69</xref>), are innervated by vagal afferents (<xref ref-type="bibr" rid="B70">70</xref>), and appear to act as chemosensory accessory cells (<xref ref-type="bibr" rid="B16">16</xref>). Furthermore, vagal afferents innervate abdominal lymph nodes that represent another interface with the visceral immune system (<xref ref-type="bibr" rid="B16">16</xref>). Unlike endocrine signaling <italic>via</italic> the bloodstream, sensory neurons are, thus, in a position to enable rapid propagation of immune signals to the brain.</p>
<p>The sensitivity of vagal afferent nerve fibers to PAMPs such as LPS and proinflammatory cytokines has been corroborated by electrophysiological recordings and c-Fos mapping in the central projection areas of sensory neurons. In addition, it has been shown that both vagal and spinal afferent neurons do not only respond to these microbial and immune messengers but can also, under their influence, undergo sensitization to other stimulants. For instance, both LPS and tumor necrosis factor-α (TNF- α) are capable of directly activating vagal afferent neurons in culture (<xref ref-type="bibr" rid="B71">71</xref>). In addition, LPS can stimulate sensory neurons <italic>via</italic> activation of the transient receptor potential ankyrin-1 (TRPA1) ion channel (<xref ref-type="bibr" rid="B72">72</xref>) and sensitize afferent fibers in mesenteric nerves to serotonin, bradykinin, and gut distension, an effect in which mast cells and cyclooxygenase-2 play a role (<xref ref-type="bibr" rid="B73">73</xref>). In a similar manner, IL-1β is able to increase action potential firing in vagal afferents (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>), to induce c-Fos expression in the nucleus tractus solitarii, the central projection area of vagal afferent nerve fibers in the medullary brainstem (<xref ref-type="bibr" rid="B76">76</xref>), and to sensitize vagal afferent pathways to gastric acid (<xref ref-type="bibr" rid="B77">77</xref>). The expression of IL-1 receptors by nodose ganglion cells makes it likely that the cytokine is capable of exciting vagal afferents by a direct action on the axons, although PGs acting <italic>via</italic> EP<sub>3</sub> receptors and cholecystokinin acting <italic>via</italic> CCK<sub>1</sub> receptors have also been implicated (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B78">78</xref>). Spinal afferent neurons supplying the murine colon are also responsive to proinflammatory cytokines, such as IL-1β and TNF-α, and the mechanical hypersensitivity of mouse colonic nerve fibers evoked by TNF-α is inhibited by a TRPA1 blocker (<xref ref-type="bibr" rid="B79">79</xref>).</p>
</sec>
</sec>
<sec id="S4">
<title>Impact of Immune Stress Signaling from the Periphery on Brain Function and Behavior</title>
<p>As discussed before, microbial and immune messages originating from the visceral system reach the brain either by an endocrine or neuronal route, the BBB being an important checkpoint for those messengers that arrive <italic>via</italic> the bloodstream. Sensitization of CNS pathways as well as long-term alterations in brain circuitry, connectivity, and activity are ultimately responsible for the mental disturbances in which immune activation and chronic inflammatory disease appear to play a role. The impact of MAMPs and PAMPs, particularly LPS, on the brain <italic>via</italic> particular immune pathways has been most extensively studied in this respect, although a contribution of other factors, such as 4-EPS (<xref ref-type="bibr" rid="B57">57</xref>), spermidine (<xref ref-type="bibr" rid="B80">80</xref>), and SCFAs is also emerging (Table <xref ref-type="table" rid="T1">1</xref>). Apart from disturbances of brain function and behavior, PAMPs acting <italic>via</italic> the pattern recognition receptor (PRR) TLR4 (such as LPS) also seem to contribute to the pathogenesis of cerebrovascular disease (<xref ref-type="bibr" rid="B81">81</xref>). Specifically, Gram-negative bacteria of the gut microbiota and TLR4 activation stimulate the formation of cerebral cavernous malformations (CCMs) that are risk factors for stroke and seizure. Activation of TLR4 by LPS accelerates CCM formation in mice, which in turn is prevented by genetic or pharmacological blockade of TLR4 signaling (<xref ref-type="bibr" rid="B81">81</xref>).</p>
<p>Short chain fatty acids can enter the brain through uptake by monocarboxylate transporters at the BBB (<xref ref-type="bibr" rid="B53">53</xref>). In the brain, SCFAs support the maturation and function of microglial cells which are the resident macrophages of the CNS (<xref ref-type="bibr" rid="B26">26</xref>). In a transgenic mouse model of Parkinson’s disease, however, SCFAs trigger a microglia-dependent immune response, enhance α-synuclein aggregation, and elicit movement disturbances (<xref ref-type="bibr" rid="B82">82</xref>). Injected systemically to mice, butyrate induces an antidepressant-like behavioral response which is associated with an increased expression of brain-derived neurotrophic factor (BDNF) (<xref ref-type="bibr" rid="B83">83</xref>). Butyrate is also able to ameliorate the memory decline that develops in aging rats (<xref ref-type="bibr" rid="B84">84</xref>), while administration of propionate to rodents has been shown to evoke behavioral abnormalities reminiscent of autism spectrum disorder (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). These findings indicate that microbiota-derived signaling molecules can have both beneficial and deleterious effects on brain function and behavior, the outcome depending very likely on both microbe and host factors.</p>
<p>While most information on the cerebral impact of PAMP/MAMP-evoked immune stimulation has been derived from animal studies, select microbial metabolites, such as LPS, have also been tested in humans. For instance, intravenous LPS injection in healthy human volunteers increases the circulating levels of IL-6, IL-10, TNF-α, soluble TNF receptor, IL-1 receptor antagonist, and cortisol, which is associated with enhanced body temperature, anxiety, negative mood, decreased memory performance, and hyperalgesia (<xref ref-type="bibr" rid="B87">87</xref>–<xref ref-type="bibr" rid="B90">90</xref>). While these effects are similar to those observed in rodents, the potency of LPS in terms of dose per body weight is &gt;100 times higher in humans (<xref ref-type="bibr" rid="B88">88</xref>). Mechanistic studies have shown that the sickness response elicited by intravenous LPS injection in healthy male humans is associated with microglial activation throughout the brain as observed by positron emission tomography (<xref ref-type="bibr" rid="B91">91</xref>).</p>
<p>Table <xref ref-type="table" rid="T1">1</xref> summarizes a number of studies in which the effects of PAMPs, MAMPs, and some other microbial metabolites on behavior and related molecular changes have been investigated in rodents and humans. In judging the relevance of these effects it is important to take account of the doses studied and the species, strain, and sex of the subjects tested. Males and females differ in both innate and adaptive immune responses (<xref ref-type="bibr" rid="B92">92</xref>) and these sex differences also extend to PAMP/MAMP reactions. For instance, macrophages of male mice express higher levels of TLR4 on their cell surface than those of females, which may explain why male mice respond to LPS with formation of more IL-6 than females (<xref ref-type="bibr" rid="B93">93</xref>). The additive effect of LPS and muramyl dipeptide (MDP) to attenuate locomotion is likewise more pronounced in female than male rats (<xref ref-type="bibr" rid="B94">94</xref>). Similar observations have been made in humans, given that women react to LPS with enhanced release of proinflammatory cytokines, cortisol, and prolactin compared to males (<xref ref-type="bibr" rid="B90">90</xref>). Despite these sex differences, men and women do not differ in LPS-evoked anxiety, mood depression, and sickness, which points to compensatory mechanisms that balance the cerebral impact of the exaggerated immune response in women (<xref ref-type="bibr" rid="B90">90</xref>). Sex differences may also influence the pharmacokinetics and pharmacodynamics of immune responses to microbial metabolites (<xref ref-type="bibr" rid="B95">95</xref>), and the molecular targets and mechanisms of action of PAMPs/MAMPs may considerably differ with dose (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>). This is true for LPS that at the lower dose range induces various dimensions of the sickness reponse as well as depression-like behavior (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>) whereas, at a higher dose range, it causes septic shock.</p>
<sec id="S4-1">
<title>Cytokines As Mediators of LPS-Induced Effects on the Brain</title>
<p>Immune stress signaling across the BBB evokes a neuroinflammatory reaction in the CNS, which contributes to the behavioral disturbances associated with peripheral immune activation. The underlying processes have been most extensively studied with LPS, a PAMP known to target a variety of immune and other cells <italic>via</italic> stimulation of TLR4. At doses &lt;1 mg/kg, LPS reproducibly evokes acute sickness which may evolve into depression-like behavior about 24 h after its injection (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). Chronic exposure to LPS for 8 weeks exerts similar behavioral effects (<xref ref-type="bibr" rid="B100">100</xref>). There is some evidence that LPS may induce neuroinflammation also by a mechanism involving NOD-like receptor pyrin domain-containing protein-3 (NLRP3) inflammasome activation and in this way cause long-term deficits in affective and cognitive behavior (<xref ref-type="bibr" rid="B101">101</xref>). Although the NLRP3 inflammasome inhibitor Ac-Tyr-Val-Ala-Asp-chloromethylketone prevents the LPS-induced effects on brain and behavior (<xref ref-type="bibr" rid="B101">101</xref>), the high dose of LPS used (5 mg/kg) may have caused sepsis-like effects that limit the interpretation of the findings.</p>
<p>Through activation of TLR4, peripheral administration of LPS leads to increased expression of proinflammatory cytokines in the periphery and brain (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B103">103</xref>). Among these proinflammatory cytokines, IL-1β and TNF-α are considered to be the predominant mediators of LPS-induced sickness behavior, while other cytokines, such as IL-6 and IFN-γ, are thought to primarily amplify the effects of IL-1β and TNF-α (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B104">104</xref>). Circulating TNFα and IL-1β interact with their receptors on cerebral endothelial cells (CECs), induce the production of cytokines and other secondary messengers, such as PG and nitric oxide (NO), and thereby modulate CNS function and behavior (<xref ref-type="bibr" rid="B105">105</xref>–<xref ref-type="bibr" rid="B107">107</xref>). Proinflammatory cytokines can also access the brain <italic>via</italic> structures that lack a BBB, such as the circumventricular organs and the choroid plexus, and thus alter brain function (<xref ref-type="bibr" rid="B108">108</xref>). Furthermore, monocyte chemoattractants such as monocyte chemoattractant protein-1 (MCP-1/CCL2), which can be expressed by circumventricular organs or activated microglia in response to proinflammatory cytokines, can promote monocyte migration into the brain (<xref ref-type="bibr" rid="B103">103</xref>).</p>
<p>Peripheral administration of LPS, IL-1β, or TNF-α induces cytokine expression within the brain and leads to the full spectrum of sickness behavior (<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>). However, when both IL-1β and TNF-α are blocked, LPS-induced sickness is attenuated (<xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B111">111</xref>). IL-1β and TNF-α have been demonstrated to exert their behavioral effects <italic>via</italic> activation of the IL-1 receptor of type I (<xref ref-type="bibr" rid="B111">111</xref>) and TNF receptor of type 1 (<xref ref-type="bibr" rid="B112">112</xref>), respectively. Both receptors are expressed on neurons and other cell types of the CNS and have been proposed to impact on behavior ultimately through direct effects on neuronal activity (<xref ref-type="bibr" rid="B104">104</xref>). However, type-1 TNF receptor signaling on astrocytes has been shown to modify hippocampal excitatory synapses and impair contextual learning/memory through an astrocyte–neuron signaling cascade involving presynaptic <italic>N</italic>-methyl-<sc>d</sc>-aspartate (NMDA)-type glutamate receptors containing the NR2B subunit (<xref ref-type="bibr" rid="B113">113</xref>). On the neuronal level, prolonged exposure to TNF-α is able to inhibit long-term potentiation in hippocampal slices (<xref ref-type="bibr" rid="B114">114</xref>). In hippocampal neuronal cultures, TNF-α is able to evoke neuronal excitation through activation of sphingomyelin phosphodiesterase 3 and production of ceramide, an intracellular signaling molecule that leads to NMDA receptor-mediated calcium influx (<xref ref-type="bibr" rid="B115">115</xref>). This process enhances the insertion of NMDA receptors containing NR1 subunits into the cell membrane and increases the rate and amplitude of NMDA-receptor-mediated calcium bursts. In addition, the mitogen-activated protein kinase (MAPK) signaling pathway is stimulated by TNF-α, given that inhibition of c-jun N-terminal kinase blocks TNF-α-induced sickness (<xref ref-type="bibr" rid="B116">116</xref>). The MAPK pathway may also be responsible for the effect of TNF-α to induce depression-like behavior at intracerebroventricular (ICV) doses that are too low to induce signs of sickness (<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B118">118</xref>).</p>
<p>The transduction mechanisms operated by IL-1β in the CNS comprise the MAPK pathway (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>) and inhibition of neuronal long-term potentiation by inhibiting calcium channels (<xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B122">122</xref>) but also induction of neuronal hyperexcitation <italic>via</italic> formation of ceramide (<xref ref-type="bibr" rid="B123">123</xref>). Moreover, activation of the IL-1 receptor stimulates the mTOR pathway and leads to synaptic defects through increased levels of the epigenetic regulator methyl-CpG binding protein 2 (<xref ref-type="bibr" rid="B124">124</xref>). Some of the adverse effects of IL-1β in the brain may also result from its ability to impair long-distance signaling of BDNF by attenuating retrograde endosome trafficking (<xref ref-type="bibr" rid="B125">125</xref>). Unlike IL-1β, acute ICV injection of IL-6 does not induce sickness behavior, although it is able to induce fever and activate the HPA axis (<xref ref-type="bibr" rid="B126">126</xref>). In addition, IL-6 is required for the manifestation of a full sickness response, and genetic deletion of IL-6 blunts the sickness response to LPS and IL-1β (<xref ref-type="bibr" rid="B127">127</xref>). The differences in the behavioral effects of IL-1β and IL-6 have been attributed to the apparent inability of IL-6 to stimulate ceramide synthesis (<xref ref-type="bibr" rid="B104">104</xref>) although IL-6 is able to activate similar signaling pathways as IL-1β and TNF-α, leading to a reinforcement of proinflammatory cytokine formation. There is also information that the induction of IL-6 by LPS may differ from that of other cytokines. Thus, while LPS causes an early stimulation of nuclear factor κB (NF-κB), activation of the transduction factor NF-IL-6, which contributes to the expression of IL-6 (<xref ref-type="bibr" rid="B128">128</xref>), reaches its peak only 8 h post-treatment (<xref ref-type="bibr" rid="B129">129</xref>). An involvement of NF-IL-6 in the delayed inflammatory and behavioral response to LPS has been confirmed by genetic deletion of NF-IL-6, the response being reversed 24 h after LPS treatment (<xref ref-type="bibr" rid="B130">130</xref>).</p>
<p>When used as a treatment for cancer or hepatitis C, IFN-α induces signs of sickness (fatigue, decreased motivation, reduced appetite, altered sleep) in nearly all patients within the first week, later followed by the development of symptoms of major depression (sadness, decreased mood, anhedonia, impaired cognitive function) in 30–50% of the patients (<xref ref-type="bibr" rid="B131">131</xref>). Analysis of potential vulnerability factors has shown that the patients at risk to develop major depression experience a threefold higher increase of circulating ACTH and cortisol levels in response to the first administration of IFN-α than resilient patients (<xref ref-type="bibr" rid="B17">17</xref>). Peripheral (<xref ref-type="bibr" rid="B132">132</xref>) and central (<xref ref-type="bibr" rid="B133">133</xref>) administration of IFN-α to mice causes depression-like behavior (<xref ref-type="bibr" rid="B133">133</xref>), and long-term administration of LPS to rats produces a specific cytokine response in the brain characterized by increased IL-1β and IFN-γ levels (<xref ref-type="bibr" rid="B100">100</xref>). Inoculation of mice with Bacille Calmette–Guérin, an attenuated form of <italic>Mycobacterium bovis</italic>, induces depression-like behavior, an effect that is absent in IFN-γ receptor knockout mice while an acute episode of sickness behavior persists (<xref ref-type="bibr" rid="B134">134</xref>).</p>
</sec>
<sec id="S4-2">
<title>Behavioral Effects of Bacterial PAMPs and MAMPs Other Than LPS</title>
<p>In its effect on the brain, LPS is joined by many bacterial, viral, and fungal PAMPs and MAMPs (Table <xref ref-type="table" rid="T1">1</xref>). Peptidoglycan, for instance, is a cell wall constituent of many bacteria that has been demonstrated to stimulate the innate immune system and modulate behavior. While peptidoglycan is a TLR2 agonist, its fragments γ-<sc>d</sc>-glutamyl-meso-diaminopimelic acid (iE-DAP) and MDP activate the intracellular nucleotide-binding and oligomerization domain (NOD) innate immune receptors NOD1 and NOD2, respectively (<xref ref-type="bibr" rid="B135">135</xref>). Furthermore, the family of antibacterial pattern recognition molecules termed peptidoglycan recognition proteins (PGRPs) typically binds the muramyl pentapeptide, or tetrapeptide fragment of peptidoglycan (<xref ref-type="bibr" rid="B136">136</xref>). In a mechanistic perspective, it is relevant to know that TLR2 can heterodimerize with TLR1 and TLR6, forming TLR2/1 and TLR2/6 heterodimers, respectively. IP injection of the TLR2/6 agonists macrophage-activating lipopeptide-2 or the synthetic analog fibroblast-stimulating lipopeptide-1 induces cytokine release and sickness behavior in rats (<xref ref-type="bibr" rid="B137">137</xref>). Similarly, ICV injection of the TLR2/1 agonist Pam3CSK4 evokes sickness which can be attenuated by NF-κB or COX inhibition with indomethacin (<xref ref-type="bibr" rid="B138">138</xref>). In addition, TLR2/1 activation causes hypothalamic inflammation and microglia activation, increases physical contacts between microglia and proopiomelanocortin (POMC) neurons, and stimulates the activity of POMC neurons (<xref ref-type="bibr" rid="B138">138</xref>). In line with these hypothalamic effects, Pam3CSK4-induced anorexia can be reversed by ICV administration of a melanocortin receptor 3/4 antagonist (<xref ref-type="bibr" rid="B138">138</xref>).</p>
<p>Exposure to peptidoglycan early in life, either during pregnancy or postnatally, has adverse effects on the brain. Intravenous injection of peptidoglycan into pregnant dams traverses the placenta and reaches the fetal brain where it causes marked neuronal proliferation through TLR2/6 agonism (<xref ref-type="bibr" rid="B139">139</xref>). This fetal neuroproliferative response which involves the neuronal nuclear transcription factor FoxG1 is associated with abnormal cognitive behavior in the pups following birth (<xref ref-type="bibr" rid="B139">139</xref>). Exposure of the postnatal mouse brain to the TLR2/1 agonist Pam3CSK4 or TLR2/6 agonist fibroblast-stimulating lipopeptide-1 has a life-long effect on learning and memory, spatial memory being impaired by the TLR2/1 agonist only, while contextual and cued fear learning in adult mice is enhanced by both agonists (<xref ref-type="bibr" rid="B140">140</xref>). Peptidoglycan derived from the gut microbiota can also translocate into the brain and activate cerebral PRRs (<xref ref-type="bibr" rid="B141">141</xref>). Specifically, the levels of peptidoglycan in the developing brain parallel the postnatal microbial colonization of the gut, while peptidoglycan-sensing molecules (TLR2, NODs, PGRPs) are expressed during early postnatal brain development and altered in response to perturbation of the gut microbiota (<xref ref-type="bibr" rid="B141">141</xref>). Knockout of the PGRP 2 is associated with enhanced sociability and alterations in the expression of the autism risk gene <italic>c-Met</italic>, the synaptogenesis marker <italic>Synaptophysin</italic> and <italic>Bdnf</italic> (<xref ref-type="bibr" rid="B141">141</xref>). Germ-free mice are likewise more sociable as reported by the same laboratory (<xref ref-type="bibr" rid="B142">142</xref>), whereas Desbonnet et al. (<xref ref-type="bibr" rid="B143">143</xref>) find decreased sociability in germ-free mice. Besides acting on the brain, peptidoglycan derived from the gut microbiota also impacts on the systemic immune system, given that it stimulates and primes bone marrow-derived neutrophils through NOD1 (<xref ref-type="bibr" rid="B144">144</xref>).</p>
<p>Lipoteichoic acid is a cell wall component of Gram-positive bacteria, which activates primarily TLR2 and in this way causes peripheral immune activation and initiates neuroinflammatory processes in the mouse brain that are associated with downregulation of BBB components and activation of the HPA axis, although emotional behavior is not affected (<xref ref-type="bibr" rid="B97">97</xref>). Many commercial LTA preparations are potentially contaminated with LPS, in which case the biological effects of LTA preparations can in part be attributed to the presence of LPS or a particular interaction between TLR2 and TLR4 activation (<xref ref-type="bibr" rid="B97">97</xref>). Such positive or negative interactions between different PAMPs in their effects on immune system and brain are of pathophysiological relevance because bacteria are usually equipped with a multitude of PAMPs. NOD agonists, for instance, evoke only mild immune stimulation on their own but synergize with LPS and lead to aggravated cytokine expression and sickness behavior (<xref ref-type="bibr" rid="B10">10</xref>). In the colon, however, the interaction of NOD and TLR4 is antagonistic, with NOD2 activation attenuating TLR4-dependent cytokine production and experimental colitis (<xref ref-type="bibr" rid="B145">145</xref>).</p>
<p>While activation of PRRs induces behavioral disturbances, inactivation of these receptors can also cause behavioral deficits. Thus, TLR4 knockout mice exhibit reduced novelty-seeking and social interaction in an approach-avoidance conflict situation, a deficit that can be reversed by administration of GABA into the nucleus accumbens shell which appears to be hyperactivated in response to behavioral testing of TLR4 knockout mice (<xref ref-type="bibr" rid="B146">146</xref>). TLR2 knockout mice display reduced exploratory behavior, impaired spatial learning, and enhanced contextual and cued fear learning (<xref ref-type="bibr" rid="B140">140</xref>). While Park et al. (<xref ref-type="bibr" rid="B147">147</xref>) likewise report cognitive impairment in TLR2 knockout mice, they also observe schizophrenia-like symptoms, such as hyperlocomotion, anxiolytic-like behavior, prepulse inhibition deficits, and social withdrawal. These behavioral perturbations and the associated biochemical alterations (increased p-Akt and p-GSK-3α/β expression) are reversed by antipsychotic drug administration (<xref ref-type="bibr" rid="B147">147</xref>). Double deletion of the <italic>Tlr2</italic> and <italic>Tlr4</italic> genes is associated with decreased exploratory behavior and impaired performance in a visual discrimination reversal task (<xref ref-type="bibr" rid="B148">148</xref>).</p>
</sec>
<sec id="S4-3">
<title>Behavioral Effects of Viral PAMPs</title>
<p>While research on the impact of immune stress on the brain has thus far been focused on bacterial immune stimulants, interest in the contribution of viral immune stimulants is also increasing. It is well recognized that psychological stress can adversely influence the outbreak and recurrence of Herpes simplex virus, human immunodeficiency virus (HIV), and hepatitis C virus (HCV) infections (<xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B150">150</xref>) <italic>via</italic> activation of the HPA axis and sympathetic adrenomedullary system (<xref ref-type="bibr" rid="B151">151</xref>, <xref ref-type="bibr" rid="B152">152</xref>). Vice versa, HIV seropositive patients may suffer from many neuropsychiatric disorders, in particular major depression and dementia (<xref ref-type="bibr" rid="B153">153</xref>). Like HCV (<xref ref-type="bibr" rid="B154">154</xref>), HIV can cross the BBB simply by infecting macrophages that migrate to the brain where the virus leads to neurotoxin-mediated neuronal loss and synaptic damage (<xref ref-type="bibr" rid="B155">155</xref>, <xref ref-type="bibr" rid="B156">156</xref>).</p>
<p>The PAMPs presented by viruses are DNA and RNA molecules as well as surface glycoproteins (<xref ref-type="bibr" rid="B157">157</xref>, <xref ref-type="bibr" rid="B158">158</xref>). Nucleic acids of viral origin are recognized by TLR3, TLR7, TLR8, and TLR9 in endosomal compartments, as well as by RNA helicase retinoic acid-inducible gene-I (RIG-I) and melanoma-differentiation-associated gene 5 (MDA5) found in the cytosol. Receptor stimulation leads to a proinflammatory immune response by activating a battery of transcription factors followed by the production of type I IFNs and other cytokines including IL-1β, IL-6, TNF-α, and IFN-γ, depending on the kind of viral infection (<xref ref-type="bibr" rid="B157">157</xref>, <xref ref-type="bibr" rid="B159">159</xref>–<xref ref-type="bibr" rid="B161">161</xref>). Furthermore, sensing of viral nucleic acids by RIG-I and other PRRs leads to inflammasome formation and activation of caspase-1, resulting in the production of IL-1β and IL-18, enhancement of the antiviral response of the immune system and pyroptosis (<xref ref-type="bibr" rid="B162">162</xref>, <xref ref-type="bibr" rid="B163">163</xref>). The cytokines formed in response to viral infection signal to the brain, evoke sickness behavior and cause other perturbations of brain function and behavior. The effect of the influenza virus to depress food intake in mice, for instance, is attenuated by an IL-1 receptor antagonist (<xref ref-type="bibr" rid="B164">164</xref>). In humans, the plasma levels of IL-1β are elevated in patients suffering from post-viral depression when compared to patients who do not develop post-viral depression (<xref ref-type="bibr" rid="B165">165</xref>).</p>
<p>Polyinosinic:polycytidylic acid (Poly I:C) is a synthetic PAMP that is widely used to study virus-evoked stimulation of the innate immune system, as it specifically mimics dsRNA molecules occurring during the replication of most viruses except negative-strand RNA viruses (<xref ref-type="bibr" rid="B166">166</xref>). Like dsRNA, Poly I:C binds to TLR3 in endosomal compartments (<xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B167">167</xref>) and, to a much lesser extent, to cytosolic RIG-I as well as MDA5 if the molecule contains more than 2,000 base pairs (<xref ref-type="bibr" rid="B168">168</xref>). Systemic Poly I:C administration to rodents induces expression and release of proinflammatory cytokines, especially type I IFNs, IL-6, IL-1β, and TNF-α (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B160">160</xref>), the magnitude of effect being considerably smaller than that evoked by the TLR4 agonist LPS (<xref ref-type="bibr" rid="B169">169</xref>). Since Poly I:C is rapidly degraded by RNases (<xref ref-type="bibr" rid="B170">170</xref>), its prolonged neuroinflammatory and behavioral effects are mediated by the cytokines it induces (<xref ref-type="bibr" rid="B171">171</xref>, <xref ref-type="bibr" rid="B172">172</xref>).</p>
<p>Poly I:C given to adult rodents mimics the acute phase of a viral infection, alters a variety of brain functions and gives rise to a sequence of behavioral alterations (Table <xref ref-type="table" rid="T1">1</xref>). Within 4 h, Poly I:C causes fever and attenuates activity, followed by anxiety-like behavior and anhedonic depression-like behavior that can be observed during the period 24–72 h post-treatment (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B173">173</xref>, <xref ref-type="bibr" rid="B174">174</xref>). In addition, an impairment of working memory and a deficit in contextual fear memory consolidation become manifest (<xref ref-type="bibr" rid="B175">175</xref>, <xref ref-type="bibr" rid="B176">176</xref>). These behavioral perturbations are associated with disruption of the BBB, enhanced expression of indoleamine 2,3-dioxygenase (IDO) in hippocampus and frontal cortex, suppression of hippocampal neurogenesis and decreased expression of BDNF in hippocampus and cortex (<xref ref-type="bibr" rid="B173">173</xref>, <xref ref-type="bibr" rid="B174">174</xref>, <xref ref-type="bibr" rid="B176">176</xref>, <xref ref-type="bibr" rid="B177">177</xref>). In line with the common notion that systemic infection can impair cognitive function, administration of Poly I:C over several days increases amyloid-β<sub>1–42</sub> levels in hippocampal tissues, paralleled by a deficit in hippocampus-dependent learning tasks (<xref ref-type="bibr" rid="B178">178</xref>). Further analysis has revealed that peripheral immune activation by Poly I:C causes dendritic spine loss and impairs dendritic spine formation associated with learning (<xref ref-type="bibr" rid="B179">179</xref>). The resulting deficit in multiple learning tasks in mice is mediated by cells derived from peripheral monocytes and a TNF-α-dependent mechanism but does not require microglial function in the CNS (<xref ref-type="bibr" rid="B179">179</xref>). Furthermore, systemic Poly I:C amplifies brain pathology in the ME7 model of prion disease and accelerates progression of neurodegeneration (<xref ref-type="bibr" rid="B180">180</xref>). In confirmation of the hypothesis that a viral infection during pregnancy is a risk factor for particular neuropsychiatric diseases in the offspring (<xref ref-type="bibr" rid="B181">181</xref>), Poly I:C administration to pregnant rodents has been found to evoke a schizophrenia-like phenotype (<xref ref-type="bibr" rid="B182">182</xref>–<xref ref-type="bibr" rid="B184">184</xref>) as well as depression-like phenotype (<xref ref-type="bibr" rid="B185">185</xref>) in the adult offspring, changes that are associated with hippocampal synaptic deficits in the absence of microglial alterations (<xref ref-type="bibr" rid="B186">186</xref>).</p>
</sec>
<sec id="S4-4">
<title>Signaling Molecules in the Brain Affected by Peripheral Immune Stress</title>
<p>IFN-γ is a strong inducer of the tryptophan-degrading enzyme IDO (<xref ref-type="bibr" rid="B187">187</xref>) which has gained center stage as a factor in cytokine-induced mood disorders. Cytokine-induced activation of IDO causes augmented conversion of tryptophan to kynurenine. While kynurenine itself is inactive, its metabolites, 3-hydroxykynurenine and quinolinic acid exert neurotoxic effects through NMDA receptor agonism and generation of oxidative radicals (<xref ref-type="bibr" rid="B188">188</xref>). By contrast, kynurenic acid, another kynurenine metabolite, is neuroprotective, acting as an antagonist of NMDA and α7 nicotinic acetylcholine receptors (<xref ref-type="bibr" rid="B188">188</xref>). Depressed patients display in fact a reduction of kynurenic acid/3-hydroxykynurenine and/or kynurenic acid/quinolinic acid ratios (<xref ref-type="bibr" rid="B189">189</xref>). Kynurenine levels rise not only in response to proinflammatory cytokines but also in response to corticosteroids, given that multiple mRNA transcripts of IDO are differentially expressed in response to different immune stimulants and corticosteroids (<xref ref-type="bibr" rid="B190">190</xref>). Importantly, the IDO antagonist 1-methyl-<sc>d</sc>,<sc>l</sc>-tryptophan is able to block LPS-induced depression-like behavior, while the levels of proinflammatory cytokines and sickness behavior remain unchanged (<xref ref-type="bibr" rid="B191">191</xref>). In a similar vein, the NMDA receptor antagonist ketamine abrogates LPS-induced depression-like behavior without affecting the sickness response (<xref ref-type="bibr" rid="B192">192</xref>). Ketamine is able to induce rapid antidepressant effects in patients with treatment-refractory depression, highlighting the potential of targeting glutamatergic neurotransmission as a treatment option for depressive disorders (<xref ref-type="bibr" rid="B193">193</xref>).</p>
<p>The sickness behavior evoked by immune stimulation comprises anorexia, a response in which IL-18 plays a role through inhibition of type III GABAergic neurons in the bed nucleus of the stria terminalis (<xref ref-type="bibr" rid="B194">194</xref>). Secretion of the “satiety hormone” leptin in response to LPS also contributes to inflammation-induced anorexia. Thus, leptin deficiency attenuates LPS-induced anorexia, and further analysis has shown that both the PI3K and STAT3 signaling pathways in leptin receptor-expressing cells are required for the acute hypophagic response to LPS (<xref ref-type="bibr" rid="B195">195</xref>). In addition, leptin is involved in cytokine-induced depression, as ICV leptin administration induces depression-like behavior, while leptin antagonism attenuates particular components of this behavioral response (<xref ref-type="bibr" rid="B196">196</xref>). Apart from cytokines and leptin, PGs also mediate some aspects of the sickness in response to immune activation. PGE<sub>2</sub>, for instance, has been implicated in inflammation-induced feelings of malaise and discomfort (<xref ref-type="bibr" rid="B197">197</xref>). An analogous behavioral readout in mice, LPS-induced conditioned place aversion, is mediated through MyD88-dependent activation of CECs, resulting in cyclooxygenase-1 (COX-1)-dependent PGE<sub>2</sub> synthesis. By activating EP<sub>1</sub> receptors on striatal neurons, PGE<sub>2</sub> inhibits a motivational circuitry through GABA-mediated inhibition of dopaminergic neurons (<xref ref-type="bibr" rid="B197">197</xref>).</p>
<p>Cytokines induce a wide range of neurochemical changes in the brain including altered function of monoamine, glutamate, and neuropeptide systems as well as deficits in growth factors such as BDNF (<xref ref-type="bibr" rid="B198">198</xref>). Neuropeptide Y (NPY) signaling <italic>via</italic> Y2 and Y4 receptors has in particular been implicated in the short-and long-term behavioral effects of peripheral immune challenge. Thus, Y2 receptor knockout mice are particularly sensitive to the effects of LPS-evoked immune stress to attenuate locomotion and social interaction and to increase anxiety-like behavior, while the LPS-induced rise of circulating corticosterone is suppressed by Y2 receptor knockout (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). Furthermore, knockout of Y2 and Y4 receptors unmasks the ability of a single LPS injection to cause a delayed and prolonged increase in depression-like behavior, which indicates that NPY signaling conveys resilience to some of the adverse effects of immune stress on the brain (<xref ref-type="bibr" rid="B98">98</xref>). In addition, combined deletion of NPY and PYY aggravates and prolongs the weight loss caused by Bacille Calmette–Guérin, which attests to an important role of NPY and PYY in orchestrating homeostatic reactions to infection and immune stimulation (<xref ref-type="bibr" rid="B199">199</xref>). Changes in serotoninergic and glutamatergic systems seem to be prominently involved in cytokine-induced mood and cognitive symptoms, while the dopamine system has been implicated in symptoms such as fatigue, decreased motivation and altered appetite (<xref ref-type="bibr" rid="B200">200</xref>). Cytokine-induced activation of the enzyme GTP cyclohydrolase I (GTP-CH1) is an important mechanism whereby immune activation affects dopamine and serotonin synthesis. Thus, GTP-CH1 activation inhibits the formation of tetrahydrobiopterin which is an essential co-factor of dopamine and serotonin biosynthesis (<xref ref-type="bibr" rid="B201">201</xref>). In addition, RNA-Seq studies reveal wide ranging changes of the microglial transcriptome associated with depression-like behavior recorded 7 days after peripheral immune activation by Bacille Calmette–Guérin (<xref ref-type="bibr" rid="B202">202</xref>).</p>
<p>Emerging evidence indicates that bioactive lipids, including eicosanoids, endocannabinoids, and specialized pro-resolving mediators (resolvins, maresins, protectins, lipoxins) participate in the regulation of the neuroinflammatory, cerebral and behavioral consequences of immune activation and inflammation (<xref ref-type="bibr" rid="B203">203</xref>). PGs are very likely involved in the development of sickness and depression-like behavior induced by peripheral immune challenge. In particular, PGE<sub>2</sub> is synthesized in the brain in response to a variety of immune signals such as LPS or cytokines, and its administration has been found to evoke sickness behavior through stimulation of EP<sub>2</sub> receptors (<xref ref-type="bibr" rid="B204">204</xref>). Conditional deletion of EP<sub>2</sub> receptors in myeloid linage cells blunts the brain microglial response to systemic LPS injection, which attests to a role of EP<sub>2</sub> receptor stimulation in immune–brain signaling (<xref ref-type="bibr" rid="B205">205</xref>). Chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) is a PG D<sub>2</sub> receptor that is also involved in the behavioral effects of LPS (<xref ref-type="bibr" rid="B206">206</xref>, <xref ref-type="bibr" rid="B207">207</xref>). Inhibition of PG synthesis by nonsteroidal antiinflammatory drugs attenuates the sickness and depression-like behavior induced by LPS, Bacille Calmette–Guérin and interferon-α-2b (<xref ref-type="bibr" rid="B204">204</xref>, <xref ref-type="bibr" rid="B208">208</xref>–<xref ref-type="bibr" rid="B211">211</xref>). Cyclooxygenase-2 inhibitors, particularly celecoxib, have the potential to ameliorate depression in humans, although a meta-analysis of the pertinent clinical trials points out that the subgroup of patients who could benefit from such therapy has not yet been identified (<xref ref-type="bibr" rid="B212">212</xref>).</p>
<p>Endocannabinoids such as 2-arachidonoylglycerol and anandamide constitute another class of lipid mediators that have an impact at several levels of the immune–brain axis (<xref ref-type="bibr" rid="B213">213</xref>). Apart from their inhibitory effect on inflammation in the GI tract (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B213">213</xref>, <xref ref-type="bibr" rid="B214">214</xref>), endocannabinoids influence the responsiveness of vagal and spinal afferent neurons and modify neuronal as well as microglial activity in the CNS. Activation of cannabinoid CB1 receptors which are expressed by visceral afferent neurons in the vagus nerve (<xref ref-type="bibr" rid="B215">215</xref>) blocks the effect of TNF to amplify vagal afferent responsiveness (<xref ref-type="bibr" rid="B216">216</xref>). In the brain, endocannabinoids appear to protect from BBB dysfunction and neuroinflammatory processes under conditions of immune challenge. Such a homeostatic role is, for instance, deduced from the finding that hydrolysis of the endocannabinoid 2-arachidonoylglycerol by monoacylglycerol lipase generates neuroinflammatory PGs in response to peripheral LPS administration (<xref ref-type="bibr" rid="B217">217</xref>, <xref ref-type="bibr" rid="B218">218</xref>). Prevention of the hydrolysis of the endocannabinoid anandamide by an inhibitor of fatty acid amide hydrolyase likewise attenuates the expression of pro- and antiinflammatory cytokines in the frontal cortex and hippocampus of rats following peripheral stimulation of TLR3 (poly I:C) or TLR4 (LPS) and inhibits the LPS-induced anhedonia, but not sickness response (<xref ref-type="bibr" rid="B219">219</xref>, <xref ref-type="bibr" rid="B220">220</xref>). Moreover, deletion of CB2 receptors exacerbates, while CB2 receptor agonism attenuates, stress-induced neuroinflammatory responses in the brain (<xref ref-type="bibr" rid="B221">221</xref>). These observations are in line with the emerging concept that the endocannbinoid system in the brain operates at the intersection between stress, immune activation, neuroinflammation, emotionality, and neuropsychiatric disease (<xref ref-type="bibr" rid="B222">222</xref>, <xref ref-type="bibr" rid="B223">223</xref>).</p>
<p>Specialized pro-resolving mediators, such as resolvins, maresins, protectins, and lipoxins, play not only a role in the resolution of inflammation but also emerge as regulators of neuroinflammatory processes and their impact on brain function and behavior (<xref ref-type="bibr" rid="B203">203</xref>, <xref ref-type="bibr" rid="B224">224</xref>). The antiinflammatory effect of resolvins appears to involve neurons, given that the ability of resolvin D1 (RvD1) to attenuate zymosan-evoked peritonitis in mice depends on the vagus nerve, since vagotomy increases the severity of inflammation (<xref ref-type="bibr" rid="B224">224</xref>). This implication of the vagus nerve appears to be mediated by netrin-1, an axonal guidance molecule (<xref ref-type="bibr" rid="B224">224</xref>). Both RvD1 and resolvin E1 (RvE1) are able to decrease the LPS-evoked expression of proinflammatory cytokines (TNF-α, IL-6, and IL-1β) in microglia cells <italic>in vitro</italic> (<xref ref-type="bibr" rid="B225">225</xref>). The underlying mechanisms differ, however, as RvE1 regulates the NFκB signaling pathway and RvD1 acts via microRNA expression (<xref ref-type="bibr" rid="B225">225</xref>). <italic>In vivo</italic> experiments demonstrate that RvD1 and RvD2 counteract the depressogenic effect of LPS <italic>via</italic> the mammalian target of rapamycin complex 1 signaling pathway, an effect in which the medial prefrontal cortex and dentate gyrus are of particular relevance (<xref ref-type="bibr" rid="B226">226</xref>). A similar antidepressant effect of RvD1 and RvD2 has been observed in the chronic unpredictable stress model (<xref ref-type="bibr" rid="B227">227</xref>). The ability of other specialized pro-resolving mediators such as lipoxins, protectins and maresins to regulate neuroinflammatory processes and behavioral reactions to immune stimulation has not yet been systematically investigated. Systemic administration of lipoxin A4 to mice reduces anxiety-related behavior (<xref ref-type="bibr" rid="B228">228</xref>), and treatment of rats with an analog of lipoxin A4 has been reported to attenuate neuroinflammation in a rat model of ischemic stroke and to promote sensorimotor recovery (<xref ref-type="bibr" rid="B229">229</xref>). Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid present in the brain, and acute ICV infusion of unesterified docosahexaenoic acid protects from LPS-evoked neuroinflammation, an action that involves conversion to specialized pro-resolving mediators such as neuroprotectin D1 (<xref ref-type="bibr" rid="B230">230</xref>).</p>
</sec>
</sec>
<sec id="S5">
<title>Cytokine Hypothesis of Depression</title>
<p>The changes in emotional-affective behavior seen in experimental studies of immune stress and in therapeutic trials of interferon therapy are consistent with the cytokine hypothesis of depression. Following its first formulation as macrophage theory of depression by Smith (<xref ref-type="bibr" rid="B231">231</xref>), proinflammatory cytokines as well as microglial activation and neuroinflammation have been demonstrated to occur not only in depression but also in other psychiatric disorders such as schizophrenia and bipolar disorder (<xref ref-type="bibr" rid="B232">232</xref>–<xref ref-type="bibr" rid="B235">235</xref>). In identifying the precise Research Domain Criteria driven by inflammation it has been recognized that inflammatory processes represent pivotal factors in the psychopathology of symptom dimensions shared by different psychiatric conditions (<xref ref-type="bibr" rid="B200">200</xref>). In testing the therapeutic potential of antiinflammatory agents in depressed patients (<xref ref-type="bibr" rid="B236">236</xref>), the TNF-α blocker infliximab has been found to improve symptoms only in patients with high inflammatory markers, while patients with low levels of peripheral inflammation experience rather negative effects (<xref ref-type="bibr" rid="B237">237</xref>). A similar response pattern has been reported for the treatment with omega-3 fatty acids (<xref ref-type="bibr" rid="B238">238</xref>). Low levels of TLR3 in peripheral blood mononuclear cells of depressed patients also predict therapeutic efficacy of antidepressant drugs while high expression of this PRR is associated with treatment failure (<xref ref-type="bibr" rid="B239">239</xref>). These clinical observations are in part supported by experimental findings that low cytokine concentrations have a positive influence on learning, memory, and synaptic plasticity (<xref ref-type="bibr" rid="B240">240</xref>), that meninges-derived T-cells exert beneficial effects on learning behavior through IL-4 and BDNF expression (<xref ref-type="bibr" rid="B241">241</xref>), and that adaptive immunity of the meninges supports cerebral circuits underlying social behavior through IFN-γ (<xref ref-type="bibr" rid="B242">242</xref>).</p>
</sec>
<sec id="S6">
<title>Implications of the Gut Microbiota in Mood Disorders</title>
<p>The cytokine hypothesis of depression has been extended by an increasing number of observations to suggest that the gut microbiota contributes to the pathogenesis of depression, given that depressed patients may present with a change in the microbial community structure, a disruption of the intestinal barrier and increased endotoxinemia (<xref ref-type="bibr" rid="B243">243</xref>). Depression-associated changes in the gut microbial community have been observed at the phylum level, with either a decrease (<xref ref-type="bibr" rid="B244">244</xref>, <xref ref-type="bibr" rid="B245">245</xref>) or increase (<xref ref-type="bibr" rid="B246">246</xref>) in the relative abundance of <italic>Bacteroidetes</italic>. A decrease in <italic>Bacteroidetes</italic> has also been observed in other disorders of the gut–brain axis such as obesity and irritable bowel syndrome (IBS) (<xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B248">248</xref>), although comorbid depression in IBS patients is not associated with particular alterations in the microbial profile (<xref ref-type="bibr" rid="B249">249</xref>). A causal relationship between gut microbiota and depression has been inferred from the observations that transplantation of fecal microbiota from depressed patients to germ-free or germ-depleted rodents induces a depression-like phenotype in the animals (<xref ref-type="bibr" rid="B245">245</xref>, <xref ref-type="bibr" rid="B250">250</xref>). This transfer of a depression-like pathology is accompanied by an increase in the kynurenine/tryptophan ratio and other inflammation markers (<xref ref-type="bibr" rid="B250">250</xref>) and an altered profile of metabolites involved in carbohydrate and amino acid metabolism (<xref ref-type="bibr" rid="B245">245</xref>).</p>
<p>Given the impact of stress on mood disorders, stress-induced alterations in the commensal microbiota community, GI barrier and GI physiology are increasingly recognized to be relevant to stress-evoked immune activation and behavioral disturbances (<xref ref-type="bibr" rid="B251">251</xref>). It has long been known that stress enhances the permeability of the GI mucosa (<xref ref-type="bibr" rid="B19">19</xref>), and there is now increasing evidence that a dysfunctional intestinal barrier enables microbiota-driven immune activation to impact on the brain (<xref ref-type="bibr" rid="B252">252</xref>). Stress-evoked alterations of the microbial community toward a composition favoring immune stimulation may exacerbate the adverse influence of gut leakiness on the immune–brain interaction. Stress exposure not only disrupts the community structure of the gut microbiota (<xref ref-type="bibr" rid="B253">253</xref>) but also induces translocation of, for instance, <italic>Lactobacillus</italic> spp. to the spleen and primes the innate immune system for enhanced reactivity (<xref ref-type="bibr" rid="B254">254</xref>).</p>
<p>Antibiotic-induced depletion of the intestinal microbiota blocks stress-induced bacterial translocation and, consequently, TLR activation and neuroinflammation in the brain (<xref ref-type="bibr" rid="B255">255</xref>). Antibiotic treatment as well as neutralization of LPS also blunts the formation of the inflammasome-dependent cytokines IL-1β and IL-18 in response to stress, while inflammasome-independent cytokines are not affected (<xref ref-type="bibr" rid="B251">251</xref>). In addition, the depressogenic effect of LPS is attenuated in germ-free mice (<xref ref-type="bibr" rid="B256">256</xref>). Peripheral administration of the IL-6 receptor antibody MR16-1 counteracts the effect of psychosocial stress to disturb the gut microbiota and to evoke depression-like behavior along alterations in dendritic spine density and synaptic protein expression (<xref ref-type="bibr" rid="B257">257</xref>). Taken together with many other findings (<xref ref-type="bibr" rid="B252">252</xref>), it is thus emerging that gut microbiota and gut leakiness represent an important interface in the impact of stress on mood disorders.</p>
</sec>
<sec id="S7">
<title>Impact of Intestinal Inflammation on Brain and Behavior</title>
<p>Ulcerative colitis and Crohn’s disease, the two major manifestations of IBD, are associated with an increased risk of mental disorders and can be exacerbated by stress. The disease impairs the quality of life not only in terms of GI symptoms, discomfort, and pain but also in terms of psychiatric comorbidities. Several mental disorders, including major depression, panic, and generalized anxiety, are more common in IBD patients than in community controls (<xref ref-type="bibr" rid="B258">258</xref>). Moreover, the psychiatric comorbidities can affect disease prognosis and response to treatment, as Crohns’ disease patients with major depression respond poorly to infliximab (<xref ref-type="bibr" rid="B259">259</xref>). In addition, stressful life events are risk factors for IBD development, exacerbation, and relapse (<xref ref-type="bibr" rid="B260">260</xref>). Some of the relationships between GI inflammation and emotional-affective disorders can be studied in experimental models of IBD in rodents. Colitis induced by dextran sulfate sodium (DSS) is immunologically similar to ulcerative colitis, while some immune processes occurring in trinitrobenzene sulfonic acid (TNBS)-induced colitis are reminiscent of those seen in Crohn’s disease (<xref ref-type="bibr" rid="B261">261</xref>). This range of chemically induced models of colonic inflammation is complemented by immunologically provoked paradigms of IBD. Thus, mice deficient in the antiinflammatory cytokine IL-10 (IL-10<sup>−/−</sup>) spontaneously develop a mild, patchy form of colitis which is highly dependent on the composition of the gut microbiota, given that the commensal <italic>Akkermansia muciniphila</italic> is able to induce colitis in IL-10<sup>−/−</sup> mice (<xref ref-type="bibr" rid="B262">262</xref>).</p>
<sec id="S7-1">
<title>Cerebral and Behavioral Disturbances in Experimental Models of Inflammatory Bowel Disease (IBD)</title>
<p>Various experimental models of GI inflammation are associated with alterations in brain function and behavior (Table <xref ref-type="table" rid="T2">2</xref>). While IL-10<sup>−/−</sup> mice have been little studied in this respect, DSS-treated animals exhibit a number of behavioral alterations associated with intestinal inflammation, which have been linked to changes in gut–brain signaling (Table <xref ref-type="table" rid="T2">2</xref>). For instance, mice with DSS-induced colitis are more anxious and less socially interactive than control mice, and these disturbances occur in parallel with increased circulating IL-6, IL-18, and NPY levels as well as with altered <italic>Npy, Bdnf, Cox-2</italic>, and <italic>Mineralocorticoid receptor</italic> gene expression in the brain, which points to an involvement of inflammatory and stress mechanisms in the behavioral perturbations (<xref ref-type="bibr" rid="B263">263</xref>). Moreover, DSS-treated mice display deficits in novel object recognition memory, which can be prevented by a probiotic (<italic>Lactobacillus rhamnosus</italic> R0011 and <italic>Lactobacillus helveticus</italic> R0052) and, thus, may involve a major influence of the GI microbiota on behavioral disturbances during colitis (<xref ref-type="bibr" rid="B264">264</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Effects of gastrointestinal inflammation on emotional-affective and cognitive behavior.</p>
</caption>
<table frame="hsides" rules="rows">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Type of inflammation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Experimental design</th>
<th align="left" colspan="1" rowspan="1" valign="top">Species (sex)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Behavioral effects</th>
<th align="left" colspan="1" rowspan="1" valign="top">Additional effects</th>
<th align="center" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Three 7-day DSS cycles (3.5, 3, 3% w/v in drinking water) with 5-day recovery periods (tap water) in between</td>
<td align="left" colspan="1" rowspan="1" valign="top">AKR mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety</td>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced anxiety prevented by vagotomy and by the probiotic <italic>Bifidobacterium longum</italic> NCC3001 given daily during and after DSS exposure for 14 d</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B64">64</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">11-day exposure to DSS (2% w/v) in drinking water</td>
<td align="left" colspan="1" rowspan="1" valign="top">WT; NPY KO and PYY KO mice on mixed C57BL/6:129/SvJ (1:1) background (male and female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety (male WT); increased depression-like behavior (female WT)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased anxiety (female NPY KO and PYY KO); decreased depression-like behavior (male PYY KO)</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">7-day exposure to DSS (2% w/v) in drinking water</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6N mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety; decreased social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Repeated WAS exposure (7 d) during DSS exposure prevents behavioral deficits</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B263">263</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-day exposure to DSS (5% w/v) in drinking water</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sprague-Dawley rats (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety; increased depression-like behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resiniferatoxin-induced desensitization of colonic TRPV1 channels reverses behavioral deficits</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B265">265</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DSS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">5-day exposure to DSS (3% w/v) in drinking water</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6 mice (male and female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety; decreased novel object recognition memory</td>
<td align="left" colspan="1" rowspan="1" valign="top">Probiotics (mixture of <italic>Lactobacillus rhamnosus</italic> R0011 and <italic>L. helveticus</italic> R0052) administered daily for 7 days before and during DSS exposure) prevent behavioral deficits</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B264">264</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TNBS-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single intrarectal administration of TNBS (10 mg in 50% ethanol)</td>
<td align="left" colspan="1" rowspan="1" valign="top">NMRI mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased depression-like behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nitric oxide synthase inhibition ameliorates depression-like behavior</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B270">270</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Trichuris muris</italic> infection-induced colitis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Single infection with <italic>Trichuris muris</italic> (300 eggs/mouse)</td>
<td align="left" colspan="1" rowspan="1" valign="top">AKR mice (male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased anxiety-like behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">Etanercept, budesonide and the probiotic <italic>Bifidobacterium longum</italic> NCC3001 normalize behavior</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B275">275</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>DSS, dextran sulfate sodium; KO, knockout; NPY, neuropeptide Y; PYY, peptide YY; TNBS, trinitrobenzene sulfonic acid; TRPV1, transient receptor potential vanilloid-1; WAS, water avoidance stress; WT, wildtype</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Besides enhanced anxiety, DSS-treated rodents also display aggravated depression-like behavior, a relationship that appears to be sex dependent (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B265">265</xref>). The increase in anxiety- and depression-like behavior accompanying DSS-evoked colitis in rats is associated with increased firing rates of colonic afferents, which suggests that altered neuronal signaling is a major factor responsible for the colitis-induced behavioral changes (<xref ref-type="bibr" rid="B265">265</xref>). A similar conclusion can be drawn in mice in which DSS-evoked colitis is accompanied by increased anxiety-like behavior only if the vagus nerves are intact (<xref ref-type="bibr" rid="B64">64</xref>). In addition, DSS-evoked colitis alters the activity of central neurons. At the height of inflammation, stress-induced c-Fos expression, a marker of neuronal activation, is blunted throughout the corticolimbic system depending on housing conditions (<xref ref-type="bibr" rid="B266">266</xref>). Moreover, DSS-treated mice exhibit altered stress-associated behavior, increases in brain IL-6 and growth-regulated oncogene-α levels and brain region-specific changes in <italic>corticotropin-releasing factor (Crf), Bdnf</italic>, and <italic>Npy</italic> gene expression (<xref ref-type="bibr" rid="B267">267</xref>). In view of the emerging role of NPY in mediating stress resilience and treating post-traumatic stress disorder (<xref ref-type="bibr" rid="B268">268</xref>, <xref ref-type="bibr" rid="B269">269</xref>) it appears worth investigating whether pharmacological manipulation of the NPY system has therapeutic effects in animal models of IBD which are sensitive to stress exposure.</p>
<p>Cerebral alterations associated with TNBS-induced colitis have been less thoroughly examined, but a relevant study has shown that TNBS-evoked colitis induces behavioral despair in mice (Table <xref ref-type="table" rid="T2">2</xref>), which can be mitigated by inhibition of NO synthase (<xref ref-type="bibr" rid="B270">270</xref>). Potential effects of TNBS-induced colitis on other behavioral dimensions await to be explored, as TNBS-induced colitis has a number of cerebral effects such as increased excitability of hippocampal slices, altered hippocampal glutamatergic transmission and microglial activation, and lowered seizure threshold (<xref ref-type="bibr" rid="B271">271</xref>, <xref ref-type="bibr" rid="B272">272</xref>). These effects appear to be cytokine and microglia dependent, because they are reversed by ICV administration of an anti-TNF-α antibody and minocycline, an inhibitor of microglial activation (<xref ref-type="bibr" rid="B273">273</xref>). In line with these findings, a positron emission tomography and <italic>ex vivo</italic> biodistribution study found increased levels of [<sup>11</sup>C]PBR28, an imaging biomarker of neuroinflammation, in the cerebellum 11 days after induction of colitis, suggesting activation of microglia or infiltration of macrophages in the brain (<xref ref-type="bibr" rid="B274">274</xref>).</p>
<p>Intestinal inflammation can also be triggered by parasites, and infection of mice with <italic>Trichuris muris</italic> has been found not only to cause mild to moderate colonic inflammation but also to elicit anxiety-like behavior (<xref ref-type="bibr" rid="B275">275</xref>). These effects are associated with increased circulating levels of TNF-α, IFN-γ, kynurenine and kynurenine/tryptophan ratio, and decreased hippocampal expression of <italic>Bdnf</italic> (<xref ref-type="bibr" rid="B275">275</xref>). Etanercept and, to a lesser degree, budesonide reduce cytokine and kynurenine levels and normalize behavior (Table <xref ref-type="table" rid="T2">2</xref>) but do not influence <italic>Bdnf</italic> expression. By contrast, the probiotic <italic>Bifidobacterium longum</italic> NCC3001 normalizes both behavior and hippocampal <italic>Bdnf</italic> expression but does not affect circulating cytokine and kynurenine levels. Moreover, the anxiety-like behavior associated with <italic>Trichuris muris</italic> infection persists after vagotomy (<xref ref-type="bibr" rid="B275">275</xref>), unlike the anxiety-like behavior associated with DSS-induced colitis, which is prevented by vagotomy (<xref ref-type="bibr" rid="B64">64</xref>). Thus, the pathways and mechanisms underlying the behavioral perturbations in response to experimental colitis depend on the immunological triggers of GI inflammation.</p>
</sec>
<sec id="S7-2">
<title>Intestinal Inflammation and Visceral Pain</title>
<p>IBD and experimental colitis are frequently linked to visceral and somatic hyperalgesia (<xref ref-type="bibr" rid="B276">276</xref>). Importantly, DSS-induced colitis enhances the spontaneous activity of spinal afferent neurons supplying the rat colon, and reduction of this spontaneous activity by intracolonic administration of lidocaine causes conditioned place preference in DSS-treated but not control rats (<xref ref-type="bibr" rid="B265">265</xref>). This finding indicates that colitis gives rise to continuous abdominal discomfort and not just to hyperalgesia toward acute stimuli (<xref ref-type="bibr" rid="B265">265</xref>). Continuous firing of afferent neurons from the inflamed gut is also likely to explain the increased expression of c-Fos and the enhanced phosphorylation of p42/44 MAPK in the lumbosacral spinal cord that takes place in mice suffering from DSS-induced colitis in the absence of noxious stimulation (<xref ref-type="bibr" rid="B277">277</xref>). Although inflammatory mediators are known to sensitize GI nociceptors, peripheral pain hypersensitivity alone does not explain all pain symptoms in IBD patients as some patients still suffer from pain in remission, and pain is poorly correlated with inflammatory markers (<xref ref-type="bibr" rid="B276">276</xref>, <xref ref-type="bibr" rid="B278">278</xref>). Likewise, under conditions of experimental colitis in rodents, visceral hyperalgesia is not always going in parallel with inflammation. For example, DSS-induced colitis in mice leads to chemical and mechanical visceral hyperalgesia that persists for several weeks post-DSS treatment when intestinal inflammation has already subsided (<xref ref-type="bibr" rid="B279">279</xref>, <xref ref-type="bibr" rid="B280">280</xref>). Similarly, mechanical visceral hyperalgesia associated with TNBS-induced colitis in rats can still be measured at a time when inflammation has resolved (<xref ref-type="bibr" rid="B281">281</xref>). Although a review of GI hyperalgesia mechanisms is beyond the scope of this article, it should not go unnoticed that TRPV1 ion channels play a role in post-inflammatory visceral hyperalgesia, since TRPV1 knockout and TRPV1 blockade prevent the development of mechanical visceral hyperalgesia after colitis (<xref ref-type="bibr" rid="B280">280</xref>, <xref ref-type="bibr" rid="B282">282</xref>).</p>
<p>Chronic pain is a major internal stressor and as such a risk factor for the pathogenesis of anxiety and mood disorders (<xref ref-type="bibr" rid="B283">283</xref>, <xref ref-type="bibr" rid="B284">284</xref>), a relationship that is also true for patients with Crohn’s disease in whom pain is associated with enhanced anxiety (<xref ref-type="bibr" rid="B285">285</xref>). TRPV1 desensitization in DSS-treated rats not only suppresses ongoing activity in spinal afferent neurons but also prevents the development of anxiety- and depression-like behavior associated with DSS-induced colitis (<xref ref-type="bibr" rid="B265">265</xref>). This observation confirms that nociceptive signaling from the colon is an important trigger for secondary changes in the brain that underlie the emotional-affective disturbances induced by experimental colitis.</p>
</sec>
<sec id="S7-3">
<title>Gut Hormone Signaling in Intestinal Inflammation</title>
<p>Apart from immune and inflammatory mediators and nociceptive messages, gut hormones emerge as an important interface between GI inflammation, visceral pain, and perturbations of brain function, and behavior. IBD alters the expression of several GI and circulating gut hormones, including PYY and GLP-1 (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B286">286</xref>–<xref ref-type="bibr" rid="B288">288</xref>), although the data are inconsistent due to heterogeneities in patient selection and assay methodology. Similarly, colonic PYY has been found to be reduced in response to TNBS in rats, while in response to DSS both increased and reduced colonic PYY levels have been reported (<xref ref-type="bibr" rid="B289">289</xref>–<xref ref-type="bibr" rid="B291">291</xref>). PYY can influence not only appetite but also emotional-affective behavior and visceral pain. Genetic deletion of PYY enhances depression-like behavior in mice, whereas anxiety-related behavior stays unaltered (<xref ref-type="bibr" rid="B33">33</xref>). Under conditions of DSS-induced colitis, PYY influences emotional-affective behavior in a sex-dependent manner, because anxiety-like behavior is modified only in female PYY knockout mice while depression-like behavior is altered only in male PYY knockout mice (<xref ref-type="bibr" rid="B33">33</xref>). Acute IP administration of PYY (<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B36">36</xref>) induces schizophrenia-relevant behaviors including a profound impairment of social interaction (<xref ref-type="bibr" rid="B292">292</xref>). PYY is also involved in regulation of pain signaling, given that PYY knockout mice are more sensitive to somatic and visceral pain (<xref ref-type="bibr" rid="B293">293</xref>). In a wider perspective, these findings point to a potential involvement of PYY in the pain and emotional-affective alterations seen in animal models of colitis and IBD patients alike.</p>
<p>Like PYY, GLP-1 also influences emotional-affective behavior as revealed by the anxiogenic effect after acute administration and antidepressant effect after chronic administration of the GLP-1 analog, exendin-4, in rats (<xref ref-type="bibr" rid="B294">294</xref>). Other GLP-1 analogs have been reported to have an analgesic effect in both somatic and visceral pain states: ROSE-010 shows promising results in relieving visceral pain in patients suffering from IBS (<xref ref-type="bibr" rid="B295">295</xref>), while liraglutide suppresses the visceral hyperalgesia induced by LPS or water avoidance stress (WAS) in rats (<xref ref-type="bibr" rid="B296">296</xref>). In addition, intrathecally administered GLP-1 receptor agonists are able to alleviate pain evoked by peripheral nerve injury, bone cancer, and diabetes in rats and formalin-induced pain in rats and mice without affecting acute nociceptive responses (<xref ref-type="bibr" rid="B297">297</xref>). Therefore, PYY, GLP-1, and potentially other gut hormones emerge as targets for the control of GI inflammation, pain, and their relation to brain processes regulating emotion and affect.</p>
</sec>
<sec id="S7-4">
<title>Gut Microbiota, Intestinal Inflammation, and Stress Responsivity</title>
<p>An emerging interface between GI immune system, GI inflammation and brain is posed by the gut microbiota and its multitude of signaling molecules. Germ-free mice display an exaggerated neuroendocrine response to restraint stress (<xref ref-type="bibr" rid="B298">298</xref>), and there is increasing evidence that the GI microbiota plays a role in the impact of stress on gut and brain (<xref ref-type="bibr" rid="B299">299</xref>). Mice lacking any microbiota display enlarged volumes of amygdala, hippocampus, and periaqueductal gray but a decreased volume of the anterior cingulate cortex compared to conventionally colonized mice (<xref ref-type="bibr" rid="B300">300</xref>, <xref ref-type="bibr" rid="B301">301</xref>). These findings, together with marked alterations in brain neurochemistry, brain ultrastructure (<xref ref-type="bibr" rid="B300">300</xref>, <xref ref-type="bibr" rid="B302">302</xref>, <xref ref-type="bibr" rid="B303">303</xref>), brain microglia (<xref ref-type="bibr" rid="B26">26</xref>), and BBB function (<xref ref-type="bibr" rid="B28">28</xref>) may explain why germ-free mice display exaggerated stress responsivity (<xref ref-type="bibr" rid="B298">298</xref>), hyperactivity (<xref ref-type="bibr" rid="B302">302</xref>, <xref ref-type="bibr" rid="B303">303</xref>), and visceral pain hypersensitivity (<xref ref-type="bibr" rid="B301">301</xref>). It would appear that the GI microbiota plays an important role in the development of the gut–brain axis, and that its disruption predisposes to maladaptive stress responsivity and behavioral profile (<xref ref-type="bibr" rid="B299">299</xref>, <xref ref-type="bibr" rid="B304">304</xref>).</p>
<p>As discussed above, SCFAs seem to be important messengers of GI bacteria with a beneficial impact on the brain, and such a role may also be attributed to food, prebiotics, and probiotics that facilitate a physiological community structure of the GI microbiota. The prebiotic sialyllactose, for instance, has been shown to prevent the change in colonic microbiota composition, the increase in anxiety-like behavior and the decrease in hippocampal neurogenesis evoked by social disruption stress in mice (<xref ref-type="bibr" rid="B305">305</xref>). Fructooligosaccharides and galactosaccharides are likewise able to protect mice from the disruption of the microbiota community structure, the enhancement of anxiety- and depression-like behavior, and the rise of the circulating corticosterone concentration elicited by chronic psychosocial stress (<xref ref-type="bibr" rid="B306">306</xref>). The benefical effects of the prebiotics are associated with increased production of SCFAs in the gut (<xref ref-type="bibr" rid="B306">306</xref>).</p>
<p>Despite the clinical observations that stress has an adverse influence on IBD, <italic>predictable</italic> chronic WAS fails to modify the severity of DSS-evoked colitis in the mouse, but prevents colitis-evoked sickness behavior anxiety and disruption of social interaction (<xref ref-type="bibr" rid="B263">263</xref>). This effect of repeated WAS is associated with a rise of circulating corticosterone, an increase in hypothalamic <italic>Npy</italic> expression and a blockade of the colitis-associated induction of c-Fos in thalamus, hypothalamus, amygdala, and prefrontal cortex (<xref ref-type="bibr" rid="B263">263</xref>, <xref ref-type="bibr" rid="B277">277</xref>). Likewise, the ability of colitis to amplify the expression of c-Fos in the lumbosacral spinal cord in response to noxious chemical stimulation of the colon is blunted by repeated WAS (<xref ref-type="bibr" rid="B277">277</xref>). In keeping with this finding, repeated WAS fails to aggravate mechanical and thermal hyperalgesia associated with DSS-induced colitis in mice (<xref ref-type="bibr" rid="B277">277</xref>) much as it fails to exacerbate visceral hyperalgesia associated with TNBS-induced colitis in rats (<xref ref-type="bibr" rid="B307">307</xref>). Taken together, these observations provide an explanation for the resilience effect of predictable chronic stress and show that the immune stress associated with experimental colitis alters not only brain function but also the cerebral processing of psychological stress and its impact on behavior. In addition, the influence of GI inflammation on stress processing in the brain is modified by environmental conditions, given that environmental enrichment appears to improve stress resilience as deduced from region-specific changes in the activity of the central amygdala, hippocampus, and infralimbic cortex (<xref ref-type="bibr" rid="B266">266</xref>).</p>
</sec>
</sec>
<sec id="S8">
<title>The Circle Completed: The Stressed Brain Facilitates Immune Activation and Inflammation in the Gut</title>
<sec id="S8-1">
<title>Adverse and Beneficial Effects of Stress on Intestinal Inflammation</title>
<p>Psychosocial stress is known to trigger disease exacerbation and relapses of IBD as well as IBS, a relationship that has been confirmed in animal models of GI inflammation (<xref ref-type="bibr" rid="B308">308</xref>). For instance, restraint stress amplifies the severity of colitis in IL-10<sup>−/−</sup> mice as revealed by histopathology, increased expression of proinflammatory cytokines, and aggravated loss of body weight (<xref ref-type="bibr" rid="B309">309</xref>). Likewise, neonatal maternal separation stress enhances the permeability of the colonic mucosa both in wildtype and IL-10<sup>−/−</sup> mice, but colitis develops only in IL-10<sup>−/−</sup> mice (<xref ref-type="bibr" rid="B310">310</xref>), which attests to the multifactorial pathogenesis of chronic GI inflammation (<xref ref-type="bibr" rid="B311">311</xref>). DSS-treated mice exposed to chronic restraint stress (<xref ref-type="bibr" rid="B312">312</xref>), repeated psychological stress (<xref ref-type="bibr" rid="B313">313</xref>), repeated WAS (<xref ref-type="bibr" rid="B314">314</xref>), or a combination of repeated social defeat stress and overcrowding (<xref ref-type="bibr" rid="B315">315</xref>) also present with enhanced colonic inflammation scores, lowered body weight, and increased proinflammatory cytokine levels. Similarly, TNBS-induced colitis is aggravated after exposure to various stressors (<xref ref-type="bibr" rid="B316">316</xref>–<xref ref-type="bibr" rid="B319">319</xref>), which demonstrates an adverse impact of stress on disease course and severity. However, the outcome of the interaction between stress and GI inflammation is variable, depending on the type and duration of stress, the type of experimental inflammation and the experimental design. Repeated WAS, for example, has been shown to be without effect on acute and chronic DSS-induced colonic inflammation, on the one hand (<xref ref-type="bibr" rid="B263">263</xref>, <xref ref-type="bibr" rid="B320">320</xref>), but to reactivate a quiescent chronic inflammation after exposure to DSS, on the other hand (<xref ref-type="bibr" rid="B314">314</xref>).</p>
<p>By contrast, there are also studies attesting to an ameliorating effect of stress on colonic inflammation. Cakir et al. (<xref ref-type="bibr" rid="B321">321</xref>) and Gülpinar et al. (<xref ref-type="bibr" rid="B322">322</xref>) both report that colitis severity is attenuated if animals are exposed to WAS during colitis induction, or if they are subjected to a controllable electric shock prior to colitis induction, respectively. In contrast to other experiments, these two studies used a single acute stressor, which raises the hypothesis that the acutely stressed brain and body are able to suppress inflammation. In fact, high concentrations of glucocorticoids released by the acute stress exposure are very likely responsible for the antiinflammatory action of stress, as deduced from the antagonistic effects of a glucocorticoid receptor antagonist (<xref ref-type="bibr" rid="B321">321</xref>, <xref ref-type="bibr" rid="B322">322</xref>) and a CRF receptor antagonist (<xref ref-type="bibr" rid="B322">322</xref>). In line with this contention, chemical stimulation of the paraventricular hypothalamic nucleus, the major source of brain CRF, with glutamic acid alleviates TNBS-evoked colitis as measured by reduced colonic damage scores and blunted colonic levels of IL-6 and IL-17 (<xref ref-type="bibr" rid="B323">323</xref>).</p>
<p>In some animal studies, chronic stress <italic>per se</italic> has been shown to provoke the development of spontaneous colitis. In mice exposed to chronic subordinate colony housing, the colon displays an increased histological damage score, a higher number of inflammatory cells, and increased cytokine secretion (<xref ref-type="bibr" rid="B324">324</xref>, <xref ref-type="bibr" rid="B325">325</xref>). Similar findings have been obtained in mice exposed to repeated social interaction stress, in which body weight loss, increased circulating cytokine levels and signs of colonic damage were observed (<xref ref-type="bibr" rid="B326">326</xref>). Changes in both glucocorticoid and cytokine signaling appear to be involved in the disease onset, but the relative importance of peripheral and central mechanisms remains to be investigated. It is not known whether chronic psychological stress may also trigger GI inflammation in humans. There are only some case reports that extensive physical stress such as that experienced by long-distance runners may give rise to reversible ischemic colitis (<xref ref-type="bibr" rid="B327">327</xref>, <xref ref-type="bibr" rid="B328">328</xref>).</p>
</sec>
<sec id="S8-2">
<title>Mechanisms Involved in the Impact of Stress on the Gut</title>
<p>Psychosocial stress acts primarily on the brain and disturbs brain function in many ways (<xref ref-type="bibr" rid="B329">329</xref>), and these cerebral perturbations can adversely affect many peripheral organs, including the GI tract (Figure <xref ref-type="fig" rid="F2">2</xref>). Exposure to stress alters not only the activity of the HPA axis and its adrenocortical hormonal system but also that of the parasympathetic nervous system, the sympathetic nervous system, and the sympathetic adrenomedullary hormonal system (Figure <xref ref-type="fig" rid="F2">2</xref>). The HPA axis appears to be the most important stress response system (<xref ref-type="bibr" rid="B330">330</xref>) and represents a particularly important interface between stress and the gut, with CRF as a mediator operating both in the brain and GI tract (<xref ref-type="bibr" rid="B331">331</xref>). Glucocorticoids released from the adrenal cortex (cortisol in humans, corticosterone in rodents) dampen immune processes and are likely to interfere with immunological processes during stress. In addition, glucocorticoids can also induce non-neuronal catecholamine enzymes (<xref ref-type="bibr" rid="B332">332</xref>) which may add to the multiple signaling mechanisms of chronic stress exposure.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>The circle completed: bidirectional communication between gut and brain under conditions of stress. The stressed brain facilitates immune activation and inflammation in the gut, while immune stress in the gut and periphery feeds back to the brain.</p>
</caption>
<graphic xlink:href="fimmu-08-01613-g002"></graphic>
</fig>
<p>Both physical and psychological stressors cause formation of proinflammatory cytokines in the periphery (<xref ref-type="bibr" rid="B333">333</xref>), which may be due to “sterile inflammation” (<xref ref-type="bibr" rid="B334">334</xref>). In this process, damage-associated molecular pattern molecules, such as heat shock protein-72, uric acid, and ATP activate various PRRs (TLRs, NODs) that stimulate cytokine production (<xref ref-type="bibr" rid="B334">334</xref>). Importantly, there are individual differences in the sensitivity of the peripheral immune system that predict vulnerability to social stress (<xref ref-type="bibr" rid="B335">335</xref>). Specifically, IL-6 is most highly upregulated in mice that respond to chronic stress with exaggerated social avoidance behavior, whereas IL-6 knockout mice as well as mice treated with an IL-6 monoclonal antibody are resilient to social stress (<xref ref-type="bibr" rid="B335">335</xref>). These findings may have a bearing on stress-related psychiatric disorders as patients with treatment-resistant major depression display highly elevated serum levels of IL-6 (<xref ref-type="bibr" rid="B335">335</xref>).</p>
<p>In the gut, stress leads to disruption of mucosal tight junctions, which enhances mucosal permeability, facilitates microbial translocation, induces an immune response, and promotes inflammation (<xref ref-type="bibr" rid="B19">19</xref>). In addition, stress disrupts the community structure of the gut microbiota (<xref ref-type="bibr" rid="B253">253</xref>), which also weakens the mucosal barrier. The paracellular permeability through tight junctions of the GI mucosa is under the control of myosin light chain kinase (MLCK) which is involved in cytoskeletal regulation. MLCK can be activated by cytokines such as TNF-α, which enhances tight junction permeability by actomyosin contraction and reorganization of the tight junction (<xref ref-type="bibr" rid="B19">19</xref>). ML-7, a specific MLCK inhibitor, is able to blunt the increase of colonic paracellular permeability and the rise of LPS, ACTH, and corticosterone plasma levels evoked by partial restraint stress in rats (<xref ref-type="bibr" rid="B336">336</xref>).</p>
<p>CRF and NPY have proved to be important mediators of stress-related brain–gut interactions because both peptides occur at multiple sites in the gut and brain and affect various functions in both organ systems (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B331">331</xref>, <xref ref-type="bibr" rid="B337">337</xref>). CRF, for instance, participates in the stress-evoked inhibition of upper GI transit and stimulation of colonic motility (<xref ref-type="bibr" rid="B331">331</xref>). NPY serves a proinflammatory role in the gut, while cerebral NPY protects against distinct disturbances in response to immune challenge, enforcing stress resilience both in brain and periphery (<xref ref-type="bibr" rid="B337">337</xref>, <xref ref-type="bibr" rid="B338">338</xref>). During restraint stress, fecal pellet output is significantly increased in mice deficient in NPY or the gut hormone PYY, relative to wildtype mice (<xref ref-type="bibr" rid="B338">338</xref>, <xref ref-type="bibr" rid="B339">339</xref>). CRF<sub>1</sub> receptor blockade reduces defecation in wildtype and NPY knockout mice but has no effect in PYY knockout mice (<xref ref-type="bibr" rid="B338">338</xref>). Endogenous NPY and PYY thus appear to inhibit the colonic motor stimulation evoked by stress, the effect of NPY depending on endogenous CRF acting via CRF<sub>1</sub> receptors (<xref ref-type="bibr" rid="B338">338</xref>).</p>
</sec>
</sec>
<sec id="S9">
<title>Translational Implications</title>
<p>The information reviewed here reveals a bidirectional interplay between stress and the immune system, which is particularly obvious in the complex relationship between the GI immune system and the CNS. Psychosomatic medicine has long known that the digestive system is a preferred target of somatoform manifestations of stress. This is not, however, the end of the story. The stress-evoked disturbance of GI function, in which the cross-talk between the gut microbiota and the local immune system is of particular relevance, is signaled back to the CNS and may cause further disturbances of brain function. Thus, the impact of stress on the gut initiates a vicious cycle that is composed of both a brain–gut and gut–brain segment, the two segments being connected in the gut <italic>via</italic> the microbiota-immune network (Figure <xref ref-type="fig" rid="F2">2</xref>). This integrated view is important to consider in order to appreciate the mutual relationship between “stress and immunity” in a broad perspective.</p>
<p>The research we have reviewed here focusses on the impact of peripheral immune stress on the brain, given that a dysbalance of gut microbiota-immune homeostasis is thought to have a bearing on many neuropsychiatric disorders including Parkinson’s disease, multiple sclerosis, autism spectrum disorder, anxiety disorders, chronic fatigue syndrome, IBS, major depressive disorder, and cognitive decline (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B250">250</xref>, <xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B299">299</xref>). Although research involving animal models provides compelling evidence for a causal relationship in an increasing number of instances, most evidence obtained from clinical studies is still of an associative nature. Thus, there is an appreciable gap in the translation of basic research to clinical applications across different microbe and host species. In addition, nutritional, environmental, genetic, epigenetic, and physiological factors will shape the microbiota-immune network in rodents in a quite different manner than that of humans. Furthermore, we still know little about the resilience of this GI network under changes of the external and internal environment, given that a disturbance of microbiota-immune homeostasis represents itself a local stress scenario.</p>
<p>The pathways along which peripheral immune stress is communicated to the brain are multifactorial, comprising both circulating molecules (microbe-derived molecules, immune mediators, gut hormones) and neuronal messengers. Through these signaling systems, several transmitter and neuropeptide systems within the brain are altered, enabling adaptive processes related to stress coping and resilience to take place or, if these measures are exhausted, giving rise to various CNS pathologies. Particular microbe-derived molecules (e.g., SCFAs), immune mediators (e.g., cytokines), and CNS messengers (e.g., neurotrophic factors, NPY) may play a particular role in determining whether inputs from the gut have a beneficial or deleterious effect on the brain. Dissection of the complex information flow from gut to brain will help identifying biomarkers of immune processes that carry a risk to stress the brain and unfold novel opportunities for therapeutic intervention.</p>
</sec>
<sec id="S10">
<title>Author Contributions</title>
<p>PH conceived the article layout, wrote part of the review, integrated the parts written by the coauthors, and approved the final manuscript. AF, AMH, GZ, AJ, and FR assisted in the article layout, wrote part of the review, created the tables and figures, and approved the final manuscript.</p>
</sec>
<sec id="S11">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer CJ and handling Editor declared their shared affiliation.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Work in the authors’ laboratory was supported by the Austrian Science Fund (FWF grants P23097-B18, P25912-B23, and W1241-B18) and the Austrian Research Promotion Agency (FFG) within the CBmed K1 Competence Centre.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>JL</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>. <source/>Nat Rev Immunol (<year>2009</year>) <volume>9</volume>:<fpage>313</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1038/nri2515</pub-id><pub-id pub-id-type="pmid">19343057</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lathrop</surname><given-names>SK</given-names></name><name><surname>Bloom</surname><given-names>SM</given-names></name><name><surname>Rao</surname><given-names>SM</given-names></name><name><surname>Nutsch</surname><given-names>K</given-names></name><name><surname>Lio</surname><given-names>CW</given-names></name><name><surname>Santacruz</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Peripheral education of the immune system by colonic commensal microbiota</article-title>. <source/>Nature (<year>2011</year>) <volume>478</volume>:<fpage>250</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature10434</pub-id><pub-id pub-id-type="pmid">21937990</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Seo</surname><given-names>SU</given-names></name><name><surname>Chen</surname><given-names>GY</given-names></name><name><surname>Núñez</surname><given-names>G</given-names></name></person-group>. <article-title>Role of the gut microbiota in immunity and inflammatory disease</article-title>. <source/>Nat Rev Immunol (<year>2013</year>) <volume>13</volume>:<fpage>321</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1038/nri3430</pub-id><pub-id pub-id-type="pmid">23618829</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Kolodziejczyk</surname><given-names>AA</given-names></name><name><surname>Thaiss</surname><given-names>CA</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name></person-group>. <article-title>Dysbiosis and the immune system</article-title>. <source/>Nat Rev Immunol (<year>2017</year>) <volume>17</volume>:<fpage>219</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2017.7</pub-id><pub-id pub-id-type="pmid">28260787</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name></person-group>. <article-title>Neuroimmune pharmacological approaches</article-title>. <source/>Curr Opin Pharmacol (<year>2015</year>) <volume>25</volume>:<fpage>13</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1007/s11481-017-9738-5</pub-id><pub-id pub-id-type="pmid">26426677</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>AJ</given-names></name></person-group>. <article-title>Infection as a stressor: a cytokine-mediated activation of the hypothalamo-pituitary-adrenal axis?</article-title>
<source/>Ciba Found Symp (<year>1993</year>) <volume>172</volume>:<fpage>226</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">8491088</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>AJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ando</surname><given-names>T</given-names></name></person-group>. <article-title>Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress</article-title>. <source/>Adv Exp Med Biol (<year>1999</year>) <volume>461</volume>:<fpage>117</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1007/978-0-585-37970-8_8</pub-id><pub-id pub-id-type="pmid">10442171</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Herzog</surname><given-names>H</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice</article-title>. <source/>Neuropharmacology (<year>2008</year>) <volume>55</volume>:<fpage>117</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.05.004</pub-id><pub-id pub-id-type="pmid">18508096</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>ML</given-names></name><name><surname>Mustafa</surname><given-names>T</given-names></name><name><surname>Eiden</surname><given-names>AM</given-names></name><name><surname>Herkenham</surname><given-names>M</given-names></name><name><surname>Eiden</surname><given-names>LE</given-names></name></person-group>. <article-title>PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress</article-title>. <source/>Psychoneuroendocrinology (<year>2013</year>) <volume>38</volume>:<fpage>702</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.09.006</pub-id><pub-id pub-id-type="pmid">23062748</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Meinitzer</surname><given-names>A</given-names></name><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>AM</given-names></name><etal></etal></person-group>
<article-title>Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>44</volume>:<fpage>106</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2014.08.011</pub-id><pub-id pub-id-type="pmid">25218901</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Wiertelak</surname><given-names>EP</given-names></name><name><surname>Goehler</surname><given-names>LE</given-names></name><name><surname>Smith</surname><given-names>KP</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name></person-group>. <article-title>Characterization of cytokine-induced hyperalgesia</article-title>. <source/>Brain Res (<year>1994</year>) <volume>654</volume>:<fpage>15</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/0006-8993(94)91566-0</pub-id><pub-id pub-id-type="pmid">7982088</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieczorek</surname><given-names>M</given-names></name><name><surname>Swiergiel</surname><given-names>AH</given-names></name><name><surname>Pournajafi-Nazarloo</surname><given-names>H</given-names></name><name><surname>Dunn</surname><given-names>AJ</given-names></name></person-group>. <article-title>Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice</article-title>. <source/>Physiol Behav (<year>2005</year>) <volume>85</volume>:<fpage>500</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.physbeh.2005.05.012</pub-id><pub-id pub-id-type="pmid">15996692</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frenois</surname><given-names>F</given-names></name><name><surname>Moreau</surname><given-names>M</given-names></name><name><surname>O’Connor</surname><given-names>J</given-names></name><name><surname>Lawson</surname><given-names>M</given-names></name><name><surname>Micon</surname><given-names>C</given-names></name><name><surname>Lestage</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior</article-title>. <source/>Psychoneuroendocrinology (<year>2007</year>) <volume>32</volume>:<fpage>516</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2007.03.005</pub-id><pub-id pub-id-type="pmid">17482371</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Freund</surname><given-names>GG</given-names></name><name><surname>Johnson</surname><given-names>RW</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name></person-group>. <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain</article-title>. <source/>Nat Rev Neurosci (<year>2008</year>) <volume>9</volume>:<fpage>46</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1038/nrn2297</pub-id><pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name></person-group>. <article-title>Immune system to brain signaling: neuropsychopharmacological implications</article-title>. <source/>Pharmacol Ther (<year>2011</year>) <volume>130</volume>:<fpage>226</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.01.014</pub-id><pub-id pub-id-type="pmid">21334376</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goehler</surname><given-names>LE</given-names></name><name><surname>Gaykema</surname><given-names>RPA</given-names></name><name><surname>Hansen</surname><given-names>MK</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name></person-group>. <article-title>Vagal immune-to-brain communication: a visceral chemosensory pathway</article-title>. <source/>Auton Neurosci (<year>2000</year>) <volume>85</volume>:<fpage>49</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1016/S1566-0702(00)00219-8</pub-id><pub-id pub-id-type="pmid">11189026</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Raison</surname><given-names>CL</given-names></name><name><surname>Musselman</surname><given-names>DL</given-names></name><name><surname>Lawson</surname><given-names>DH</given-names></name><name><surname>Nemeroff</surname><given-names>CB</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name></person-group>
<article-title>Association of exaggerated HPA axis response to the initial injection of interferon-α with development of depression during interferon-α therapy</article-title>. <source/>Am J Psychiatry (<year>2003</year>) <volume>160</volume>:<fpage>1342</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1176/appi.ajp.160.7.1342</pub-id><pub-id pub-id-type="pmid">12832253</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sender</surname><given-names>R</given-names></name><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Milo</surname><given-names>R</given-names></name></person-group>. <article-title>Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans</article-title>. <source/>Cell (<year>2016</year>) <volume>164</volume>:<fpage>337</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.01.013</pub-id><pub-id pub-id-type="pmid">26824647</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Punder</surname><given-names>K</given-names></name><name><surname>Pruimboom</surname><given-names>L</given-names></name></person-group>. <article-title>Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability</article-title>. <source/>Front Immunol (<year>2015</year>) <volume>6</volume>:<fpage>223</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00223</pub-id><pub-id pub-id-type="pmid">26029209</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>KR</given-names></name><name><surname>Halliday</surname><given-names>MI</given-names></name><name><surname>Barclay</surname><given-names>GR</given-names></name><name><surname>Milne</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Stephens</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Significance of systemic endotoxaemia in inflammatory bowel disease</article-title>. <source/>Gut (<year>1995</year>) <volume>36</volume>:<fpage>897</fpage>–<lpage>901</lpage>.<pub-id pub-id-type="doi">10.1136/gut.36.6.897</pub-id><pub-id pub-id-type="pmid">7615280</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harte</surname><given-names>AL</given-names></name><name><surname>da Silva</surname><given-names>NF</given-names></name><name><surname>Creely</surname><given-names>SJ</given-names></name><name><surname>McGee</surname><given-names>KC</given-names></name><name><surname>Billyard</surname><given-names>T</given-names></name><name><surname>Youssef-Elabd</surname><given-names>EM</given-names></name><etal></etal></person-group>
<article-title>Elevated endotoxin levels in non-alcoholic fatty liver disease</article-title>. <source/>J Inflamm (Lond) (<year>2010</year>) <volume>7</volume>:<fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1476-9255-7-15</pub-id><pub-id pub-id-type="pmid">20353583</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Mihaylova</surname><given-names>I</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name></person-group>. <article-title>Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of Gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability</article-title>. <source/>J Affect Disord (<year>2007</year>) <volume>99</volume>:<fpage>237</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.jad.2006.08.021</pub-id><pub-id pub-id-type="pmid">17007934</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name></person-group>
<article-title>The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression</article-title>. <source/>Neuro Endocrinol Lett (<year>2008</year>) <volume>29</volume>:<fpage>117</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">18283240</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emanuele</surname><given-names>E</given-names></name><name><surname>Orsi</surname><given-names>P</given-names></name><name><surname>Boso</surname><given-names>M</given-names></name><name><surname>Broglia</surname><given-names>D</given-names></name><name><surname>Brondino</surname><given-names>N</given-names></name><name><surname>Barale</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Low-grade endotoxemia in patients with severe autism</article-title>. <source/>Neurosci Lett (<year>2010</year>) <volume>471</volume>:<fpage>162</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2010.01.033</pub-id><pub-id pub-id-type="pmid">20097267</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kell</surname><given-names>DB</given-names></name><name><surname>Pretorius</surname><given-names>E</given-names></name></person-group>. <article-title>On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death</article-title>. <source/>Integr Biol (Camb) (<year>2015</year>) <volume>7</volume>:<fpage>1339</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1039/c5ib00158g</pub-id><pub-id pub-id-type="pmid">26345428</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erny</surname><given-names>D</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>AL</given-names></name><name><surname>Jaitin</surname><given-names>D</given-names></name><name><surname>Wieghofer</surname><given-names>P</given-names></name><name><surname>Staszewski</surname><given-names>O</given-names></name><name><surname>David</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat Neurosci (<year>2015</year>) <volume>18</volume>:<fpage>965</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1038/nn.4030</pub-id><pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooks</surname><given-names>MG</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name></person-group>. <article-title>Gut microbiota, metabolites and host immunity</article-title>. <source/>Nat Rev Immunol (<year>2016</year>) <volume>16</volume>:<fpage>341</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2016.42</pub-id><pub-id pub-id-type="pmid">27231050</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braniste</surname><given-names>V</given-names></name><name><surname>Al-Asmakh</surname><given-names>M</given-names></name><name><surname>Kowal</surname><given-names>C</given-names></name><name><surname>Anuar</surname><given-names>F</given-names></name><name><surname>Abbaspour</surname><given-names>A</given-names></name><name><surname>Tóth</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>. <source/>Sci Transl Med (<year>2014</year>) <volume>6</volume>:<fpage>263ra158</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id><pub-id pub-id-type="pmid">25411471</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname><given-names>JJ</given-names></name></person-group>. <article-title>The physiology of glucagon-like peptide 1</article-title>. <source/>Physiol Rev (<year>2007</year>) <volume>87</volume>:<fpage>1409</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1152/physrev.00034.2006</pub-id><pub-id pub-id-type="pmid">17928588</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>BS</given-names></name><name><surname>Shaito</surname><given-names>A</given-names></name><name><surname>Motoike</surname><given-names>T</given-names></name><name><surname>Rey</surname><given-names>FE</given-names></name><name><surname>Backhed</surname><given-names>F</given-names></name><name><surname>Manchester</surname><given-names>JK</given-names></name><etal></etal></person-group>
<article-title>Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2008</year>) <volume>105</volume>:<fpage>16767</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0808567105</pub-id><pub-id pub-id-type="pmid">18931303</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindels</surname><given-names>LB</given-names></name><name><surname>Dewulf</surname><given-names>EM</given-names></name><name><surname>Delzenne</surname><given-names>NM</given-names></name></person-group>. <article-title>GPR43/FFA2: physiopathological relevance and therapeutic prospects</article-title>. <source/>Trends Pharmacol Sci (<year>2013</year>) <volume>34</volume>:<fpage>226</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.tips.2013.02.002</pub-id><pub-id pub-id-type="pmid">23489932</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name></person-group>. <article-title>Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis</article-title>. <source/>Neuropeptides (<year>2012</year>) <volume>46</volume>:<fpage>261</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1016/j.npep.2012.08.005</pub-id><pub-id pub-id-type="pmid">22979996</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Herzog</surname><given-names>H</given-names></name><name><surname>Sperk</surname><given-names>G</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y</article-title>. <source/>Br J Pharmacol (<year>2011</year>) <volume>163</volume>:<fpage>1302</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01326.x</pub-id><pub-id pub-id-type="pmid">21410462</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name></person-group>. <article-title>Neuropeptides and the microbiota-gut-brain axis</article-title>. <source/>Adv Exp Med Biol (<year>2014</year>) <volume>817</volume>:<fpage>195</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-4939-0897-4_9</pub-id><pub-id pub-id-type="pmid">24997035</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duca</surname><given-names>FA</given-names></name><name><surname>Swartz</surname><given-names>TD</given-names></name><name><surname>Sakar</surname><given-names>Y</given-names></name><name><surname>Covasa</surname><given-names>M</given-names></name></person-group>. <article-title>Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota</article-title>. <source/>PLoS One (<year>2012</year>) <volume>7</volume>:<fpage>e39748</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0039748</pub-id><pub-id pub-id-type="pmid">22768116</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Finger</surname><given-names>BC</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>Ghrelin signalling and obesity: at the interface of stress, mood and food reward</article-title>. <source/>Pharmacol Ther (<year>2012</year>) <volume>135</volume>:<fpage>316</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2012.06.004</pub-id><pub-id pub-id-type="pmid">22749794</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queipo-Ortuño</surname><given-names>MI</given-names></name><name><surname>Seoane</surname><given-names>LM</given-names></name><name><surname>Murri</surname><given-names>M</given-names></name><name><surname>Pardo</surname><given-names>M</given-names></name><name><surname>Gomez-Zumaquero</surname><given-names>JM</given-names></name><name><surname>Cardona</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels</article-title>. <source/>PLoS One (<year>2013</year>) <volume>8</volume>:<fpage>e65465</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0065465</pub-id><pub-id pub-id-type="pmid">23724144</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname><given-names>T</given-names></name><name><surname>O’Farrell</surname><given-names>LS</given-names></name><name><surname>Syed</surname><given-names>SK</given-names></name><name><surname>Briere</surname><given-names>DA</given-names></name><name><surname>Beavers</surname><given-names>LS</given-names></name><name><surname>Dubois</surname><given-names>SL</given-names></name><etal></etal></person-group>
<article-title>Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY</article-title>. <source/>Endocrinology (<year>2013</year>) <volume>154</volume>:<fpage>45</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1210/en.2012-1446</pub-id><pub-id pub-id-type="pmid">23142807</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>GW</given-names></name><name><surname>Leslie</surname><given-names>FC</given-names></name><name><surname>McLaughlin</surname><given-names>JT</given-names></name></person-group>. <article-title>Crohn’s disease affecting the small bowel is associated with reduced appetite and elevated levels of circulating gut peptides</article-title>. <source/>Clin Nutr (<year>2013</year>) <volume>32</volume>:<fpage>404</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/j.clnu.2012.08.024</pub-id><pub-id pub-id-type="pmid">22999064</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>R</given-names></name><name><surname>Hiniker</surname><given-names>A</given-names></name><name><surname>Kuo</surname><given-names>YM</given-names></name><name><surname>Nussbaum</surname><given-names>RL</given-names></name><name><surname>Liddle</surname><given-names>RA</given-names></name></person-group>. <article-title>α-Synuclein in gut endocrine cells and its implications for Parkinson’s disease</article-title>. <source/>JCI Insight (<year>2017</year>) <volume>2</volume>:<fpage>92295</fpage>.<pub-id pub-id-type="doi">10.1172/jci.insight.92295</pub-id><pub-id pub-id-type="pmid">28614796</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>BC</given-names></name><name><surname>Chaudhri</surname><given-names>OB</given-names></name><name><surname>Bloom</surname><given-names>SR</given-names></name></person-group>. <article-title>Bowels control brain: gut hormones and obesity</article-title>. <source/>Nat Rev Endocrinol (<year>2010</year>) <volume>6</volume>:<fpage>444</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1038/nrendo.2010.93</pub-id><pub-id pub-id-type="pmid">20585346</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>PLR</given-names></name></person-group>
<article-title>5-HT<sub>3</sub> receptor antagonists and antiemesis</article-title>. In: <person-group person-group-type="editor"><name><surname>King</surname><given-names>FD</given-names></name><name><surname>Jones</surname><given-names>BJ</given-names></name><name><surname>Sanger</surname><given-names>GJ</given-names></name></person-group>, editors. <source/>5-Hydroxytryptamine-3 Receptor Antagonists. <publisher-loc>Boca Raton</publisher-loc>: <publisher-name>CRC Press</publisher-name> (<year>1994</year>). p. <fpage>255</fpage>–<lpage>317</lpage>.</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jänig</surname><given-names>W</given-names></name></person-group>
<article-title>Visceral afferent neurons and autonomic regulations</article-title>. In: <person-group person-group-type="editor"><name><surname>Jänig</surname><given-names>W</given-names></name></person-group>, editor. <source/>The Integrative Action of the Autonomic Nervous System. Neurobiology of Homeostasis. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name> (<year>2006</year>). p. <fpage>35</fpage>–<lpage>83</lpage>.</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>
<article-title>The role of the vagus nerve in afferent signaling and homeostasis during visceral inflammation</article-title>. In: <person-group person-group-type="editor"><name><surname>Jancsó</surname><given-names>G</given-names></name></person-group>, editor. <source/>Neurogenic Inflammation in Health and Disease, Neuroimmune Biology. (Vol. <volume>8</volume>), <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2008</year>). p. <fpage>321</fpage>–<lpage>38</lpage>.</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zagon</surname><given-names>A</given-names></name></person-group>. <article-title>Does the vagus nerve mediate the sixth sense?</article-title>
<source/>Trends Neurosci (<year>2001</year>) <volume>24</volume>:<fpage>671–673</fpage>.<pub-id pub-id-type="doi">10.1016/S0166-2236(00)01929-9</pub-id><pub-id pub-id-type="pmid">11672813</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>AD</given-names></name></person-group>
<article-title>How do you feel? Interoception: the sense of the physiological condition of the body</article-title>. <source/>Nat Rev Neurosci (<year>2002</year>) <volume>3</volume>:<fpage>655–666</fpage><pub-id pub-id-type="doi">10.1038/nrn894</pub-id><pub-id pub-id-type="pmid">12154366</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>AD</given-names></name></person-group>
<article-title>How do you feel – now? The anterior insula and human awareness</article-title>. <source/>Nat Rev Neurosci (<year>2009</year>) <volume>10</volume>:<fpage>59</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nrn2555</pub-id><pub-id pub-id-type="pmid">19096369</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berntson</surname><given-names>GG</given-names></name><name><surname>Sarter</surname><given-names>M</given-names></name><name><surname>Cacioppo</surname><given-names>JT</given-names></name></person-group>. <article-title>Ascending visceral regulation of cortical affective information processing</article-title>. <source/>Eur J Neurosci (<year>2003</year>) <volume>18</volume>:<fpage>2103</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1046/j.1460-9568.2003.02967.x</pub-id><pub-id pub-id-type="pmid">14622171</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>EA</given-names></name></person-group>. <article-title>Gut feelings: the emerging biology of gut-brain communication</article-title>. <source/>Nat Rev Neurosci (<year>2011</year>) <volume>12</volume>:<fpage>453</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1038/nrn3071</pub-id><pub-id pub-id-type="pmid">21750565</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>
<article-title>Interoception and gut feelings: unconscious body signals’ impact on brain function, behavior and belief processes</article-title>. In: <person-group person-group-type="editor"><name><surname>Angel</surname><given-names>HF</given-names></name><name><surname>Oviedo</surname><given-names>L</given-names></name><name><surname>Paloutzian</surname><given-names>RF</given-names></name><name><surname>Runehov</surname><given-names>A</given-names></name><name><surname>Seitz</surname><given-names>RJ</given-names></name></person-group>, editors. <source/>Processes of Believing: The Acquisition, Maintenance, and Change in Creditions. <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2017</year>). p. <fpage>435</fpage>–<lpage>42</lpage>.</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikoff</surname><given-names>WR</given-names></name><name><surname>Anfora</surname><given-names>AT</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Schultz</surname><given-names>PG</given-names></name><name><surname>Lesley</surname><given-names>SA</given-names></name><name><surname>Peters</surname><given-names>EC</given-names></name><etal></etal></person-group>
<article-title>Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2009</year>) <volume>106</volume>:<fpage>3698</fpage>–<lpage>703</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0812874106</pub-id><pub-id pub-id-type="pmid">19234110</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swann</surname><given-names>JR</given-names></name><name><surname>Want</surname><given-names>EJ</given-names></name><name><surname>Geier</surname><given-names>FM</given-names></name><name><surname>Spagou</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>ID</given-names></name><name><surname>Sidaway</surname><given-names>JE</given-names></name><etal></etal></person-group>
<article-title>Systemic gut microbial modulation of bile acid metabolism in host tissue compartments</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2011</year>) <volume>108</volume>(<issue>Suppl 1</issue>):<fpage>4523</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1006734107</pub-id><pub-id pub-id-type="pmid">20837534</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>Gut microbiota: the neglected endocrine organ</article-title>. <source/>Mol Endocrinol (<year>2014</year>) <volume>28</volume>:<fpage>1221</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1210/me.2014-1108</pub-id><pub-id pub-id-type="pmid">24892638</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fröhlich</surname><given-names>EE</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Jačan</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication</article-title>. <source/>Brain Behav Immun (<year>2016</year>) <volume>56</volume>:<fpage>140</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2016.02.020</pub-id><pub-id pub-id-type="pmid">26923630</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaisas</surname><given-names>S</given-names></name><name><surname>Maher</surname><given-names>J</given-names></name><name><surname>Kanthasamy</surname><given-names>A</given-names></name></person-group>. <article-title>Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases</article-title>. <source/>Pharmacol Ther (<year>2016</year>) <volume>158</volume>:<fpage>52</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.11.012</pub-id><pub-id pub-id-type="pmid">26627987</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spadoni</surname><given-names>I</given-names></name><name><surname>Zagato</surname><given-names>E</given-names></name><name><surname>Bertocchi</surname><given-names>A</given-names></name><name><surname>Paolinelli</surname><given-names>R</given-names></name><name><surname>Hot</surname><given-names>E</given-names></name><name><surname>Di Sabatino</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>A gut-vascular barrier controls the systemic dissemination of bacteria</article-title>. <source/>Science (<year>2015</year>) <volume>350</volume>:<fpage>830</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.aad0135</pub-id><pub-id pub-id-type="pmid">26564856</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>EY</given-names></name><name><surname>McBride</surname><given-names>SW</given-names></name><name><surname>Hsien</surname><given-names>S</given-names></name><name><surname>Sharon</surname><given-names>G</given-names></name><name><surname>Hyde</surname><given-names>ER</given-names></name><name><surname>McCue</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>. <source/>Cell (<year>2013</year>) <volume>155</volume>:<fpage>1451</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id><pub-id pub-id-type="pmid">24315484</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Rescigno</surname><given-names>M</given-names></name></person-group>. <article-title>The gut immune barrier and the blood-brain barrier: are they so different?</article-title>
<source/>Immunity (<year>2009</year>) <volume>31</volume>:<fpage>722</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.09.012</pub-id><pub-id pub-id-type="pmid">19836264</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>WA</given-names></name></person-group>. <article-title>The blood-brain barrier in neuroimmunology: tales of separation and assimilation</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>44</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2014.08.007</pub-id><pub-id pub-id-type="pmid">25172555</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Burgos</surname><given-names>A</given-names></name><name><surname>Mao</surname><given-names>YK</given-names></name><name><surname>Bienenstock</surname><given-names>J</given-names></name><name><surname>Kunze</surname><given-names>WA</given-names></name></person-group>
<article-title>The gut-brain axis rewired: adding a functional vagal nicotinic “sensory synapse”</article-title>. <source/>FASEB J (<year>2014</year>) <volume>28</volume>:<fpage>3064</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1096/fj.13-245282</pub-id><pub-id pub-id-type="pmid">24719355</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McVey Neufeld</surname><given-names>KA</given-names></name><name><surname>Perez-Burgos</surname><given-names>A</given-names></name><name><surname>Mao</surname><given-names>YK</given-names></name><name><surname>Bienenstock</surname><given-names>J</given-names></name><name><surname>Kunze</surname><given-names>WA</given-names></name></person-group>. <article-title>The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin</article-title>. <source/>Neurogastroenterol Motil (<year>2015</year>) <volume>27</volume>:<fpage>627</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12534</pub-id><pub-id pub-id-type="pmid">25727007</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>YK</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Forsythe</surname><given-names>P</given-names></name><name><surname>Bienenstock</surname><given-names>J</given-names></name><name><surname>Kunze</surname><given-names>WA</given-names></name></person-group>. <article-title><italic>Bacteroides fragilis</italic> polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons</article-title>. <source/>Nat Commun (<year>2013</year>) <volume>4</volume>:<fpage>1465</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms2478</pub-id><pub-id pub-id-type="pmid">23403566</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Burgos</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>YK</given-names></name><name><surname>Mistry</surname><given-names>B</given-names></name><name><surname>McVey Neufeld</surname><given-names>KA</given-names></name><name><surname>Bienenstock</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Psychoactive bacteria <italic>Lactobacillus rhamnosus</italic> (JB-1) elicits rapid frequency facilitation in vagal afferents</article-title>. <source/>Am J Physiol (<year>2013</year>) <volume>304</volume>:<fpage>G211</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00128.2012</pub-id><pub-id pub-id-type="pmid">23139216</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bercik</surname><given-names>P</given-names></name><name><surname>Park</surname><given-names>AJ</given-names></name><name><surname>Sinclair</surname><given-names>D</given-names></name><name><surname>Khoshdel</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><etal></etal></person-group>
<article-title>The anxiolytic effect of <italic>Bifidobacterium longum</italic> NCC3001 involves vagal pathways for gut-brain communication</article-title>. <source/>Neurogastroenterol Motil (<year>2011</year>) <volume>23</volume>:<fpage>1132</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2982.2011.01796.x</pub-id><pub-id pub-id-type="pmid">21988661</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>JA</given-names></name><name><surname>Forsythe</surname><given-names>P</given-names></name><name><surname>Chew</surname><given-names>MV</given-names></name><name><surname>Escaravage</surname><given-names>E</given-names></name><name><surname>Savignac</surname><given-names>HM</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal></etal></person-group>
<article-title>Ingestion of <italic>Lactobacillus</italic> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2011</year>) <volume>108</volume>:<fpage>16050</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id><pub-id pub-id-type="pmid">21876150</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>CT</given-names></name><name><surname>Kulchitsky</surname><given-names>VA</given-names></name><name><surname>Sugimoto</surname><given-names>N</given-names></name><name><surname>Homer</surname><given-names>LD</given-names></name><name><surname>Szekely</surname><given-names>M</given-names></name><name><surname>Romanovsky</surname><given-names>AA</given-names></name></person-group>. <article-title>Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis?</article-title>
<source/>Am J Physiol (<year>1998</year>) <volume>275</volume>:<fpage>R63–R68</fpage>.<pub-id pub-id-type="pmid">9688961</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthoud</surname><given-names>HR</given-names></name><name><surname>Kressel</surname><given-names>M</given-names></name><name><surname>Raybould</surname><given-names>HE</given-names></name><name><surname>Neuhuber</surname><given-names>WL</given-names></name></person-group>. <article-title>Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing</article-title>. <source/>Anat Embryol (<year>1995</year>) <volume>191</volume>:<fpage>203</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1007/BF00187819</pub-id><pub-id pub-id-type="pmid">7771683</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goehler</surname><given-names>LE</given-names></name><name><surname>Gaykema</surname><given-names>RPA</given-names></name><name><surname>Nguyen</surname><given-names>KT</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Tilders</surname><given-names>FJH</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name><etal></etal></person-group>
<article-title>Interleukin-1β in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?</article-title>
<source/>J Neurosci (<year>1999</year>) <volume>19</volume>:<fpage>2799</fpage>–<lpage>806</lpage>.<pub-id pub-id-type="pmid">10087091</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goehler</surname><given-names>LE</given-names></name><name><surname>Relton</surname><given-names>JK</given-names></name><name><surname>Dripps</surname><given-names>D</given-names></name><name><surname>Kiechle</surname><given-names>R</given-names></name><name><surname>Tartaglia</surname><given-names>N</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name><etal></etal></person-group>
<article-title>Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication</article-title>. <source/>Brain Res Bull (<year>1997</year>) <volume>43</volume>:<fpage>357–364</fpage>.<pub-id pub-id-type="pmid">9227848</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthoud</surname><given-names>HR</given-names></name><name><surname>Kressel</surname><given-names>M</given-names></name><name><surname>Neuhuber</surname><given-names>WL</given-names></name></person-group>
<article-title>Vagal afferent innervation of the rat abdominal paraganglia as revealed by anterograde DiI-tracing and confocal microscopy</article-title>. <source/>Acta Anat (<year>1995</year>) <volume>152</volume>:<fpage>127</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1159/000147691</pub-id><pub-id pub-id-type="pmid">7660756</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>TP</given-names></name><name><surname>Neal-McKinney</surname><given-names>JM</given-names></name><name><surname>Buelow</surname><given-names>DR</given-names></name><name><surname>Konkel</surname><given-names>ME</given-names></name><name><surname>Simasko</surname><given-names>SM</given-names></name></person-group>
<article-title>Capsaicin-sensitive vagal afferent neurons contribute to the detection of pathogenic bacterial colonization in the gut</article-title>. <source/>J Neuroimmunol (<year>2013</year>) <volume>257</volume>:<fpage>36</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.01.009</pub-id><pub-id pub-id-type="pmid">23481698</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meseguer</surname><given-names>V</given-names></name><name><surname>Alpizar</surname><given-names>YA</given-names></name><name><surname>Luis</surname><given-names>E</given-names></name><name><surname>Tajada</surname><given-names>S</given-names></name><name><surname>Denlinger</surname><given-names>B</given-names></name><name><surname>Fajardo</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins</article-title>. <source/>Nat Commun (<year>2014</year>) <volume>5</volume>:<fpage>3125</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms4125</pub-id><pub-id pub-id-type="pmid">24445575</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>B</given-names></name><name><surname>Kasparek</surname><given-names>MS</given-names></name><name><surname>Müller</surname><given-names>MH</given-names></name><name><surname>Kreis</surname><given-names>ME</given-names></name></person-group>. <article-title>Modulation of intestinal afferent nerve sensitivity to inflammatory mediators following systemic endotoxin in mice</article-title>. <source/>Neurogastroenterol Motil (<year>2015</year>) <volume>27</volume>:<fpage>550</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12531</pub-id><pub-id pub-id-type="pmid">25817056</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niijima</surname><given-names>A</given-names></name></person-group>
<article-title>The afferent discharges from sensors for interleukin 1β in the hepatoportal system in the anesthetized rat</article-title>. <source/>J Auton Nerv Syst (<year>1996</year>) <volume>61</volume>:<fpage>287–291</fpage>.<pub-id pub-id-type="pmid">8988487</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosawa</surname><given-names>M</given-names></name><name><surname>Uvnäs-Moberg</surname><given-names>K</given-names></name><name><surname>Miyasaka</surname><given-names>K</given-names></name><name><surname>Lundeberg</surname><given-names>T</given-names></name></person-group>. <article-title>Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats</article-title>. <source/>J Auton Nerv Syst (<year>1997</year>) <volume>62</volume>:<fpage>72</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-1838(96)00111-7</pub-id><pub-id pub-id-type="pmid">9021652</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ericsson</surname><given-names>A</given-names></name><name><surname>Kovács</surname><given-names>KJ</given-names></name><name><surname>Sawchenko</surname><given-names>PE</given-names></name></person-group>. <article-title>A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons</article-title>. <source/>J Neurosci (<year>1994</year>) <volume>14</volume>:<fpage>897</fpage>–<lpage>913</lpage>.<pub-id pub-id-type="pmid">8301368</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P</given-names></name><name><surname>Danzer</surname><given-names>M</given-names></name><name><surname>Schicho</surname><given-names>R</given-names></name><name><surname>Samberger</surname><given-names>C</given-names></name><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Lippe</surname><given-names>IT</given-names></name></person-group>
<article-title>Vagal afferent input from the acid-challenged rat stomach to the brainstem: enhancement by interleukin-1β</article-title>. <source/>Neuroscience (<year>2004</year>) <volume>129</volume>:<fpage>439</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.07.040</pub-id><pub-id pub-id-type="pmid">15501601</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ek</surname><given-names>M</given-names></name><name><surname>Kurosawa</surname><given-names>M</given-names></name><name><surname>Lundeberg</surname><given-names>T</given-names></name><name><surname>Ericsson</surname><given-names>A</given-names></name></person-group>
<article-title>Activation of vagal afferents after intravenous injection of interleukin-1β: role of endogenous prostaglandins</article-title>. <source/>J Neurosci (<year>1998</year>) <volume>18</volume>:<fpage>9471</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">9801384</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>PA</given-names></name><name><surname>Harrington</surname><given-names>AM</given-names></name><name><surname>Castro</surname><given-names>J</given-names></name><name><surname>Liebregts</surname><given-names>T</given-names></name><name><surname>Adam</surname><given-names>B</given-names></name><name><surname>Grasby</surname><given-names>DJ</given-names></name><etal></etal></person-group>
<article-title>Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes</article-title>. <source/>Gut (<year>2013</year>) <volume>62</volume>:<fpage>1456</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2011-301856</pub-id><pub-id pub-id-type="pmid">22767422</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>GP</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Mello</surname><given-names>CF</given-names></name></person-group>. <article-title>Modulation of learning and memory by natural polyamines</article-title>. <source/>Pharmacol Res (<year>2016</year>) <volume>112</volume>:<fpage>99</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="doi">10.1016/j.phrs.2016.03.023</pub-id><pub-id pub-id-type="pmid">27015893</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>AT</given-names></name><name><surname>Choi</surname><given-names>JP</given-names></name><name><surname>Kotzin</surname><given-names>JJ</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>CC</given-names></name><name><surname>Hobson</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Endothelial TLR4 and the microbiome drive cerebral cavernous malformations</article-title>. <source/>Nature (<year>2017</year>) <volume>545</volume>:<fpage>305</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1038/nature22075</pub-id><pub-id pub-id-type="pmid">28489816</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>TR</given-names></name><name><surname>Debelius</surname><given-names>JW</given-names></name><name><surname>Thron</surname><given-names>T</given-names></name><name><surname>Janssen</surname><given-names>S</given-names></name><name><surname>Shastri</surname><given-names>GG</given-names></name><name><surname>Ilhan</surname><given-names>ZE</given-names></name><etal></etal></person-group>
<article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease</article-title>. <source/>Cell (<year>2016</year>) <volume>167</volume>:<fpage>1469</fpage>–<lpage>80.e12</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id><pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>FA</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name><name><surname>Crusio</surname><given-names>WE</given-names></name><name><surname>Akbarian</surname><given-names>S</given-names></name></person-group>
<article-title>Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse</article-title>. <source/>Biol Psychiatry (<year>2007</year>) <volume>62</volume>:<fpage>55</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.06.036</pub-id><pub-id pub-id-type="pmid">16945350</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reolon</surname><given-names>GK</given-names></name><name><surname>Maurmann</surname><given-names>N</given-names></name><name><surname>Werenicz</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>VA</given-names></name><name><surname>Schröder</surname><given-names>N</given-names></name><name><surname>Wood</surname><given-names>MA</given-names></name><etal></etal></person-group>
<article-title>Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats</article-title>. <source/>Behav Brain Res (<year>2011</year>) <volume>221</volume>:<fpage>329</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2011.03.033</pub-id><pub-id pub-id-type="pmid">21421011</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name><name><surname>Cain</surname><given-names>NE</given-names></name><name><surname>Boon</surname><given-names>F</given-names></name><name><surname>Ossenkopp</surname><given-names>KP</given-names></name><name><surname>Cain</surname><given-names>DP</given-names></name></person-group>. <article-title>Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder</article-title>. <source/>Behav Brain Res (<year>2011</year>) <volume>217</volume>:<fpage>47</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2010.10.005</pub-id><pub-id pub-id-type="pmid">20937326</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>RH</given-names></name><name><surname>Meeking</surname><given-names>MM</given-names></name><name><surname>Mepham</surname><given-names>JR</given-names></name><name><surname>Tichenoff</surname><given-names>L</given-names></name><name><surname>Possmayer</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders</article-title>. <source/>J Neuroinflammation (<year>2012</year>) <volume>9</volume>:<fpage>153</fpage>.<pub-id pub-id-type="doi">10.1186/1742-2094-9-153</pub-id><pub-id pub-id-type="pmid">22747852</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichenberg</surname><given-names>A</given-names></name><name><surname>Yirmiya</surname><given-names>R</given-names></name><name><surname>Schuld</surname><given-names>A</given-names></name><name><surname>Kraus</surname><given-names>T</given-names></name><name><surname>Haack</surname><given-names>M</given-names></name><name><surname>Morag</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Cytokine-associated emotional and cognitive disturbances in humans</article-title>. <source/>Arch Gen Psychiatry (<year>2001</year>) <volume>58</volume>:<fpage>445</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1001/archpsyc.58.5.445</pub-id><pub-id pub-id-type="pmid">11343523</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeland</surname><given-names>S</given-names></name><name><surname>Warren</surname><given-names>HS</given-names></name><name><surname>Lowry</surname><given-names>SF</given-names></name><name><surname>Calvano</surname><given-names>SE</given-names></name><name><surname>Remick</surname><given-names>D</given-names></name><collab>Inflammation and the Host Response to Injury Investigators</collab></person-group>. <article-title>Acute inflammatory response to endotoxin in mice and humans</article-title>. <source/>Clin Diagn Lab Immunol (<year>2005</year>) <volume>12</volume>:<fpage>60</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/CDLI.12.1.60-67.2005</pub-id><pub-id pub-id-type="pmid">15642986</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>A</given-names></name><name><surname>Elsenbruch</surname><given-names>S</given-names></name><name><surname>Maluck</surname><given-names>J</given-names></name><name><surname>Grigoleit</surname><given-names>JS</given-names></name><name><surname>Engler</surname><given-names>H</given-names></name><name><surname>Jäger</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Inflammation-induced hyperalgesia: effects of timing, dosage, and negative affect on somatic pain sensitivity in human experimental endotoxemia</article-title>. <source/>Brain Behav Immun (<year>2014</year>) <volume>41</volume>:<fpage>46</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2014.05.001</pub-id><pub-id pub-id-type="pmid">24814500</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engler</surname><given-names>H</given-names></name><name><surname>Benson</surname><given-names>S</given-names></name><name><surname>Wegner</surname><given-names>A</given-names></name><name><surname>Spreitzer</surname><given-names>I</given-names></name><name><surname>Schedlowski</surname><given-names>M</given-names></name><name><surname>Elsenbruch</surname><given-names>S</given-names></name></person-group>. <article-title>Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms</article-title>. <source/>Brain Behav Immun (<year>2016</year>) <volume>52</volume>:<fpage>18</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.08.013</pub-id><pub-id pub-id-type="pmid">26291403</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandiego</surname><given-names>CM</given-names></name><name><surname>Gallezot</surname><given-names>JD</given-names></name><name><surname>Pittman</surname><given-names>B</given-names></name><name><surname>Nabulsi</surname><given-names>N</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>SF</given-names></name><etal></etal></person-group>
<article-title>Imaging robust microglial activation after lipopolysaccharide administration in humans with PET</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2015</year>) <volume>112</volume>:<fpage>12468</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1511003112</pub-id><pub-id pub-id-type="pmid">26385967</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>SL</given-names></name><name><surname>Flanagan</surname><given-names>KL</given-names></name></person-group>. <article-title>Sex differences in immune responses</article-title>. <source/>Nat Rev Immunol (<year>2016</year>) <volume>16</volume>:<fpage>626</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2016.90</pub-id><pub-id pub-id-type="pmid">27546235</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marriott</surname><given-names>I</given-names></name><name><surname>Bost</surname><given-names>KL</given-names></name><name><surname>Huet-Hudson</surname><given-names>YM</given-names></name></person-group>. <article-title>Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility</article-title>. <source/>J Reprod Immunol (<year>2006</year>) <volume>71</volume>:<fpage>12</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.jri.2006.01.004</pub-id><pub-id pub-id-type="pmid">16574244</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engeland</surname><given-names>CG</given-names></name><name><surname>Kavaliers</surname><given-names>M</given-names></name><name><surname>Ossenkopp</surname><given-names>KP</given-names></name></person-group>. <article-title>Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats</article-title>. <source/>Pharmacol Biochem Behav (<year>2003</year>) <volume>74</volume>:<fpage>433</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1016/S0091-3057(02)01024-9</pub-id><pub-id pub-id-type="pmid">12479965</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldin</surname><given-names>OP</given-names></name><name><surname>Mattison</surname><given-names>DR</given-names></name></person-group>
<article-title>Sex differences in pharmacokinetics and pharmacodynamics</article-title>. <source/>Clin Pharmacokinet (<year>2009</year>) <volume>48</volume>:<fpage>143</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.2165/00003088-200948030-00001</pub-id><pub-id pub-id-type="pmid">19385708</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>Campion</surname><given-names>S</given-names></name><name><surname>Teeling</surname><given-names>J</given-names></name><name><surname>Felton</surname><given-names>L</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group>. <article-title>The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C)</article-title>. <source/>Brain Behav Immun (<year>2007</year>) <volume>21</volume>:<fpage>490</fpage>–<lpage>502</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2006.12.007</pub-id><pub-id pub-id-type="pmid">17321719</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Fröhlich</surname><given-names>EE</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Kogelnik</surname><given-names>N</given-names></name><name><surname>Fröhlich</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice</article-title>. <source/>Brain Behav Immun (<year>2017</year>) <volume>60</volume>:<fpage>174</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2016.10.011</pub-id><pub-id pub-id-type="pmid">27751870</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Herzog</surname><given-names>H</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge</article-title>. <source/>J Psychopharmacol (<year>2010</year>) <volume>24</volume>:<fpage>1551</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1177/0269881109348171</pub-id><pub-id pub-id-type="pmid">19939871</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Köfer</surname><given-names>MJ</given-names></name><name><surname>Sinner</surname><given-names>F</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment</article-title>. <source/>PLoS One (<year>2011</year>) <volume>6</volume>:<fpage>e20719</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0020719</pub-id><pub-id pub-id-type="pmid">21673960</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>CW</given-names></name><name><surname>Elfving</surname><given-names>B</given-names></name><name><surname>Lund</surname><given-names>S</given-names></name><name><surname>Wegener</surname><given-names>G</given-names></name></person-group>
<article-title>Behavioral and systemic consequences of long-term inflammatory challenge</article-title>. <source/>J Neuroimmunol (<year>2015</year>) <volume>288</volume>:<fpage>40</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.08.011</pub-id><pub-id pub-id-type="pmid">26531693</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>FS</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Wan</surname><given-names>JR</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><etal></etal></person-group>
<article-title>NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide</article-title>. <source/>Neuroscience (<year>2017</year>) <volume>343</volume>:<fpage>77</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.11.037</pub-id><pub-id pub-id-type="pmid">27923741</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>N</given-names></name><name><surname>Stern</surname><given-names>EL</given-names></name><name><surname>Whiteside</surname><given-names>MB</given-names></name><name><surname>Herkenham</surname><given-names>M</given-names></name></person-group>. <article-title>Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat</article-title>. <source/>J Neuroimmunol (<year>1999</year>) <volume>93</volume>:<fpage>72</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-5728(98)00193-3</pub-id><pub-id pub-id-type="pmid">10378870</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Mello</surname><given-names>C</given-names></name><name><surname>Swain</surname><given-names>MG</given-names></name></person-group>. <article-title>Immune-to-brain communication pathways in inflammation-associated sickness and depression</article-title>. <source/>Curr Top Behav Neurosci (<year>2017</year>) <volume>31</volume>:<fpage>73</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1007/7854_2016_37</pub-id><pub-id pub-id-type="pmid">27677781</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCusker</surname><given-names>RH</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name></person-group>. <article-title>Immune-neural connections: how the immune system’s response to infectious agents influences behavior</article-title>. <source/>J Exp Biol (<year>2013</year>) <volume>216</volume>:<fpage>84</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1242/jeb.073411</pub-id><pub-id pub-id-type="pmid">23225871</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallieres</surname><given-names>L</given-names></name><name><surname>Rivest</surname><given-names>S</given-names></name></person-group>. <article-title>Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta</article-title>. <source/>J Neurochem (<year>1997</year>) <volume>69</volume>:<fpage>1668</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.69041668.x</pub-id><pub-id pub-id-type="pmid">9326296</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadeau</surname><given-names>S</given-names></name><name><surname>Rivest</surname><given-names>S</given-names></name></person-group>. <article-title>Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier</article-title>. <source/>Neuroscience (<year>1999</year>) <volume>93</volume>:<fpage>1449</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/S0306-4522(99)00225-0</pub-id><pub-id pub-id-type="pmid">10501470</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivest</surname><given-names>S</given-names></name><name><surname>Lacroix</surname><given-names>S</given-names></name><name><surname>Vallieres</surname><given-names>L</given-names></name><name><surname>Nadeau</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Laflamme</surname><given-names>N</given-names></name></person-group>. <article-title>How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli</article-title>. <source/>Proc Soc Exp Biol Med (<year>2000</year>) <volume>223</volume>:<fpage>22</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1046/j.1525-1373.2000.22304.x</pub-id><pub-id pub-id-type="pmid">10632958</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goehler</surname><given-names>LE</given-names></name><name><surname>Erisir</surname><given-names>A</given-names></name><name><surname>Gaykema</surname><given-names>RP</given-names></name></person-group>. <article-title>Neural-immune interface in the rat area postrema</article-title>. <source/>Neuroscience (<year>2006</year>) <volume>140</volume>:<fpage>1415</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.03.048</pub-id><pub-id pub-id-type="pmid">16650942</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>L</given-names></name><name><surname>Taishi</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Brandt</surname><given-names>J</given-names></name><name><surname>Cearley</surname><given-names>C</given-names></name><name><surname>Rehman</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1β or tumor necrosis factor α</article-title>. <source/>Brain Res (<year>2006</year>) <volume>1120</volume>:<fpage>64</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.brainres.2006.08.083</pub-id><pub-id pub-id-type="pmid">17022949</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anisman</surname><given-names>H</given-names></name><name><surname>Gibb</surname><given-names>J</given-names></name><name><surname>Hayley</surname><given-names>S</given-names></name></person-group>. <article-title>Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression</article-title>. <source/>Psychopharmacology (Berl) (<year>2008</year>) <volume>199</volume>:<fpage>231</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-008-1166-z</pub-id><pub-id pub-id-type="pmid">18491079</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluthé</surname><given-names>RM</given-names></name><name><surname>Laye</surname><given-names>S</given-names></name><name><surname>Michaud</surname><given-names>B</given-names></name><name><surname>Combe</surname><given-names>C</given-names></name><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>Parnet</surname><given-names>P</given-names></name></person-group>. <article-title>Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice</article-title>. <source/>Eur J Neurosci (<year>2000</year>) <volume>12</volume>:<fpage>4447</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1111/j.1460-9568.2000.01348.x</pub-id><pub-id pub-id-type="pmid">11122355</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>Bluthé</surname><given-names>RM</given-names></name><name><surname>McCusker</surname><given-names>RH</given-names></name><name><surname>Levade</surname><given-names>T</given-names></name><name><surname>Moos</surname><given-names>F</given-names></name><name><surname>Dantzer</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFα-induced sickness behavior</article-title>. <source/>Psychopharmacology (Berl) (<year>2009</year>) <volume>201</volume>:<fpage>549</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-008-1331-4</pub-id><pub-id pub-id-type="pmid">18825372</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habbas</surname><given-names>S</given-names></name><name><surname>Santello</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>D</given-names></name><name><surname>Stubbe</surname><given-names>H</given-names></name><name><surname>Zappia</surname><given-names>G</given-names></name><name><surname>Liaudet</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Neuroinflammatory TNFα impairs memory via astrocyte signaling</article-title>. <source/>Cell (<year>2015</year>) <volume>163</volume>:<fpage>1730</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.023</pub-id><pub-id pub-id-type="pmid">26686654</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tancredi</surname><given-names>V</given-names></name><name><surname>D’Arcangelo</surname><given-names>G</given-names></name><name><surname>Grassi</surname><given-names>F</given-names></name><name><surname>Tarroni</surname><given-names>P</given-names></name><name><surname>Palmieri</surname><given-names>G</given-names></name><name><surname>Santoni</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Tumor necrosis factor alters synaptic transmission in rat hippocampal slices</article-title>. <source/>Neurosci Lett (<year>1992</year>) <volume>146</volume>:<fpage>176</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/0304-3940(92)90071-E</pub-id><pub-id pub-id-type="pmid">1337194</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>D</given-names></name><name><surname>Knapp</surname><given-names>E</given-names></name><name><surname>Bandaru</surname><given-names>VV</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Knorr</surname><given-names>D</given-names></name><name><surname>Poirier</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Tumor necrosis factor-α-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors</article-title>. <source/>J Neurochem (<year>2009</year>) <volume>109</volume>:<fpage>1237</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06038.x</pub-id><pub-id pub-id-type="pmid">19476542</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>McCusker</surname><given-names>RH</given-names></name><name><surname>Strle</surname><given-names>K</given-names></name><name><surname>Moos</surname><given-names>F</given-names></name><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name></person-group>
<article-title>Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase</article-title>. <source/>Psychopharmacology (Berl) (<year>2008</year>) <volume>197</volume>:<fpage>629</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-008-1086-y</pub-id><pub-id pub-id-type="pmid">18274729</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaster</surname><given-names>MP</given-names></name><name><surname>Gadotti</surname><given-names>VM</given-names></name><name><surname>Calixto</surname><given-names>JB</given-names></name><name><surname>Santos</surname><given-names>AR</given-names></name><name><surname>Rodrigues</surname><given-names>AL</given-names></name></person-group>. <article-title>Depressive-like behavior induced by tumor necrosis factor-α in mice</article-title>. <source/>Neuropharmacology (<year>2012</year>) <volume>62</volume>:<fpage>419</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.08.018</pub-id><pub-id pub-id-type="pmid">21867719</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brüning</surname><given-names>CA</given-names></name><name><surname>Martini</surname><given-names>F</given-names></name><name><surname>Soares</surname><given-names>SM</given-names></name><name><surname>Savegnago</surname><given-names>L</given-names></name><name><surname>Sampaio</surname><given-names>TB</given-names></name><name><surname>Nogueira</surname><given-names>CW</given-names></name></person-group>
<article-title>Depressive-like behavior induced by tumor necrosis factor-α is attenuated by m-trifluoromethyl-diphenyl diselenide in mice</article-title>. <source/>J Psychiatr Res (<year>2015</year>) <volume>66-67</volume>:<fpage>75</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.04.019</pub-id><pub-id pub-id-type="pmid">25982254</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>D</given-names></name><name><surname>Yen</surname><given-names>JH</given-names></name><name><surname>Joseph</surname><given-names>DJ</given-names></name><name><surname>Friedman</surname><given-names>W</given-names></name></person-group>
<article-title>Cell type-specific interleukin-1β signaling in the CNS</article-title>. <source/>J Neurosci (<year>2004</year>) <volume>24</volume>:<fpage>6482</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5712-03.2004</pub-id><pub-id pub-id-type="pmid">15269258</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>CN</given-names></name><name><surname>Mann</surname><given-names>E</given-names></name><name><surname>Behrens</surname><given-names>MM</given-names></name><name><surname>Gaidarova</surname><given-names>S</given-names></name><name><surname>Rebek</surname><given-names>M</given-names></name><name><surname>Rebek</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional toll/IL-1 receptor domain/BB-loop mimetics</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2006</year>) <volume>103</volume>:<fpage>2953</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0510802103</pub-id><pub-id pub-id-type="pmid">16477040</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>B</given-names></name><name><surname>Gardoni</surname><given-names>F</given-names></name><name><surname>Marinovich</surname><given-names>M</given-names></name></person-group>. <article-title>Cytokines and neuronal ion channels in health and disease</article-title>. <source/>Int Rev Neurobiol (<year>2007</year>) <volume>82</volume>:<fpage>247</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/S0074-7742(07)82013-7</pub-id><pub-id pub-id-type="pmid">17678965</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfers</surname><given-names>M</given-names></name><name><surname>Sorkin</surname><given-names>L</given-names></name></person-group>
<article-title>Effect of cytokines on neuronal excitability</article-title>. <source/>Neurosci Lett (<year>2008</year>) <volume>437</volume>:<fpage>188</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.neulet.2008.03.052</pub-id><pub-id pub-id-type="pmid">18420346</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>B</given-names></name><name><surname>Bartesaghi</surname><given-names>S</given-names></name><name><surname>Gardoni</surname><given-names>F</given-names></name><name><surname>Vezzani</surname><given-names>A</given-names></name><name><surname>Behrens</surname><given-names>MM</given-names></name><name><surname>Bartfai</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases</article-title>. <source/>J Neurosci (<year>2003</year>) <volume>23</volume>:<fpage>8692</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">14507968</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasoni</surname><given-names>R</given-names></name><name><surname>Morini</surname><given-names>R</given-names></name><name><surname>Lopez-Atalaya</surname><given-names>JP</given-names></name><name><surname>Corradini</surname><given-names>I</given-names></name><name><surname>Canzi</surname><given-names>A</given-names></name><name><surname>Rasile</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects</article-title>. <source/>Elife (<year>2017</year>) <volume>6</volume>:<fpage>e21735</fpage>.<pub-id pub-id-type="doi">10.7554/eLife.21735</pub-id><pub-id pub-id-type="pmid">28347403</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlos</surname><given-names>AJ</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name><name><surname>Prieto</surname><given-names>GA</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group>. <article-title>IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking</article-title>. <source/>J Neuroinflammation (<year>2017</year>) <volume>14</volume>:<fpage>29</fpage>.<pub-id pub-id-type="doi">10.1186/s12974-017-0803-z</pub-id><pub-id pub-id-type="pmid">28153028</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenczowski</surname><given-names>MJ</given-names></name><name><surname>Bluthé</surname><given-names>RM</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Rees</surname><given-names>GS</given-names></name><name><surname>Rushforth</surname><given-names>DA</given-names></name><name><surname>van Dam</surname><given-names>AM</given-names></name><etal></etal></person-group>
<article-title>Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats</article-title>. <source/>Am J Physiol (<year>1999</year>) <volume>276</volume>:<fpage>R652</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">10070124</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluthé</surname><given-names>RM</given-names></name><name><surname>Michaud</surname><given-names>B</given-names></name><name><surname>Poli</surname><given-names>V</given-names></name><name><surname>Dantzer</surname><given-names>R</given-names></name></person-group>. <article-title>Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice</article-title>. <source/>Physiol Behav (<year>2000</year>) <volume>70</volume>:<fpage>367</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/S0031-9384(00)00269-9</pub-id><pub-id pub-id-type="pmid">11006436</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsusaka</surname><given-names>T</given-names></name><name><surname>Fujikawa</surname><given-names>K</given-names></name><name><surname>Nishio</surname><given-names>Y</given-names></name><name><surname>Mukaida</surname><given-names>N</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1993</year>) <volume>90</volume>:<fpage>10193</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.90.21.10193</pub-id><pub-id pub-id-type="pmid">8234276</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damm</surname><given-names>J</given-names></name><name><surname>Luheshi</surname><given-names>GN</given-names></name><name><surname>Gerstberger</surname><given-names>R</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Rummel</surname><given-names>C</given-names></name></person-group>. <article-title>Spatiotemporal nuclear factor interleukin-6 expression in the rat brain during lipopolysaccharide-induced fever is linked to sustained hypothalamic inflammatory target gene induction</article-title>. <source/>J Comp Neurol (<year>2011</year>) <volume>519</volume>:<fpage>480</fpage>–<lpage>505</lpage>.<pub-id pub-id-type="doi">10.1002/cne.22529</pub-id><pub-id pub-id-type="pmid">21192080</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneiders</surname><given-names>J</given-names></name><name><surname>Fuchs</surname><given-names>F</given-names></name><name><surname>Damm</surname><given-names>J</given-names></name><name><surname>Herden</surname><given-names>C</given-names></name><name><surname>Gerstberger</surname><given-names>R</given-names></name><name><surname>Soares</surname><given-names>DM</given-names></name><etal></etal></person-group>
<article-title>The transcription factor nuclear factor interleukin 6 mediates pro- and anti-inflammatory responses during LPS-induced systemic inflammation in mice</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>48</volume>:<fpage>147</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.03.008</pub-id><pub-id pub-id-type="pmid">25813145</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Gumnick</surname><given-names>JF</given-names></name><name><surname>Musselman</surname><given-names>DL</given-names></name><name><surname>Lawson</surname><given-names>DH</given-names></name><name><surname>Reemsnyder</surname><given-names>A</given-names></name><name><surname>Nemeroff</surname><given-names>CB</given-names></name><etal></etal></person-group>
<article-title>Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions</article-title>. <source/>Neuropsychopharmacology (<year>2002</year>) <volume>26</volume>:<fpage>643</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/S0893-133X(01)00407-9</pub-id><pub-id pub-id-type="pmid">11927189</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>CW</given-names></name><name><surname>Eskelund</surname><given-names>A</given-names></name><name><surname>Budac</surname><given-names>DP</given-names></name><name><surname>Tillmann</surname><given-names>S</given-names></name><name><surname>Liebenberg</surname><given-names>N</given-names></name><name><surname>Elfving</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Interferon-α treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats</article-title>. <source/>Behav Brain Res (<year>2015</year>) <volume>293</volume>:<fpage>166</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2015.07.015</pub-id><pub-id pub-id-type="pmid">26205824</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayley</surname><given-names>S</given-names></name><name><surname>Scharf</surname><given-names>J</given-names></name><name><surname>Anisman</surname><given-names>H</given-names></name></person-group>
<article-title>Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: a mini-review and original experiments</article-title>. <source/>Brain Behav Immun (<year>2013</year>) <volume>31</volume>:<fpage>115</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2012.07.023</pub-id><pub-id pub-id-type="pmid">22884959</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lawson</surname><given-names>MA</given-names></name><name><surname>Szegedi</surname><given-names>SS</given-names></name><name><surname>Lestage</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Interferon-γ and tumor necrosis factor-α mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin</article-title>. <source/>J Neurosci (<year>2009</year>) <volume>29</volume>:<fpage>4200</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5032-08.2009</pub-id><pub-id pub-id-type="pmid">19339614</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Uematsu</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name></person-group>
<article-title>Pathogen recognition and innate immunity</article-title>. <source/>Cell (<year>2006</year>) <volume>124</volume>:<fpage>783</fpage>–<lpage>801</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.015</pub-id><pub-id pub-id-type="pmid">16497588</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royet</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>D</given-names></name><name><surname>Dziarski</surname><given-names>R</given-names></name></person-group>. <article-title>Peptidoglycan recognition proteins: modulators of the microbiome and inflammation</article-title>. <source/>Nat Rev Immunol (<year>2011</year>) <volume>11</volume>:<fpage>837</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/nri3089</pub-id><pub-id pub-id-type="pmid">22076558</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hübschle</surname><given-names>T</given-names></name><name><surname>Mutze</surname><given-names>J</given-names></name><name><surname>Muhlradt</surname><given-names>PF</given-names></name><name><surname>Korte</surname><given-names>S</given-names></name><name><surname>Gerstberger</surname><given-names>R</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group>. <article-title>Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the toll-like receptors-2 and -6 agonists MALP-2 and FSL-1</article-title>. <source/>Am J Physiol (<year>2006</year>) <volume>290</volume>:<fpage>R180</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1152/ajpregu.00579.2005</pub-id><pub-id pub-id-type="pmid">16154916</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>JG</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Lee</surname><given-names>BJ</given-names></name></person-group>. <article-title>Hypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis</article-title>. <source/>Sci Rep (<year>2016</year>) <volume>6</volume>:<fpage>29424</fpage>.<pub-id pub-id-type="doi">10.1038/srep29424</pub-id><pub-id pub-id-type="pmid">27405276</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Moresco</surname><given-names>P</given-names></name><name><surname>Ramahi</surname><given-names>J</given-names></name><name><surname>Loh</surname><given-names>LN</given-names></name><etal></etal></person-group>
<article-title>Bacterial peptidoglycan transverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior</article-title>. <source/>Cell Host Microbe (<year>2016</year>) <volume>19</volume>:<fpage>388</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.02.009</pub-id><pub-id pub-id-type="pmid">26962947</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madar</surname><given-names>R</given-names></name><name><surname>Rotter</surname><given-names>A</given-names></name><name><surname>Waldman Ben-Asher</surname><given-names>H</given-names></name><name><surname>Mughal</surname><given-names>MR</given-names></name><name><surname>Arumugam</surname><given-names>TV</given-names></name><name><surname>Wood</surname><given-names>WH</given-names></name><etal></etal></person-group>
<article-title>Postnatal TLR2 activation impairs learning and memory in adulthood</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>48</volume>:<fpage>301</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.04.020</pub-id><pub-id pub-id-type="pmid">26021559</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arentsen</surname><given-names>T</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Gkotzis</surname><given-names>S</given-names></name><name><surname>Femenia</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Udekwu</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior</article-title>. <source/>Mol Psychiatry (<year>2017</year>) <volume>22</volume>:<fpage>257</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2016.182</pub-id><pub-id pub-id-type="pmid">27843150</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arentsen</surname><given-names>T</given-names></name><name><surname>Raith</surname><given-names>H</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Forssberg</surname><given-names>H</given-names></name><name><surname>Diaz Heijtz</surname><given-names>R</given-names></name></person-group>. <article-title>Host microbiota modulates development of social preference in mice</article-title>. <source/>Microb Ecol Health Dis (<year>2015</year>) <volume>26</volume>:<fpage>29719</fpage>.<pub-id pub-id-type="doi">10.3402/mehd.v26.29719</pub-id><pub-id pub-id-type="pmid">26679775</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desbonnet</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Microbiota is essential for social development in the mouse</article-title>. <source/>Mol Psychiatry (<year>2014</year>) <volume>19</volume>:<fpage>146</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2013.65</pub-id><pub-id pub-id-type="pmid">23689536</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>TB</given-names></name><name><surname>Davis</surname><given-names>KM</given-names></name><name><surname>Lysenko</surname><given-names>ES</given-names></name><name><surname>Zhou</surname><given-names>AY</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group>. <article-title>Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity</article-title>. <source/>Nat Med (<year>2010</year>) <volume>16</volume>:<fpage>228</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1038/nm.208</pub-id><pub-id pub-id-type="pmid">20081863</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Asano</surname><given-names>N</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Ozato</surname><given-names>K</given-names></name><name><surname>Tailor</surname><given-names>P</given-names></name><name><surname>Fuss</surname><given-names>IJ</given-names></name><etal></etal></person-group>
<article-title>Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis</article-title>. <source/>J Clin Invest (<year>2008</year>) <volume>118</volume>:<fpage>545</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1172/JCI33145</pub-id><pub-id pub-id-type="pmid">18188453</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Toll-like receptor 4 deficiency causes reduced exploratory behavior in mice under approach-avoidance conflict</article-title>. <source/>Neurosci Bull (<year>2016</year>) <volume>32</volume>:<fpage>127</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1007/s12264-016-0015-z</pub-id><pub-id pub-id-type="pmid">26898297</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Yune</surname><given-names>TY</given-names></name><name><surname>Ryu</surname><given-names>JH</given-names></name></person-group>
<article-title>Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice</article-title>. <source/>Sci Rep (<year>2015</year>) <volume>5</volume>:<fpage>8502</fpage><pub-id pub-id-type="doi">10.1038/srep08502</pub-id><pub-id pub-id-type="pmid">25687169</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Too</surname><given-names>LK</given-names></name><name><surname>McGregor</surname><given-names>IS</given-names></name><name><surname>Baxter</surname><given-names>AG</given-names></name><name><surname>Hunt</surname><given-names>NH</given-names></name></person-group>. <article-title>Altered behaviour and cognitive function following combined deletion of toll-like receptors 2 and 4 in mice</article-title>. <source/>Behav Brain Res (<year>2016</year>) <volume>303</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2016.01.024</pub-id><pub-id pub-id-type="pmid">26774978</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondeau</surname><given-names>JM</given-names></name><name><surname>Aoki</surname><given-names>FY</given-names></name><name><surname>Glavin</surname><given-names>GB</given-names></name></person-group>. <article-title>Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia</article-title>. <source/>J Psychosom Res (<year>1993</year>) <volume>37</volume>:<fpage>843</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/0022-3999(93)90173-D</pub-id><pub-id pub-id-type="pmid">8301624</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>HL</given-names></name><name><surname>Lutgendorf</surname><given-names>S</given-names></name><name><surname>Hartwig</surname><given-names>A</given-names></name><name><surname>Lilly</surname><given-names>J</given-names></name><name><surname>Berberich</surname><given-names>SL</given-names></name></person-group>. <article-title>Immune, stress, and mood markers related to recurrent oral herpes outbreaks</article-title>. <source/>Oral Surg Oral Med Oral Pathol Oral Radiol Endod (<year>1998</year>) <volume>86</volume>:<fpage>48</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/S1079-2104(98)90149-4</pub-id><pub-id pub-id-type="pmid">9690245</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashcraft</surname><given-names>KA</given-names></name><name><surname>Hunzeker</surname><given-names>J</given-names></name><name><surname>Bonneau</surname><given-names>RH</given-names></name></person-group>
<article-title>Psychological stress impairs the local CD8+ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanism</article-title>. <source/>Psychoneuroendocrinology (<year>2008</year>) <volume>33</volume>:<fpage>951</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.04.010</pub-id><pub-id pub-id-type="pmid">18657369</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ives</surname><given-names>AM</given-names></name><name><surname>Bertke</surname><given-names>AS</given-names></name></person-group>
<article-title>Stress hormones epinephrine and corticosterone selectively modulate herpes simplex virus 1 (HSV-1) and HSV-2 productive infection in adult sympathetic, but not sensory, neurons</article-title>. <source/>J Virol (<year>2017</year>) <volume>91</volume>:<fpage>e582</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00582-17</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubé</surname><given-names>B</given-names></name><name><surname>Benton</surname><given-names>T</given-names></name><name><surname>Cruess</surname><given-names>DG</given-names></name><name><surname>Evans</surname><given-names>DL</given-names></name></person-group>. <article-title>Neuropsychiatric manifestations of HIV infection and AIDS</article-title>. <source/>J Psychiatry Neurosci (<year>2005</year>) <volume>30</volume>:<fpage>237</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">16049567</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>NF</given-names></name><name><surname>Wilson</surname><given-names>GK</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Reynolds</surname><given-names>GM</given-names></name><etal></etal></person-group>
<article-title>Hepatitis C virus infects the endothelial cells of the blood-brain barrier</article-title>. <source/>Gastroenterology (<year>2012</year>) <volume>142</volume>:<fpage>634</fpage>–<lpage>43.e6</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2011.11.028</pub-id><pub-id pub-id-type="pmid">22138189</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everall</surname><given-names>IP</given-names></name><name><surname>Heaton</surname><given-names>RK</given-names></name><name><surname>Marcotte</surname><given-names>TD</given-names></name><name><surname>Ellis</surname><given-names>RJ</given-names></name><name><surname>McCutchan</surname><given-names>JA</given-names></name><name><surname>Atkinson</surname><given-names>JH</given-names></name><etal></etal></person-group>
<article-title>Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder</article-title>. <source/>Brain Pathol (<year>1999</year>) <volume>9</volume>:<fpage>209</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1111/j.1750-3639.1999.tb00219.x</pub-id><pub-id pub-id-type="pmid">10219738</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>DM</given-names></name><name><surname>Major</surname><given-names>EO</given-names></name></person-group>
<article-title>HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology</article-title>. <source/>Microbes Infect (<year>2002</year>) <volume>4</volume>:<fpage>301</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S1286-4579(02)01542-3</pub-id><pub-id pub-id-type="pmid">11909740</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>TH</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group>. <article-title>Molecular pathways in virus-induced cytokine production</article-title>. <source/>Microbiol Mol Biol Rev (<year>2001</year>) <volume>65</volume>:<fpage>131</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1128/MMBR.65.1.131-150.2001</pub-id><pub-id pub-id-type="pmid">11238989</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unterholzner</surname><given-names>L</given-names></name></person-group>. <article-title>The interferon response to intracellular DNA: why so many receptors?</article-title>
<source/>Immunobiology (<year>2013</year>) <volume>218</volume>:<fpage>1312</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.imbio.2013.07.007</pub-id><pub-id pub-id-type="pmid">23962476</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Kaisho</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Sanjo</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>A toll-like receptor recognizes bacterial DNA</article-title>. <source/>Nature (<year>2000</year>) <volume>408</volume>:<fpage>740</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/35047123</pub-id><pub-id pub-id-type="pmid">11130078</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Holt</surname><given-names>AC</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group>
<article-title>Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3</article-title>. <source/>Nature (<year>2001</year>) <volume>413</volume>:<fpage>732</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/35099560</pub-id><pub-id pub-id-type="pmid">11607032</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heil</surname><given-names>F</given-names></name><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Hochrein</surname><given-names>H</given-names></name><name><surname>Ampenberger</surname><given-names>F</given-names></name><name><surname>Kirschning</surname><given-names>C</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8</article-title>. <source/>Science (<year>2004</year>) <volume>303</volume>:<fpage>1526</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.1093620</pub-id><pub-id pub-id-type="pmid">14976262</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poeck</surname><given-names>H</given-names></name><name><surname>Bscheider</surname><given-names>M</given-names></name><name><surname>Gross</surname><given-names>O</given-names></name><name><surname>Finger</surname><given-names>K</given-names></name><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Rebsamen</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production</article-title>. <source/>Nat Immunol (<year>2010</year>) <volume>11</volume>:<fpage>63</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1824</pub-id><pub-id pub-id-type="pmid">19915568</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupfer</surname><given-names>C</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Kanneganti</surname><given-names>T</given-names></name></person-group>. <article-title>Inflammasome control of viral infection</article-title>. <source/>Curr Opin Virol (<year>2015</year>) <volume>12</volume>:<fpage>38</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2015.02.007</pub-id><pub-id pub-id-type="pmid">25771504</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiergiel</surname><given-names>AH</given-names></name><name><surname>Smagin</surname><given-names>GN</given-names></name><name><surname>Johnson</surname><given-names>LJ</given-names></name><name><surname>Dunn</surname><given-names>AJ</given-names></name></person-group>. <article-title>The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra)</article-title>. <source/>Brain Res (<year>1997</year>) <volume>776</volume>:<fpage>96</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1016/S0006-8993(97)01009-3</pub-id><pub-id pub-id-type="pmid">9439800</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>BM</given-names></name><name><surname>Eccleston</surname><given-names>D</given-names></name><name><surname>Ferrier</surname><given-names>IN</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name></person-group>
<article-title>Raised levels of plasma interleukin-1β in major and postviral depression</article-title>. <source/>Acta Psychiatr Scand (<year>2001</year>) <volume>103</volume>:<fpage>226</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1034/j.1600-0447.2001.00162.x</pub-id><pub-id pub-id-type="pmid">11240580</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>F</given-names></name><name><surname>Wagner</surname><given-names>V</given-names></name><name><surname>Rasmussen</surname><given-names>SB</given-names></name><name><surname>Hartmann</surname><given-names>R</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group>
<article-title>Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses</article-title>. <source/>J Virol (<year>2006</year>) <volume>80</volume>:<fpage>5059</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.80.10.5059-5064.2006</pub-id><pub-id pub-id-type="pmid">16641297</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>JN</given-names></name><name><surname>Ghirlando</surname><given-names>R</given-names></name><name><surname>Askins</surname><given-names>J</given-names></name><name><surname>Bell</surname><given-names>JK</given-names></name><name><surname>Margulies</surname><given-names>DH</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name><etal></etal></person-group>
<article-title>The TLR3 signaling complex forms by cooperative receptor dimerization</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2007</year>) <volume>105</volume>:<fpage>258</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0710779105</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Mikamo-Satoh</surname><given-names>E</given-names></name><name><surname>Hirai</surname><given-names>R</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5</article-title>. <source/>J Exp Med (<year>2008</year>) <volume>205</volume>:<fpage>1601</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20080091</pub-id><pub-id pub-id-type="pmid">18591409</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>F</given-names></name><name><surname>Laryea</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Bhattacharyya</surname><given-names>S</given-names></name></person-group>
<article-title>Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to toll-like receptor 4-mediated inflammation</article-title>. <source/>Immunology (<year>2015</year>) <volume>145</volume>:<fpage>136</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12434</pub-id><pub-id pub-id-type="pmid">25521315</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasowska-Zoladek</surname><given-names>A</given-names></name><name><surname>Banaszewska</surname><given-names>M</given-names></name><name><surname>Kraszpulski</surname><given-names>M</given-names></name><name><surname>Konat</surname><given-names>GW</given-names></name></person-group>. <article-title>Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation</article-title>. <source/>J Neurosci Res (<year>2007</year>) <volume>85</volume>:<fpage>205</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1002/jnr.21088</pub-id><pub-id pub-id-type="pmid">17061254</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konat</surname><given-names>GW</given-names></name><name><surname>Borysiewicz</surname><given-names>E</given-names></name><name><surname>Fil</surname><given-names>D</given-names></name><name><surname>James</surname><given-names>I</given-names></name></person-group>. <article-title>Peripheral challenge with double-stranded RNA elicits global up-regulation of cytokine gene expression in the brain</article-title>. <source/>J Neurosci Res (<year>2009</year>) <volume>87</volume>:<fpage>1381</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1002/jnr.21958</pub-id><pub-id pub-id-type="pmid">19115408</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>C</given-names></name><name><surname>Griffin</surname><given-names>EW</given-names></name><name><surname>O’Loughlin</surname><given-names>E</given-names></name><name><surname>Lyons</surname><given-names>A</given-names></name><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>48</volume>:<fpage>274</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.04.009</pub-id><pub-id pub-id-type="pmid">25900439</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortier</surname><given-names>ME</given-names></name><name><surname>Kent</surname><given-names>S</given-names></name><name><surname>Ashdown</surname><given-names>H</given-names></name><name><surname>Poole</surname><given-names>S</given-names></name><name><surname>Boksa</surname><given-names>P</given-names></name><name><surname>Luheshi</surname><given-names>GN</given-names></name></person-group>. <article-title>The viral mimic, polyinosinic: polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism</article-title>. <source/>Am J Physiol (<year>2004</year>) <volume>287</volume>:<fpage>R759</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1152/ajpregu.00293.2004</pub-id><pub-id pub-id-type="pmid">15205185</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibney</surname><given-names>SM</given-names></name><name><surname>McGuinness</surname><given-names>B</given-names></name><name><surname>Prendergast</surname><given-names>C</given-names></name><name><surname>Harkin</surname><given-names>A</given-names></name><name><surname>Connor</surname><given-names>TJ</given-names></name></person-group>. <article-title>Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression</article-title>. <source/>Brain Behav Immun (<year>2013</year>) <volume>28</volume>:<fpage>170</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2012.11.010</pub-id><pub-id pub-id-type="pmid">23201589</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>E</given-names></name><name><surname>Griffioen</surname><given-names>K</given-names></name><name><surname>Barak</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>NJ</given-names></name><name><surname>Castro</surname><given-names>K</given-names></name><name><surname>Pita</surname><given-names>MA</given-names></name><etal></etal></person-group>
<article-title>Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2010</year>) <volume>107</volume>:<fpage>15625</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1005807107</pub-id><pub-id pub-id-type="pmid">20713712</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranjac</surname><given-names>D</given-names></name><name><surname>McLinden</surname><given-names>KA</given-names></name><name><surname>Koster</surname><given-names>KM</given-names></name><name><surname>Kaldenbach</surname><given-names>DL</given-names></name><name><surname>Chumley</surname><given-names>MJ</given-names></name><name><surname>Boehm</surname><given-names>GW</given-names></name></person-group>. <article-title>Peripheral administration of poly I:C disrupts contextual fear memory consolidation and BDNF expression in mice</article-title>. <source/>Behav Brain Res (<year>2012</year>) <volume>228</volume>:<fpage>452</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2011.12.031</pub-id><pub-id pub-id-type="pmid">22222172</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Town</surname><given-names>T</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Anderson</surname><given-names>JF</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group>. <article-title>Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis</article-title>. <source/>Nat Med (<year>2004</year>) <volume>10</volume>:<fpage>1366</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/nm1140</pub-id><pub-id pub-id-type="pmid">15558055</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname><given-names>MK</given-names></name><name><surname>Kranjac</surname><given-names>D</given-names></name><name><surname>Eimerbrink</surname><given-names>MJ</given-names></name><name><surname>Pearson</surname><given-names>SJ</given-names></name><name><surname>Vinson</surname><given-names>BT</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Peripheral administration of poly I:C leads to increased hippocampal amyloid-β and cognitive deficits in a non-transgenic mouse</article-title>. <source/>Behav Brain Res (<year>2014</year>) <volume>266</volume>:<fpage>183</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2014.03.009</pub-id><pub-id pub-id-type="pmid">24631395</pub-id></mixed-citation>
</ref>
<ref id="B179">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garré</surname><given-names>JM</given-names></name><name><surname>Silva</surname><given-names>HM</given-names></name><name><surname>Lafaille</surname><given-names>JJ</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name></person-group>
<article-title>CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α</article-title>. <source/>Nat Med (<year>2017</year>) <volume>23</volume>:<fpage>714</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4340</pub-id><pub-id pub-id-type="pmid">28504723</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>R</given-names></name><name><surname>Campion</surname><given-names>S</given-names></name><name><surname>Warren</surname><given-names>C</given-names></name><name><surname>Murray</surname><given-names>C</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name></person-group>
<article-title>Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration</article-title>. <source/>Brain Behav Immun (<year>2010</year>) <volume>24</volume>:<fpage>996</fpage>–<lpage>1007</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2010.04.004</pub-id><pub-id pub-id-type="pmid">20399848</pub-id></mixed-citation>
</ref>
<ref id="B181">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reisinger</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>D</given-names></name><name><surname>Kong</surname><given-names>E</given-names></name><name><surname>Berger</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>DD</given-names></name></person-group>. <article-title>The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery</article-title>. <source/>Pharmacol Ther (<year>2015</year>) <volume>149</volume>:<fpage>213</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.01.001</pub-id><pub-id pub-id-type="pmid">25562580</pub-id></mixed-citation>
</ref>
<ref id="B182">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Nyffeler</surname><given-names>M</given-names></name><name><surname>Yee</surname><given-names>BK</given-names></name><name><surname>Knuesel</surname><given-names>I</given-names></name><name><surname>Feldon</surname><given-names>J</given-names></name></person-group>. <article-title>Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice</article-title>. <source/>Brain Behav Immun (<year>2008</year>) <volume>22</volume>:<fpage>469</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2007.09.012</pub-id><pub-id pub-id-type="pmid">18023140</pub-id></mixed-citation>
</ref>
<ref id="B183">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>CM</given-names></name><name><surname>Khalil</surname><given-names>OS</given-names></name><name><surname>Pisar</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>RA</given-names></name><name><surname>Darlington</surname><given-names>LG</given-names></name><name><surname>Stone</surname><given-names>TW</given-names></name></person-group>. <article-title>Prenatal activation of toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring</article-title>. <source/>Mol Brain (<year>2012</year>) <volume>5</volume>:<fpage>22</fpage>.<pub-id pub-id-type="doi">10.1186/1756-6606-5-22</pub-id><pub-id pub-id-type="pmid">22681877</pub-id></mixed-citation>
</ref>
<ref id="B184">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratnayake</surname><given-names>U</given-names></name><name><surname>Quinn</surname><given-names>T</given-names></name><name><surname>LaRosa</surname><given-names>DA</given-names></name><name><surname>Dickinson</surname><given-names>H</given-names></name><name><surname>Walker</surname><given-names>DW</given-names></name></person-group>. <article-title>Prenatal exposure to the viral mimetic poly I:C alters fetal brain cytokine expression and postnatal behaviour</article-title>. <source/>Dev Neurosci (<year>2014</year>) <volume>36</volume>:<fpage>83</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1159/000362205</pub-id><pub-id pub-id-type="pmid">24863806</pub-id></mixed-citation>
</ref>
<ref id="B185">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>D</given-names></name><name><surname>Fernando</surname><given-names>P</given-names></name><name><surname>Cicvaric</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>A</given-names></name><name><surname>Monje</surname><given-names>FJ</given-names></name><etal></etal></person-group>
<article-title>Long-term effects of maternal immune activation on depression-like behavior in the mouse</article-title>. <source/>Transl Psychiatry (<year>2014</year>) <volume>4</volume>:<fpage>e363</fpage>.<pub-id pub-id-type="doi">10.1038/tp.2013.132</pub-id><pub-id pub-id-type="pmid">24548878</pub-id></mixed-citation>
</ref>
<ref id="B186">
<label>186</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovanoli</surname><given-names>S</given-names></name><name><surname>Weber-Stadlbauer</surname><given-names>U</given-names></name><name><surname>Schedlowski</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Engler</surname><given-names>H</given-names></name></person-group>. <article-title>Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies</article-title>. <source/>Brain Behav Immun (<year>2016</year>) <volume>55</volume>:<fpage>25</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.09.015</pub-id><pub-id pub-id-type="pmid">26408796</pub-id></mixed-citation>
</ref>
<ref id="B187">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schröcksnadel</surname><given-names>K</given-names></name><name><surname>Wirleitner</surname><given-names>B</given-names></name><name><surname>Winkler</surname><given-names>C</given-names></name><name><surname>Fuchs</surname><given-names>D</given-names></name></person-group>. <article-title>Monitoring tryptophan metabolism in chronic immune activation</article-title>. <source/>Clin Chim Acta (<year>2006</year>) <volume>364</volume>:<fpage>82</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.cca.2005.06.013</pub-id><pub-id pub-id-type="pmid">16139256</pub-id></mixed-citation>
</ref>
<ref id="B188">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Lawson</surname><given-names>MA</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name></person-group>. <article-title>Inflammation-associated depression: from serotonin to kynurenine</article-title>. <source/>Psychoneuroendocrinology (<year>2011</year>) <volume>36</volume>:<fpage>426</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.09.012</pub-id><pub-id pub-id-type="pmid">21041030</pub-id></mixed-citation>
</ref>
<ref id="B189">
<label>189</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savitz</surname><given-names>J</given-names></name><name><surname>Drevets</surname><given-names>WC</given-names></name><name><surname>Wurfel</surname><given-names>BE</given-names></name><name><surname>Ford</surname><given-names>BN</given-names></name><name><surname>Bellgowan</surname><given-names>PS</given-names></name><name><surname>Victor</surname><given-names>TA</given-names></name><etal></etal></person-group>
<article-title>Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>46</volume>:<fpage>55</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.02.007</pub-id><pub-id pub-id-type="pmid">25686798</pub-id></mixed-citation>
</ref>
<ref id="B190">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>AK</given-names></name><name><surname>Lawson</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>RA</given-names></name><name><surname>Janda</surname><given-names>TM</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name><name><surname>McCusker</surname><given-names>RH</given-names></name></person-group>. <article-title>Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the kynurenine pathway in the mouse hippocampus</article-title>. <source/>J Neuroinflammation (<year>2016</year>) <volume>13</volume>:<fpage>98</fpage>.<pub-id pub-id-type="doi">10.1186/s12974-016-0563-1</pub-id><pub-id pub-id-type="pmid">27142940</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Lawson</surname><given-names>MA</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Moreau</surname><given-names>M</given-names></name><name><surname>Lestage</surname><given-names>J</given-names></name><name><surname>Castanon</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice</article-title>. <source/>Mol Psychiatry (<year>2009</year>) <volume>14</volume>:<fpage>511</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/sj.mp.4002148</pub-id><pub-id pub-id-type="pmid">18195714</pub-id></mixed-citation>
</ref>
<ref id="B192">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AK</given-names></name><name><surname>Budac</surname><given-names>DP</given-names></name><name><surname>Bisulco</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>AW</given-names></name><name><surname>Smith</surname><given-names>RA</given-names></name><name><surname>Beenders</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice</article-title>. <source/>Neuropsychopharmacology (<year>2013</year>) <volume>38</volume>:<fpage>1609</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1038/npp.2013.71</pub-id><pub-id pub-id-type="pmid">23511700</pub-id></mixed-citation>
</ref>
<ref id="B193">
<label>193</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvadore</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>JB</given-names></name></person-group>. <article-title>Ketamine as a fast acting antidepressant: current knowledge and open questions</article-title>. <source/>CNS Neurosci Ther (<year>2013</year>) <volume>19</volume>:<fpage>428</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1111/cns.12103</pub-id><pub-id pub-id-type="pmid">23578128</pub-id></mixed-citation>
</ref>
<ref id="B194">
<label>194</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francesconi</surname><given-names>W</given-names></name><name><surname>Sanchez-Alavez</surname><given-names>M</given-names></name><name><surname>Berton</surname><given-names>F</given-names></name><name><surname>Alboni</surname><given-names>S</given-names></name><name><surname>Benatti</surname><given-names>C</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis</article-title>. <source/>J Neurosci (<year>2016</year>) <volume>36</volume>:<fpage>5170</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3919-15.2016</pub-id><pub-id pub-id-type="pmid">27147667</pub-id></mixed-citation>
</ref>
<ref id="B195">
<label>195</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>BC</given-names></name><name><surname>Garcia-Galiano</surname><given-names>D</given-names></name><name><surname>Rorato</surname><given-names>R</given-names></name><name><surname>Elias</surname><given-names>LL</given-names></name><name><surname>Elias</surname><given-names>CF</given-names></name></person-group>
<article-title>PI3K p110β subunit in leptin receptor expressing cells is required for the acute hypophagia induced by endotoxemia</article-title>. <source/>Mol Metab (<year>2016</year>) <volume>5</volume>:<fpage>379</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.molmet.2016.03.003</pub-id><pub-id pub-id-type="pmid">27257598</pub-id></mixed-citation>
</ref>
<ref id="B196">
<label>196</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosawa</surname><given-names>N</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Seki</surname><given-names>K</given-names></name></person-group>
<article-title>The development of depression-like behavior is consolidated by IL-6-induced activation of locus coeruleus neurons and IL-1β-induced elevated leptin levels in mice</article-title>. <source/>Psychopharmacology (Berl) (<year>2016</year>) <volume>233</volume>:<fpage>1725</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-015-4084-x</pub-id><pub-id pub-id-type="pmid">26385227</pub-id></mixed-citation>
</ref>
<ref id="B197">
<label>197</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>M</given-names></name><name><surname>Klawonn</surname><given-names>AM</given-names></name><name><surname>Nilsson</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Zajdel</surname><given-names>J</given-names></name><name><surname>Wilhelms</surname><given-names>DB</given-names></name><etal></etal></person-group>
<article-title>Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice</article-title>. <source/>J Clin Invest (<year>2016</year>) <volume>126</volume>:<fpage>695</fpage>–<lpage>705</lpage>.<pub-id pub-id-type="doi">10.1172/JCI83844</pub-id><pub-id pub-id-type="pmid">26690700</pub-id></mixed-citation>
</ref>
<ref id="B198">
<label>198</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felger</surname><given-names>JC</given-names></name><name><surname>Lotrich</surname><given-names>FE</given-names></name></person-group>. <article-title>Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications</article-title>. <source/>Neuroscience (<year>2013</year>) <volume>246</volume>:<fpage>199</fpage>–<lpage>229</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.04.060</pub-id><pub-id pub-id-type="pmid">23644052</pub-id></mixed-citation>
</ref>
<ref id="B199">
<label>199</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Köfer</surname><given-names>MJ</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Dischinger</surname><given-names>US</given-names></name><name><surname>Sinner</surname><given-names>F</given-names></name><name><surname>Herzog</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice</article-title>. <source/>Br J Pharmacol (<year>2013</year>) <volume>170</volume>:<fpage>1014</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1111/bph.12354</pub-id><pub-id pub-id-type="pmid">23992467</pub-id></mixed-citation>
</ref>
<ref id="B200">
<label>200</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Castanon</surname><given-names>N</given-names></name></person-group>. <article-title>Role of inflammation in the development of neuropsychiatric symptom domains: evidence and mechanisms</article-title>. <source/>Curr Top Behav Neurosci (<year>2017</year>) <volume>31</volume>:<fpage>31</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1007/7854_2016_14</pub-id><pub-id pub-id-type="pmid">27221626</pub-id></mixed-citation>
</ref>
<ref id="B201">
<label>201</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Schroecksnadel</surname><given-names>S</given-names></name><name><surname>Feart</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>A</given-names></name><name><surname>Higueret</surname><given-names>D</given-names></name><name><surname>Barberger-Gateau</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms</article-title>. <source/>Biol Psychiatry (<year>2011</year>) <volume>70</volume>:<fpage>175</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.12.006</pub-id><pub-id pub-id-type="pmid">21277567</pub-id></mixed-citation>
</ref>
<ref id="B202">
<label>202</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Pena</surname><given-names>D</given-names></name><name><surname>Nixon</surname><given-names>SE</given-names></name><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Southey</surname><given-names>BR</given-names></name><name><surname>Lawson</surname><given-names>MA</given-names></name><name><surname>McCusker</surname><given-names>RH</given-names></name><etal></etal></person-group>
<article-title>Microglia transcriptome changes in a model of depressive behavior after immune challenge</article-title>. <source/>PLoS One (<year>2016</year>) <volume>11</volume>:<fpage>e0150858</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0150858</pub-id><pub-id pub-id-type="pmid">26959683</pub-id></mixed-citation>
</ref>
<ref id="B203">
<label>203</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiurchiu</surname><given-names>V</given-names></name><name><surname>Maccarrone</surname><given-names>M</given-names></name></person-group>. <article-title>Bioactive lipids as modulators of immunity, inflammation and emotions</article-title>. <source/>Curr Opin Pharmacol (<year>2016</year>) <volume>29</volume>:<fpage>54</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.coph.2016.06.005</pub-id><pub-id pub-id-type="pmid">27372887</pub-id></mixed-citation>
</ref>
<ref id="B204">
<label>204</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecchi</surname><given-names>E</given-names></name><name><surname>Dallaporta</surname><given-names>M</given-names></name><name><surname>Jean</surname><given-names>A</given-names></name><name><surname>Thirion</surname><given-names>S</given-names></name><name><surname>Troadec</surname><given-names>JD</given-names></name></person-group>. <article-title>Prostaglandins and sickness behavior: old story, new insights</article-title>. <source/>Physiol Behav (<year>2009</year>) <volume>97</volume>:<fpage>279</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.physbeh.2009.02.040</pub-id><pub-id pub-id-type="pmid">19275907</pub-id></mixed-citation>
</ref>
<ref id="B205">
<label>205</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>JU</given-names></name><name><surname>Pradhan</surname><given-names>S</given-names></name><name><surname>Lokteva</surname><given-names>LA</given-names></name><name><surname>Woodling</surname><given-names>NS</given-names></name><name><surname>Ko</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>HD</given-names></name><etal></etal></person-group>
<article-title>Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia</article-title>. <source/>J Neurosci (<year>2013</year>) <volume>33</volume>:<fpage>16016</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2203-13.2013</pub-id><pub-id pub-id-type="pmid">24089506</pub-id></mixed-citation>
</ref>
<ref id="B206">
<label>206</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haba</surname><given-names>R</given-names></name><name><surname>Shintani</surname><given-names>N</given-names></name><name><surname>Onaka</surname><given-names>Y</given-names></name><name><surname>Kanoh</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Takenaga</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model</article-title>. <source/>J Neurosci (<year>2014</year>) <volume>34</volume>:<fpage>2514</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1407-13.2014</pub-id><pub-id pub-id-type="pmid">24523542</pub-id></mixed-citation>
</ref>
<ref id="B207">
<label>207</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>Y</given-names></name><name><surname>Shintani</surname><given-names>N</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Haba</surname><given-names>R</given-names></name><name><surname>Ago</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice</article-title>. <source/>Behav Brain Res (<year>2015</year>) <volume>284</volume>:<fpage>131</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2015.02.013</pub-id><pub-id pub-id-type="pmid">25698598</pub-id></mixed-citation>
</ref>
<ref id="B208">
<label>208</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugarini</surname><given-names>F</given-names></name><name><surname>Hrupka</surname><given-names>BJ</given-names></name><name><surname>Schwartz</surname><given-names>GJ</given-names></name><name><surname>Plata-Salaman</surname><given-names>CR</given-names></name><name><surname>Langhans</surname><given-names>W</given-names></name></person-group>
<article-title>A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats</article-title>. <source/>Am J Physiol (<year>2002</year>) <volume>283</volume>:<fpage>R862</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1152/ajpregu.00200.2002</pub-id></mixed-citation>
</ref>
<ref id="B209">
<label>209</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Paiva</surname><given-names>VN</given-names></name><name><surname>Lima</surname><given-names>SN</given-names></name><name><surname>Fernandes</surname><given-names>MM</given-names></name><name><surname>Soncini</surname><given-names>R</given-names></name><name><surname>Andrade</surname><given-names>CA</given-names></name><name><surname>Giusti-Paiva</surname><given-names>A</given-names></name></person-group>. <article-title>Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice</article-title>. <source/>Behav Brain Res (<year>2010</year>) <volume>215</volume>:<fpage>146</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2010.07.015</pub-id><pub-id pub-id-type="pmid">20654654</pub-id></mixed-citation>
</ref>
<ref id="B210">
<label>210</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>LA</given-names></name><name><surname>Hamza</surname><given-names>M</given-names></name><name><surname>El Gayar</surname><given-names>NH</given-names></name><name><surname>Abd El-Samad</surname><given-names>AA</given-names></name><name><surname>Nasr</surname><given-names>EA</given-names></name><name><surname>Masoud</surname><given-names>SI</given-names></name></person-group>. <article-title>Ibuprofen suppresses depressive like behavior induced by BCG inoculation in mice: role of nitric oxide and prostaglandin</article-title>. <source/>Pharmacol Biochem Behav (<year>2014</year>) <volume>125</volume>:<fpage>29</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/j.pbb.2014.07.013</pub-id><pub-id pub-id-type="pmid">25101545</pub-id></mixed-citation>
</ref>
<ref id="B211">
<label>211</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>S</given-names></name><name><surname>Pundarikakshudu</surname><given-names>K</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Panchal</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Beneficial effect of aspirin against interferon-alpha-2b-induced depressive behavior in Sprague Dawley rats</article-title>. <source/>Clin Exp Pharmacol Physiol (<year>2016</year>) <volume>43</volume>:<fpage>1208</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1111/1440-1681.12660</pub-id><pub-id pub-id-type="pmid">27561157</pub-id></mixed-citation>
</ref>
<ref id="B212">
<label>212</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>O</given-names></name><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Farkouh</surname><given-names>ME</given-names></name><name><surname>Iyengar</surname><given-names>RL</given-names></name><name><surname>Mors</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials</article-title>. <source/>JAMA Psychiatry (<year>2014</year>) <volume>71</volume>:<fpage>1381</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.1611</pub-id><pub-id pub-id-type="pmid">25322082</pub-id></mixed-citation>
</ref>
<ref id="B213">
<label>213</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Wiley</surname><given-names>JW</given-names></name></person-group>
<article-title>The role of the endocannabinoid system in the brain-gut axis</article-title>. <source/>Gastroenterology (<year>2016</year>) <volume>151</volume>:<fpage>252</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2016.04.015</pub-id><pub-id pub-id-type="pmid">27133395</pub-id></mixed-citation>
</ref>
<ref id="B214">
<label>214</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPatrizio</surname><given-names>NV</given-names></name></person-group>
<article-title>Endocannabinoids in the gut</article-title>. <source/>Cannabis Cannabinoid Res (<year>2016</year>) <volume>1</volume>:<fpage>67</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1089/can.2016.0001</pub-id><pub-id pub-id-type="pmid">27413788</pub-id></mixed-citation>
</ref>
<ref id="B215">
<label>215</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdyga</surname><given-names>G</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Dimaline</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>DG</given-names></name><name><surname>Dockray</surname><given-names>GJ</given-names></name></person-group>
<article-title>Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype</article-title>. <source/>Am J Physiol (<year>2010</year>) <volume>299</volume>:<fpage>G63</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00059.2010</pub-id></mixed-citation>
</ref>
<ref id="B216">
<label>216</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>RC</given-names></name><name><surname>Hermann</surname><given-names>GE</given-names></name></person-group>. <article-title>Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids</article-title>. <source/>J Neurosci (<year>2012</year>) <volume>32</volume>:<fpage>5237</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6220-11.2012</pub-id><pub-id pub-id-type="pmid">22496569</pub-id></mixed-citation>
</ref>
<ref id="B217">
<label>217</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>DK</given-names></name><name><surname>Morrison</surname><given-names>BE</given-names></name><name><surname>Blankman</surname><given-names>JL</given-names></name><name><surname>Long</surname><given-names>JZ</given-names></name><name><surname>Kinsey</surname><given-names>SG</given-names></name><name><surname>Marcondes</surname><given-names>MC</given-names></name><etal></etal></person-group>
<article-title>Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation</article-title>. <source/>Science (<year>2011</year>) <volume>334</volume>:<fpage>809</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1126/science.1209200</pub-id><pub-id pub-id-type="pmid">22021672</pub-id></mixed-citation>
</ref>
<ref id="B218">
<label>218</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabner</surname><given-names>GF</given-names></name><name><surname>Eichmann</surname><given-names>TO</given-names></name><name><surname>Wagner</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Taschler</surname><given-names>U</given-names></name><etal></etal></person-group>
<article-title>Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation</article-title>. <source/>J Biol Chem (<year>2016</year>) <volume>291</volume>:<fpage>913</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M115.683615</pub-id><pub-id pub-id-type="pmid">26565024</pub-id></mixed-citation>
</ref>
<ref id="B219">
<label>219</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>RJ</given-names></name><name><surname>Kerr</surname><given-names>DM</given-names></name><name><surname>Finn</surname><given-names>DP</given-names></name><name><surname>Roche</surname><given-names>M</given-names></name></person-group>. <article-title>FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus</article-title>. <source/>J Neuroimmunol (<year>2014</year>) <volume>276</volume>:<fpage>126</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2014.09.002</pub-id><pub-id pub-id-type="pmid">25245162</pub-id></mixed-citation>
</ref>
<ref id="B220">
<label>220</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>RJ</given-names></name><name><surname>Kerr</surname><given-names>DM</given-names></name><name><surname>Flannery</surname><given-names>LE</given-names></name><name><surname>Killilea</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>EM</given-names></name><name><surname>Corcoran</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: an effect partially mediated by central TRPV1</article-title>. <source/>Brain Behav Immun (<year>2017</year>) <volume>62</volume>:<fpage>318</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2017.02.016</pub-id><pub-id pub-id-type="pmid">28237711</pub-id></mixed-citation>
</ref>
<ref id="B221">
<label>221</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoppi</surname><given-names>S</given-names></name><name><surname>Madrigal</surname><given-names>JL</given-names></name><name><surname>Caso</surname><given-names>JR</given-names></name><name><surname>García-Gutiérrez</surname><given-names>MS</given-names></name><name><surname>Manzanares</surname><given-names>J</given-names></name><name><surname>Leza</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice</article-title>. <source/>Br J Pharmacol (<year>2014</year>) <volume>171</volume>:<fpage>2814</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1111/bph.12607</pub-id><pub-id pub-id-type="pmid">24467609</pub-id></mixed-citation>
</ref>
<ref id="B222">
<label>222</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowe</surname><given-names>MS</given-names></name><name><surname>Nass</surname><given-names>SR</given-names></name><name><surname>Gabella</surname><given-names>KM</given-names></name><name><surname>Kinsey</surname><given-names>SG</given-names></name></person-group>. <article-title>The endocannabinoid system modulates stress, emotionality, and inflammation</article-title>. <source/>Brain Behav Immun (<year>2014</year>) <volume>42</volume>:<fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2014.06.007</pub-id><pub-id pub-id-type="pmid">24953427</pub-id></mixed-citation>
</ref>
<ref id="B223">
<label>223</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>RJ</given-names></name><name><surname>Kerr</surname><given-names>DM</given-names></name><name><surname>Finn</surname><given-names>DP</given-names></name><name><surname>Roche</surname><given-names>M</given-names></name></person-group>. <article-title>For whom the endocannabinoid tolls: modulation of innate immune function and implications for psychiatric disorders</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2016</year>) <volume>64</volume>:<fpage>167</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.03.006</pub-id><pub-id pub-id-type="pmid">25794989</pub-id></mixed-citation>
</ref>
<ref id="B224">
<label>224</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirakaj</surname><given-names>V</given-names></name><name><surname>Dalli</surname><given-names>J</given-names></name><name><surname>Granja</surname><given-names>T</given-names></name><name><surname>Rosenberger</surname><given-names>P</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Vagus nerve controls resolution and pro-resolving mediators of inflammation</article-title>. <source/>J Exp Med (<year>2014</year>) <volume>211</volume>:<fpage>1037</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20132103</pub-id><pub-id pub-id-type="pmid">24863066</pub-id></mixed-citation>
</ref>
<ref id="B225">
<label>225</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey</surname><given-names>C</given-names></name><name><surname>Nadjar</surname><given-names>A</given-names></name><name><surname>Buaud</surname><given-names>B</given-names></name><name><surname>Vaysse</surname><given-names>C</given-names></name><name><surname>Aubert</surname><given-names>A</given-names></name><name><surname>Pallet</surname><given-names>V</given-names></name><etal></etal></person-group>
<article-title>Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro</article-title>. <source/>Brain Behav Immun (<year>2016</year>) <volume>55</volume>:<fpage>249</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.12.013</pub-id><pub-id pub-id-type="pmid">26718448</pub-id></mixed-citation>
</ref>
<ref id="B226">
<label>226</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deyama</surname><given-names>S</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>K</given-names></name><name><surname>Shimoda</surname><given-names>K</given-names></name><name><surname>Ide</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway</article-title>. <source/>Int J Neuropsychopharmacol (<year>2017</year>) <volume>20</volume>:<fpage>575</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1093/ijnp/pyx023</pub-id><pub-id pub-id-type="pmid">28419244</pub-id></mixed-citation>
</ref>
<ref id="B227">
<label>227</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Deyama</surname><given-names>S</given-names></name><name><surname>Shimoda</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>K</given-names></name><name><surname>Ide</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model</article-title>. <source/>Behav Brain Res (<year>2017</year>) <volume>332</volume>:<fpage>233</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2017.06.010</pub-id><pub-id pub-id-type="pmid">28610917</pub-id></mixed-citation>
</ref>
<ref id="B228">
<label>228</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leo</surname><given-names>LM</given-names></name><name><surname>Almeida-Corrêa</surname><given-names>S</given-names></name><name><surname>Canetti</surname><given-names>CA</given-names></name><name><surname>Amaral</surname><given-names>OB</given-names></name><name><surname>Bozza</surname><given-names>FA</given-names></name><name><surname>Pamplona</surname><given-names>FA</given-names></name></person-group>. <article-title>Age-dependent relevance of endogenous 5-lipoxygenase derivatives in anxiety-like behavior in mice</article-title>. <source/>PLoS One (<year>2014</year>) <volume>9</volume>:<fpage>e85009</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.00850</pub-id><pub-id pub-id-type="pmid">24416334</pub-id></mixed-citation>
</ref>
<ref id="B229">
<label>229</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>KE</given-names></name><name><surname>DeMars</surname><given-names>KM</given-names></name><name><surname>Alexander</surname><given-names>JC</given-names></name><name><surname>de Leon</surname><given-names>LG</given-names></name><name><surname>Pacheco</surname><given-names>SC</given-names></name><name><surname>Graves</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: protective mechanisms and long-term effects on neurological recovery</article-title>. <source/>Brain Behav (<year>2017</year>) <volume>7</volume>:<fpage>e00688</fpage>.<pub-id pub-id-type="doi">10.1002/brb3.688</pub-id><pub-id pub-id-type="pmid">28523230</pub-id></mixed-citation>
</ref>
<ref id="B230">
<label>230</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>SK</given-names></name><name><surname>Palumbo</surname><given-names>S</given-names></name><name><surname>Bosetti</surname><given-names>F</given-names></name><name><surname>Mount</surname><given-names>HT</given-names></name><name><surname>Kang</surname><given-names>JX</given-names></name><name><surname>Greenwood</surname><given-names>CE</given-names></name><etal></etal></person-group>
<article-title>Unesterified docosahexaenoic acid is protective in neuroinflammation</article-title>. <source/>J Neurochem (<year>2013</year>) <volume>127</volume>:<fpage>378</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1111/jnc.12392</pub-id><pub-id pub-id-type="pmid">23919613</pub-id></mixed-citation>
</ref>
<ref id="B231">
<label>231</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RS</given-names></name></person-group>
<article-title>The macrophage theory of depression</article-title>. <source/>Med Hypotheses (<year>1991</year>) <volume>35</volume>:<fpage>298</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="doi">10.1016/0306-9877(91)90272-Z</pub-id><pub-id pub-id-type="pmid">1943879</pub-id></mixed-citation>
</ref>
<ref id="B232">
<label>232</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Vandoolaeghe</surname><given-names>E</given-names></name><name><surname>Ranjan</surname><given-names>R</given-names></name><name><surname>Bosmans</surname><given-names>E</given-names></name><name><surname>Bergmans</surname><given-names>R</given-names></name><name><surname>Desnyder</surname><given-names>R</given-names></name></person-group>. <article-title>Increased serum interleukin-1-receptor-antagonist concentrations in major depression</article-title>. <source/>J Affect Disord (<year>1995</year>) <volume>36</volume>:<fpage>29</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/0165-0327(95)00049-6</pub-id><pub-id pub-id-type="pmid">8988262</pub-id></mixed-citation>
</ref>
<ref id="B233">
<label>233</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowlati</surname><given-names>Y</given-names></name><name><surname>Herrmann</surname><given-names>N</given-names></name><name><surname>Swardfager</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Sham</surname><given-names>L</given-names></name><name><surname>Reim</surname><given-names>EK</given-names></name><etal></etal></person-group>
<article-title>A meta-analysis of cytokines in major depression</article-title>. <source/>Biol Psychiatry (<year>2010</year>) <volume>67</volume>:<fpage>446</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.033</pub-id><pub-id pub-id-type="pmid">20015486</pub-id></mixed-citation>
</ref>
<ref id="B234">
<label>234</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiawan</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>AA</given-names></name><name><surname>Mizrahi</surname><given-names>R</given-names></name><name><surname>Rusjan</surname><given-names>PM</given-names></name><name><surname>Miler</surname><given-names>L</given-names></name><name><surname>Rajkowska</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes</article-title>. <source/>JAMA Psychiatry (<year>2015</year>) <volume>72</volume>:<fpage>268</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2427</pub-id><pub-id pub-id-type="pmid">25629589</pub-id></mixed-citation>
</ref>
<ref id="B235">
<label>235</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsmith</surname><given-names>DR</given-names></name><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Miller</surname><given-names>BJ</given-names></name></person-group>. <article-title>A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>:<fpage>1696</fpage>–<lpage>709</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2016.3</pub-id><pub-id pub-id-type="pmid">26903267</pub-id></mixed-citation>
</ref>
<ref id="B236">
<label>236</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raison</surname><given-names>CL</given-names></name></person-group>. <article-title>The promise and limitations of anti-inflammatory agents for the treatment of major depressive disorder</article-title>. <source/>Curr Top Behav Neurosci (<year>2017</year>) <volume>31</volume>:<fpage>287</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1007/7854_2016_26</pub-id><pub-id pub-id-type="pmid">27278642</pub-id></mixed-citation>
</ref>
<ref id="B237">
<label>237</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raison</surname><given-names>CL</given-names></name><name><surname>Rutherford</surname><given-names>RE</given-names></name><name><surname>Woolwine</surname><given-names>BJ</given-names></name><name><surname>Shuo</surname><given-names>C</given-names></name><name><surname>Schettler</surname><given-names>P</given-names></name><name><surname>Drake</surname><given-names>DF</given-names></name><etal></etal></person-group>
<article-title>A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers</article-title>. <source/>JAMA Psychiatry (<year>2013</year>) <volume>70</volume>:<fpage>31</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1001/2013.jamapsychiatry.4</pub-id><pub-id pub-id-type="pmid">22945416</pub-id></mixed-citation>
</ref>
<ref id="B238">
<label>238</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Nierenberg</surname><given-names>AA</given-names></name><name><surname>Schettler</surname><given-names>PJ</given-names></name><name><surname>Kinkead</surname><given-names>B</given-names></name><name><surname>Cardoos</surname><given-names>A</given-names></name><name><surname>Walker</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>:<fpage>71</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2015.22</pub-id><pub-id pub-id-type="pmid">25802980</pub-id></mixed-citation>
</ref>
<ref id="B239">
<label>239</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>YY</given-names></name><name><surname>Huang</surname><given-names>KW</given-names></name><name><surname>Kang</surname><given-names>HY</given-names></name><name><surname>Huang</surname><given-names>GYW</given-names></name><name><surname>Huang</surname><given-names>TL</given-names></name></person-group>. <article-title>Antidepressants normalize elevated toll-like receptor profile in major depressive disorder</article-title>. <source/>Psychopharmacology (Berl) (<year>2016</year>) <volume>233</volume>:<fpage>1707</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1007/s00213-015-4087</pub-id><pub-id pub-id-type="pmid">26415953</pub-id></mixed-citation>
</ref>
<ref id="B240">
<label>240</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>R</given-names></name><name><surname>Goshen</surname><given-names>I</given-names></name></person-group>
<article-title>Immune modulation of learning, memory, neural plasticity and neurogenesis</article-title>. <source/>Brain Behav Immun (<year>2011</year>) <volume>25</volume>:<fpage>181</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2010.10.015</pub-id><pub-id pub-id-type="pmid">20970492</pub-id></mixed-citation>
</ref>
<ref id="B241">
<label>241</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derecki</surname><given-names>NC</given-names></name><name><surname>Cardani</surname><given-names>AN</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Quinnies</surname><given-names>KM</given-names></name><name><surname>Crihfield</surname><given-names>A</given-names></name><name><surname>Lynch</surname><given-names>KR</given-names></name><etal></etal></person-group>
<article-title>Regulation of learning and memory by meningeal immunity: a key role for IL-4</article-title>. <source/>J Exp Med (<year>2010</year>) <volume>207</volume>:<fpage>1067</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091419</pub-id><pub-id pub-id-type="pmid">20439540</pub-id></mixed-citation>
</ref>
<ref id="B242">
<label>242</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filiano</surname><given-names>AJ</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Tustison</surname><given-names>NJ</given-names></name><name><surname>Marsh</surname><given-names>RL</given-names></name><name><surname>Baker</surname><given-names>W</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour</article-title>. <source/>Nature (<year>2016</year>) <volume>535</volume>:<fpage>425</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature18626</pub-id><pub-id pub-id-type="pmid">27409813</pub-id></mixed-citation>
</ref>
<ref id="B243">
<label>243</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keri</surname><given-names>S</given-names></name><name><surname>Szabo</surname><given-names>C</given-names></name><name><surname>Kelemen</surname><given-names>O</given-names></name></person-group>. <article-title>Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder</article-title>. <source/>Brain Behav Immun (<year>2014</year>) <volume>40</volume>:<fpage>235</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2014</pub-id><pub-id pub-id-type="pmid">24726793</pub-id></mixed-citation>
</ref>
<ref id="B244">
<label>244</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseribafrouei</surname><given-names>A</given-names></name><name><surname>Hestad</surname><given-names>K</given-names></name><name><surname>Avershina</surname><given-names>E</given-names></name><name><surname>Sekelja</surname><given-names>M</given-names></name><name><surname>Linlokken</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Correlation between the human fecal microbiota and depression</article-title>. <source/>Neurogastroenterol Motil (<year>2014</year>) <volume>26</volume>:<fpage>1155</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12378</pub-id><pub-id pub-id-type="pmid">24888394</pub-id></mixed-citation>
</ref>
<ref id="B245">
<label>245</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><etal></etal></person-group>
<article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>:<fpage>786</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2016.44</pub-id><pub-id pub-id-type="pmid">27067014</pub-id></mixed-citation>
</ref>
<ref id="B246">
<label>246</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Ling</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Altered fecal microbiota composition in patients with major depressive disorder</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>48</volume>:<fpage>186</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.03.016</pub-id><pub-id pub-id-type="pmid">25882912</pub-id></mixed-citation>
</ref>
<ref id="B247">
<label>247</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Backhed</surname><given-names>F</given-names></name><name><surname>Turnbaugh</surname><given-names>P</given-names></name><name><surname>Lozupone</surname><given-names>CA</given-names></name><name><surname>Knight</surname><given-names>RD</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<article-title>Obesity alters gut microbial ecology</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2005</year>) <volume>102</volume>:<fpage>11070</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0504978102</pub-id><pub-id pub-id-type="pmid">16033867</pub-id></mixed-citation>
</ref>
<ref id="B248">
<label>248</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajilic-Stojanovic</surname><given-names>M</given-names></name><name><surname>Biagi</surname><given-names>E</given-names></name><name><surname>Heilig</surname><given-names>HG</given-names></name><name><surname>Kajander</surname><given-names>K</given-names></name><name><surname>Kekkonen</surname><given-names>RA</given-names></name><name><surname>Tims</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome</article-title>. <source/>Gastroenterology (<year>2011</year>) <volume>141</volume>:<fpage>1792</fpage>–<lpage>801</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2011.07.043</pub-id><pub-id pub-id-type="pmid">21820992</pub-id></mixed-citation>
</ref>
<ref id="B249">
<label>249</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>IB</given-names></name><name><surname>O’Toole</surname><given-names>PW</given-names></name><name><surname>Ohman</surname><given-names>L</given-names></name><name><surname>Claesson</surname><given-names>MJ</given-names></name><name><surname>Deane</surname><given-names>J</given-names></name><name><surname>Quigley</surname><given-names>EM</given-names></name><etal></etal></person-group>
<article-title>An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota</article-title>. <source/>Gut (<year>2012</year>) <volume>61</volume>:<fpage>997</fpage>–<lpage>1006</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2011-301501</pub-id><pub-id pub-id-type="pmid">22180058</pub-id></mixed-citation>
</ref>
<ref id="B250">
<label>250</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Borre</surname><given-names>Y</given-names></name><name><surname>O’Brien</surname><given-names>C</given-names></name><name><surname>Patterson</surname><given-names>E</given-names></name><name><surname>El Aidy</surname><given-names>S</given-names></name><name><surname>Deane</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title>. <source/>J Psychiatr Res (<year>2016</year>) <volume>82</volume>:<fpage>109</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.07.019</pub-id><pub-id pub-id-type="pmid">27491067</pub-id></mixed-citation>
</ref>
<ref id="B251">
<label>251</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslanik</surname><given-names>T</given-names></name><name><surname>Tannura</surname><given-names>K</given-names></name><name><surname>Mahaffey</surname><given-names>L</given-names></name><name><surname>Loughridge</surname><given-names>AB</given-names></name><name><surname>Beninson</surname><given-names>L</given-names></name><name><surname>Ursell</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Commensal bacteria and MAMPs are necessary for stress-induced increases in IL-1β and IL-18 but not IL-6, IL-10 or MCP-1</article-title>. <source/>PLoS One (<year>2012</year>) <volume>7</volume>:<fpage>e50636</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0050636</pub-id><pub-id pub-id-type="pmid">23236381</pub-id></mixed-citation>
</ref>
<ref id="B252">
<label>252</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Hyland</surname><given-names>NP</given-names></name></person-group>. <article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>. <source/>Front Cell Neurosci (<year>2015</year>) <volume>9</volume>:<fpage>392</fpage>.<pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id><pub-id pub-id-type="pmid">26528128</pub-id></mixed-citation>
</ref>
<ref id="B253">
<label>253</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galley</surname><given-names>JD</given-names></name><name><surname>Nelson</surname><given-names>MC</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name><name><surname>Walter</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>PS</given-names></name><etal></etal></person-group>
<article-title>Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota</article-title>. <source/>BMC Microbiol (<year>2014</year>) <volume>14</volume>:<fpage>189</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-14-189</pub-id><pub-id pub-id-type="pmid">25028050</pub-id></mixed-citation>
</ref>
<ref id="B254">
<label>254</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafuse</surname><given-names>WP</given-names></name><name><surname>Gearinger</surname><given-names>R</given-names></name><name><surname>Fisher</surname><given-names>S</given-names></name><name><surname>Nealer</surname><given-names>C</given-names></name><name><surname>Mackos</surname><given-names>AR</given-names></name><name><surname>Bailey</surname><given-names>MT</given-names></name></person-group>. <article-title>Exposure to a social stressor induces translocation of commensal lactobacilli to the spleen and priming of the innate immune system</article-title>. <source/>J Immunol (<year>2017</year>) <volume>198</volume>:<fpage>2383</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601269</pub-id><pub-id pub-id-type="pmid">28167628</pub-id></mixed-citation>
</ref>
<ref id="B255">
<label>255</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gárate</surname><given-names>I</given-names></name><name><surname>Garcia-Bueno</surname><given-names>B</given-names></name><name><surname>Madrigal</surname><given-names>JL</given-names></name><name><surname>Caso</surname><given-names>JR</given-names></name><name><surname>Alou</surname><given-names>L</given-names></name><name><surname>Gomez-Lus</surname><given-names>ML</given-names></name><etal></etal></person-group>
<article-title>Stress-induced neuroinflammation: role of the toll-like receptor-4 pathway</article-title>. <source/>Biol Psychiatry (<year>2013</year>) <volume>73</volume>:<fpage>32</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2012.07.005</pub-id><pub-id pub-id-type="pmid">22906518</pub-id></mixed-citation>
</ref>
<ref id="B256">
<label>256</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>AC</given-names></name><name><surname>Rocha</surname><given-names>NP</given-names></name><name><surname>Nicoli</surname><given-names>JR</given-names></name><name><surname>Vieira</surname><given-names>LQ</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Teixeira</surname><given-names>AL</given-names></name></person-group>. <article-title>Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes in mice</article-title>. <source/>Behav Brain Res (<year>2016</year>) <volume>312</volume>:<fpage>186</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2016.06.027</pub-id><pub-id pub-id-type="pmid">27316342</pub-id></mixed-citation>
</ref>
<ref id="B257">
<label>257</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JC</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis</article-title>. <source/>Transl Psychiatry (<year>2017</year>) <volume>7</volume>:<fpage>e1138</fpage>.<pub-id pub-id-type="doi">10.1038/tp.2017.112</pub-id><pub-id pub-id-type="pmid">28556833</pub-id></mixed-citation>
</ref>
<ref id="B258">
<label>258</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikocka-Walus</surname><given-names>A</given-names></name><name><surname>Knowles</surname><given-names>SR</given-names></name><name><surname>Keefer</surname><given-names>L</given-names></name><name><surname>Graff</surname><given-names>L</given-names></name></person-group>. <article-title>Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases</article-title>. <source/>Inflamm Bowel Dis (<year>2016</year>) <volume>22</volume>:<fpage>752</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1097/MIB.0000000000000620</pub-id><pub-id pub-id-type="pmid">26841224</pub-id></mixed-citation>
</ref>
<ref id="B259">
<label>259</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persoons</surname><given-names>P</given-names></name><name><surname>Vermeire</surname><given-names>S</given-names></name><name><surname>Demyttenaere</surname><given-names>K</given-names></name><name><surname>Fischler</surname><given-names>B</given-names></name><name><surname>Vandenberghe</surname><given-names>J</given-names></name><name><surname>Van Oudenhove</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>The impact of major depressive disorder on the short-and long-term outcome of Crohn’s disease treatment with infliximab</article-title>. <source/>Aliment Pharmacol Ther (<year>2005</year>) <volume>22</volume>:<fpage>101</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2036.2005.02535.x</pub-id><pub-id pub-id-type="pmid">16011668</pub-id></mixed-citation>
</ref>
<ref id="B260">
<label>260</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ananthakrishnan</surname><given-names>AN</given-names></name></person-group>. <article-title>Epidemiology and risk factors for IBD</article-title>. <source/>Nat Rev Gastroenterol Hepatol (<year>2015</year>) <volume>12</volume>:<fpage>205</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1038/nrgastro.2015.34</pub-id><pub-id pub-id-type="pmid">25732745</pub-id></mixed-citation>
</ref>
<ref id="B261">
<label>261</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dothel</surname><given-names>G</given-names></name><name><surname>Vasina</surname><given-names>V</given-names></name><name><surname>Barbara</surname><given-names>G</given-names></name><name><surname>De Ponti</surname><given-names>F</given-names></name></person-group>. <article-title>Animal models of chemically induced intestinal inflammation: predictivity and ethical issues</article-title>. <source/>Pharmacol Ther (<year>2013</year>) <volume>139</volume>:<fpage>71</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.04.005</pub-id><pub-id pub-id-type="pmid">23563278</pub-id></mixed-citation>
</ref>
<ref id="B262">
<label>262</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seregin</surname><given-names>SS</given-names></name><name><surname>Golovchenko</surname><given-names>N</given-names></name><name><surname>Schaf</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Pudlo</surname><given-names>NA</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>NLRP6 protects Il10-/- mice from colitis by limiting colonization of Akkermansia muciniphila</article-title>. <source/>Cell Rep (<year>2017</year>) <volume>19</volume>:<fpage>733</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.080</pub-id><pub-id pub-id-type="pmid">28445725</pub-id></mixed-citation>
</ref>
<ref id="B263">
<label>263</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Schuligoi</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Repeated predictable stress causes resilience against colitis-induced behavioral changes in mice</article-title>. <source/>Front Behav Neurosci (<year>2014</year>) <volume>8</volume>:<fpage>386</fpage>.<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00386</pub-id><pub-id pub-id-type="pmid">25414650</pub-id></mixed-citation>
</ref>
<ref id="B264">
<label>264</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emge</surname><given-names>JR</given-names></name><name><surname>Huynh</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>EN</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name><name><surname>Reardon</surname><given-names>C</given-names></name><name><surname>Barrett</surname><given-names>KE</given-names></name><etal></etal></person-group>
<article-title>Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease</article-title>. <source/>Am J Physiol (<year>2016</year>) <volume>310</volume>:<fpage>G989</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00086.2016</pub-id><pub-id pub-id-type="pmid">27056723</pub-id></mixed-citation>
</ref>
<ref id="B265">
<label>265</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Winston</surname><given-names>JH</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Guptarak</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>KL</given-names></name><name><surname>Shi</surname><given-names>XZ</given-names></name><etal></etal></person-group>
<article-title>Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation</article-title>. <source/>Am J Physiol (<year>2015</year>) <volume>308</volume>:<fpage>R18</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1152/ajpregu.00298.2014</pub-id><pub-id pub-id-type="pmid">25411361</pub-id></mixed-citation>
</ref>
<ref id="B266">
<label>266</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Painsipp</surname><given-names>E</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Environmental enrichment and gut inflammation modify stress-induced c-fos expression in the mouse corticolimbic system</article-title>. <source/>PLoS One (<year>2013</year>) <volume>8</volume>:<fpage>e54811</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0054811</pub-id><pub-id pub-id-type="pmid">23349972</pub-id></mixed-citation>
</ref>
<ref id="B267">
<label>267</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Schuligoi</surname><given-names>R</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>. <article-title>Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice</article-title>. <source/>Sci Rep (<year>2015</year>) <volume>5</volume>:<fpage>9970</fpage>.<pub-id pub-id-type="doi">10.1038/srep09970</pub-id><pub-id pub-id-type="pmid">26066467</pub-id></mixed-citation>
</ref>
<ref id="B268">
<label>268</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>
<article-title>Neuropeptide Y: a stressful review</article-title>. <source/>Neuropeptides (<year>2016</year>) <volume>55</volume>:<fpage>99</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="doi">10.1016/j.npep.2015.09.008</pub-id><pub-id pub-id-type="pmid">26441327</pub-id></mixed-citation>
</ref>
<ref id="B269">
<label>269</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabban</surname><given-names>EL</given-names></name><name><surname>Alaluf</surname><given-names>LG</given-names></name><name><surname>Serova</surname><given-names>LI</given-names></name></person-group>
<article-title>Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder</article-title>. <source/>Neuropeptides (<year>2016</year>) <volume>56</volume>:<fpage>19</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/j.npep.2015.11.004</pub-id><pub-id pub-id-type="pmid">26617395</pub-id></mixed-citation>
</ref>
<ref id="B270">
<label>270</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heydarpour</surname><given-names>P</given-names></name><name><surname>Rahimian</surname><given-names>R</given-names></name><name><surname>Fakhfouri</surname><given-names>G</given-names></name><name><surname>Khoshkish</surname><given-names>S</given-names></name><name><surname>Fakhraei</surname><given-names>N</given-names></name><name><surname>Salehi-Sadaghiani</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Behavioral despair associated with a mouse model of Crohn’s disease: role of nitric oxide pathway</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2016</year>) <volume>64</volume>:<fpage>131</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.08.004</pub-id><pub-id pub-id-type="pmid">26268932</pub-id></mixed-citation>
</ref>
<ref id="B271">
<label>271</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riazi</surname><given-names>K</given-names></name><name><surname>Galic</surname><given-names>MA</given-names></name><name><surname>Kentner</surname><given-names>AC</given-names></name><name><surname>Reid</surname><given-names>AY</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Pittman</surname><given-names>QJ</given-names></name></person-group>. <article-title>Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation</article-title>. <source/>J Neurosci (<year>2015</year>) <volume>35</volume>:<fpage>4942</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4485-14</pub-id><pub-id pub-id-type="pmid">25810524</pub-id></mixed-citation>
</ref>
<ref id="B272">
<label>272</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyuyki</surname><given-names>KD</given-names></name><name><surname>Pittman</surname><given-names>QJ</given-names></name></person-group>. <article-title>Toward a better understanding of the central consequences of intestinal inflammation</article-title>. <source/>Ann N Y Acad Sci (<year>2015</year>) <volume>1351</volume>:<fpage>149</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1111/nyas.12935</pub-id><pub-id pub-id-type="pmid">26378439</pub-id></mixed-citation>
</ref>
<ref id="B273">
<label>273</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riazi</surname><given-names>K</given-names></name><name><surname>Galic</surname><given-names>MA</given-names></name><name><surname>Kuzmiski</surname><given-names>JB</given-names></name><name><surname>Ho</surname><given-names>W</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Pittman</surname><given-names>QJ</given-names></name></person-group>. <article-title>Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2008</year>) <volume>105</volume>:<fpage>17151</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0806682105</pub-id><pub-id pub-id-type="pmid">18955701</pub-id></mixed-citation>
</ref>
<ref id="B274">
<label>274</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtys</surname><given-names>E</given-names></name><name><surname>Doorduin</surname><given-names>J</given-names></name><name><surname>Eisel</surname><given-names>UL</given-names></name><name><surname>Dierckx</surname><given-names>RA</given-names></name><name><surname>de Vries</surname><given-names>EF</given-names></name></person-group>. <article-title>Evaluating [<sup>11</sup>C]PBR28 PET for monitoring gut and brain inflammation in a rat model of chemically induced colitis</article-title>. <source/>Mol Imaging Biol (<year>2017</year>) <volume>19</volume>:<fpage>68</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1007/s11307-016-0979-0</pub-id><pub-id pub-id-type="pmid">27402092</pub-id></mixed-citation>
</ref>
<ref id="B275">
<label>275</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bercik</surname><given-names>P</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Foster</surname><given-names>JA</given-names></name><name><surname>Macri</surname><given-names>J</given-names></name><name><surname>Potter</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><etal></etal></person-group>
<article-title>Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice</article-title>. <source/>Gastroenterology (<year>2010</year>) <volume>139</volume>:<fpage>2102</fpage>–<lpage>12.e1</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro</pub-id><pub-id pub-id-type="pmid">20600016</pub-id></mixed-citation>
</ref>
<ref id="B276">
<label>276</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielefeldt</surname><given-names>K</given-names></name><name><surname>Davis</surname><given-names>B</given-names></name><name><surname>Binion</surname><given-names>DG</given-names></name></person-group>
<article-title>Pain and inflammatory bowel disease</article-title>. <source/>Inflamm Bowel Dis (<year>2009</year>) <volume>15</volume>:<fpage>778</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1002/ibd.20848</pub-id><pub-id pub-id-type="pmid">19130619</pub-id></mixed-citation>
</ref>
<ref id="B277">
<label>277</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Koyani</surname><given-names>CN</given-names></name><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Behavioral and molecular processing of visceral pain in the brain of mice: impact of colitis and psychological stress</article-title>. <source/>Front Behav Neurosci (<year>2015</year>) <volume>9</volume>:<fpage>177</fpage>.<pub-id pub-id-type="doi">10.3389/fnbeh.2015.00177</pub-id><pub-id pub-id-type="pmid">26217204</pub-id></mixed-citation>
</ref>
<ref id="B278">
<label>278</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriksen</surname><given-names>M</given-names></name><name><surname>Jahnsen</surname><given-names>J</given-names></name><name><surname>Lygren</surname><given-names>I</given-names></name><name><surname>Sauar</surname><given-names>J</given-names></name><name><surname>Kjellevold</surname><given-names>Ø</given-names></name><name><surname>Schulz</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study)</article-title>. <source/>Inflamm Bowel Dis (<year>2006</year>) <volume>12</volume>:<fpage>543</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1097/01.MIB.0000225339.91484.fc</pub-id><pub-id pub-id-type="pmid">16804390</pub-id></mixed-citation>
</ref>
<ref id="B279">
<label>279</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eijkelkamp</surname><given-names>N</given-names></name><name><surname>Kavelaars</surname><given-names>A</given-names></name><name><surname>Elsenbruch</surname><given-names>S</given-names></name><name><surname>Schedlowski</surname><given-names>M</given-names></name><name><surname>Holtmann</surname><given-names>G</given-names></name><name><surname>Heijnen</surname><given-names>CJ</given-names></name></person-group>. <article-title>Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior</article-title>. <source/>Am J Physiol (<year>2007</year>) <volume>293</volume>:<fpage>G749</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00114.2007</pub-id><pub-id pub-id-type="pmid">17656446</pub-id></mixed-citation>
</ref>
<ref id="B280">
<label>280</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapointe</surname><given-names>TK</given-names></name><name><surname>Basso</surname><given-names>L</given-names></name><name><surname>Iftinca</surname><given-names>MC</given-names></name><name><surname>Flynn</surname><given-names>R</given-names></name><name><surname>Chapman</surname><given-names>K</given-names></name><name><surname>Dietrich</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>TRPV1 sensitization mediates postinflammatory visceral pain following acute colitis</article-title>. <source/>Am J Physiol (<year>2015</year>) <volume>309</volume>:<fpage>G87</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00421.2014</pub-id></mixed-citation>
</ref>
<ref id="B281">
<label>281</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gschossmann</surname><given-names>JM</given-names></name><name><surname>Liebregts</surname><given-names>T</given-names></name><name><surname>Adam</surname><given-names>B</given-names></name><name><surname>Buenger</surname><given-names>L</given-names></name><name><surname>Ruwe</surname><given-names>M</given-names></name><name><surname>Gerken</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Long-term effects of transient chemically induced colitis on the visceromotor response to mechanical colorectal distension</article-title>. <source/>Dig Dis Sci (<year>2004</year>) <volume>49</volume>:<fpage>96</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1023/B:DDAS.0000011609.68882.3a</pub-id><pub-id pub-id-type="pmid">14992442</pub-id></mixed-citation>
</ref>
<ref id="B282">
<label>282</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>A</given-names></name><name><surname>Nordstrom</surname><given-names>E</given-names></name><name><surname>Mannem</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Banerjee</surname><given-names>B</given-names></name><name><surname>Sengupta</surname><given-names>JN</given-names></name></person-group>. <article-title>The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis</article-title>. <source/>Neuroscience (<year>2007</year>) <volume>148</volume>:<fpage>1021</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.05.034</pub-id><pub-id pub-id-type="pmid">17719181</pub-id></mixed-citation>
</ref>
<ref id="B283">
<label>283</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilderink</surname><given-names>PH</given-names></name><name><surname>Burger</surname><given-names>H</given-names></name><name><surname>Deeg</surname><given-names>DJ</given-names></name><name><surname>Beekman</surname><given-names>AT</given-names></name><name><surname>Oude Voshaar</surname><given-names>RC</given-names></name></person-group>. <article-title>The temporal relation between pain and depression: results from the longitudinal aging study Amsterdam</article-title>. <source/>Psychosom Med (<year>2012</year>) <volume>74</volume>:<fpage>945</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1097/PSY.0b013e3182733fdd</pub-id><pub-id pub-id-type="pmid">23115345</pub-id></mixed-citation>
</ref>
<ref id="B284">
<label>284</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerrits</surname><given-names>MM</given-names></name><name><surname>van Oppen</surname><given-names>P</given-names></name><name><surname>van Marwijk</surname><given-names>HW</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>van der Horst</surname><given-names>HE</given-names></name></person-group>
<article-title>Pain and the onset of depressive and anxiety disorders</article-title>. <source/>Pain (<year>2014</year>) <volume>155</volume>:<fpage>53</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.pain.2013.09.005</pub-id><pub-id pub-id-type="pmid">24012953</pub-id></mixed-citation>
</ref>
<ref id="B285">
<label>285</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodhand</surname><given-names>JR</given-names></name><name><surname>Wahed</surname><given-names>M</given-names></name><name><surname>Mawdsley</surname><given-names>JE</given-names></name><name><surname>Farmer</surname><given-names>AD</given-names></name><name><surname>Aziz</surname><given-names>Q</given-names></name><name><surname>Rampton</surname><given-names>DS</given-names></name></person-group>. <article-title>Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors</article-title>. <source/>Inflamm Bowel Dis (<year>2012</year>) <volume>18</volume>:<fpage>2301</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/ibd.22916</pub-id><pub-id pub-id-type="pmid">22359369</pub-id></mixed-citation>
</ref>
<ref id="B286">
<label>286</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Salhy</surname><given-names>M</given-names></name><name><surname>Suhr</surname><given-names>O</given-names></name><name><surname>Danielsson</surname><given-names>A</given-names></name></person-group>. <article-title>Peptide YY in gastrointestinal disorders</article-title>. <source/>Peptides (<year>2002</year>) <volume>23</volume>:<fpage>397</fpage>–<lpage>402</lpage>.<pub-id pub-id-type="doi">10.1016/S0196-9781(01)00617-9</pub-id><pub-id pub-id-type="pmid">11825655</pub-id></mixed-citation>
</ref>
<ref id="B287">
<label>287</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>J</given-names></name><name><surname>Beglinger</surname><given-names>C</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>Andresen</surname><given-names>V</given-names></name><name><surname>Layer</surname><given-names>P</given-names></name></person-group>
<article-title>Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract</article-title>. <source/>Am J Physiol (<year>2009</year>) <volume>297</volume>:<fpage>G861</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00145.2009</pub-id></mixed-citation>
</ref>
<ref id="B288">
<label>288</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>GW</given-names></name><name><surname>Pennock</surname><given-names>J</given-names></name><name><surname>McLaughlin</surname><given-names>JT</given-names></name></person-group>. <article-title>Enteroendocrine cells in terminal ileal Crohn’s disease</article-title>. <source/>J Crohns Colitis (<year>2012</year>) <volume>6</volume>:<fpage>871</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.crohns.2012.01.013</pub-id><pub-id pub-id-type="pmid">22398079</pub-id></mixed-citation>
</ref>
<ref id="B289">
<label>289</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirotani</surname><given-names>Y</given-names></name><name><surname>Mikajiri</surname><given-names>K</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Myotoku</surname><given-names>M</given-names></name><name><surname>Kurokawa</surname><given-names>N</given-names></name></person-group>
<article-title>Changes of intestinal mucosal and plasma PYY in a diarrhea model rat and influence of loperamide as the treatment agent for diarrhea</article-title>. <source/>Yakugaku Zasshi (<year>2008</year>) <volume>128</volume>:<fpage>1311</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1248/yakushi.128.1311</pub-id><pub-id pub-id-type="pmid">18758145</pub-id></mixed-citation>
</ref>
<ref id="B290">
<label>290</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Salhy</surname><given-names>M</given-names></name><name><surname>Hatlebakk</surname><given-names>JG</given-names></name></person-group>. <article-title>Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats</article-title>. <source/>Mol Med Rep (<year>2016</year>) <volume>14</volume>:<fpage>4967</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.3892/mmr.2016.5902</pub-id><pub-id pub-id-type="pmid">27840918</pub-id></mixed-citation>
</ref>
<ref id="B291">
<label>291</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Salhy</surname><given-names>M</given-names></name><name><surname>Hatlebakk</surname><given-names>JG</given-names></name><name><surname>Gilja</surname><given-names>OH</given-names></name></person-group>
<article-title>Abnormalities in endocrine and immune cells are correlated in dextran-sulfate-sodium-induced colitis in rats</article-title>. <source/>Mol Med Rep (<year>2017</year>) <volume>15</volume>:<fpage>12</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.3892/mmr.2016.6023</pub-id><pub-id pub-id-type="pmid">27959399</pub-id></mixed-citation>
</ref>
<ref id="B292">
<label>292</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadlbauer</surname><given-names>U</given-names></name><name><surname>Langhans</surname><given-names>W</given-names></name><name><surname>Meyer</surname><given-names>U</given-names></name></person-group>. <article-title>Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia</article-title>. <source/>Neuropsychopharmacology (<year>2013</year>) <volume>38</volume>:<fpage>2446</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1038/npp.2013.146</pub-id><pub-id pub-id-type="pmid">23748226</pub-id></mixed-citation>
</ref>
<ref id="B293">
<label>293</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AM</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Mayerhofer</surname><given-names>R</given-names></name><name><surname>Fröhlich</surname><given-names>EE</given-names></name><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism</article-title>. <source/>Sci Rep (<year>2017</year>) <volume>7</volume>:<fpage>40968</fpage>.<pub-id pub-id-type="doi">10.1038/srep40968</pub-id><pub-id pub-id-type="pmid">28106168</pub-id></mixed-citation>
</ref>
<ref id="B294">
<label>294</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderberg</surname><given-names>RH</given-names></name><name><surname>Richard</surname><given-names>JE</given-names></name><name><surname>Hansson</surname><given-names>C</given-names></name><name><surname>Nissbrandt</surname><given-names>H</given-names></name><name><surname>Bergquist</surname><given-names>F</given-names></name><name><surname>Skibicka</surname><given-names>KP</given-names></name></person-group>. <article-title>GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality</article-title>. <source/>Psychoneuroendocrinology (<year>2016</year>) <volume>65</volume>:<fpage>54</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.11.021</pub-id><pub-id pub-id-type="pmid">26724568</pub-id></mixed-citation>
</ref>
<ref id="B295">
<label>295</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellström</surname><given-names>PM</given-names></name><name><surname>Hein</surname><given-names>J</given-names></name><name><surname>Bytzer</surname><given-names>P</given-names></name><name><surname>Björnssön</surname><given-names>E</given-names></name><name><surname>Kristensen</surname><given-names>J</given-names></name><name><surname>Schambye</surname><given-names>H</given-names></name></person-group>. <article-title>Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study</article-title>. <source/>Aliment Pharmacol Ther (<year>2009</year>) <volume>29</volume>:<fpage>198</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2036.2008.03870.x</pub-id><pub-id pub-id-type="pmid">18945254</pub-id></mixed-citation>
</ref>
<ref id="B296">
<label>296</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nozu</surname><given-names>T</given-names></name><name><surname>Miyagishi</surname><given-names>S</given-names></name><name><surname>Kumei</surname><given-names>S</given-names></name><name><surname>Nozu</surname><given-names>R</given-names></name><name><surname>Takakusaki</surname><given-names>K</given-names></name><name><surname>Okumura</surname><given-names>T</given-names></name></person-group>
<article-title>A glucagon-like peptide-1 analog, liraglutide improves visceral sensation and gut permeability in rats</article-title>. <source/>J Gastroenterol Hepatol (<year>2017</year>).<pub-id pub-id-type="doi">10.1111/jgh.13808</pub-id></mixed-citation>
</ref>
<ref id="B297">
<label>297</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity</article-title>. <source/>J Neurosci (<year>2014</year>) <volume>34</volume>:<fpage>5322</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4703-13.2014</pub-id><pub-id pub-id-type="pmid">24719110</pub-id></mixed-citation>
</ref>
<ref id="B298">
<label>298</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudo</surname><given-names>N</given-names></name><name><surname>Chida</surname><given-names>Y</given-names></name><name><surname>Aiba</surname><given-names>Y</given-names></name><name><surname>Sonoda</surname><given-names>J</given-names></name><name><surname>Oyama</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>XN</given-names></name><etal></etal></person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source/>J Physiol (<year>2004</year>) <volume>558</volume>:<fpage>263</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id><pub-id pub-id-type="pmid">15133062</pub-id></mixed-citation>
</ref>
<ref id="B299">
<label>299</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>K</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>The microbiome: a key regulator of stress and neuroinflammation</article-title>. <source/>Neurobiol Stress (<year>2016</year>) <volume>4</volume>:<fpage>23</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.ynstr.2016.03.001</pub-id><pub-id pub-id-type="pmid">27981187</pub-id></mixed-citation>
</ref>
<ref id="B300">
<label>300</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczynski</surname><given-names>P</given-names></name><name><surname>Whelan</surname><given-names>SO</given-names></name><name><surname>O’Sullivan</surname><given-names>C</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal></etal></person-group>
<article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus</article-title>. <source/>Eur J Neurosci (<year>2016</year>) <volume>44</volume>:<fpage>2654</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1111/ejn.13291</pub-id><pub-id pub-id-type="pmid">27256072</pub-id></mixed-citation>
</ref>
<ref id="B301">
<label>301</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczynski</surname><given-names>P</given-names></name><name><surname>Tramullas</surname><given-names>M</given-names></name><name><surname>Viola</surname><given-names>M</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>O’Mahony</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Microbiota regulates visceral pain in the mouse</article-title>. <source/>Elife (<year>2017</year>) <volume>6</volume>:<fpage>e25887</fpage>.<pub-id pub-id-type="doi">10.7554/eLife.25887</pub-id><pub-id pub-id-type="pmid">28629511</pub-id></mixed-citation>
</ref>
<ref id="B302">
<label>302</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz Heijtz</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Anuar</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Björkholm</surname><given-names>B</given-names></name><name><surname>Samuelsson</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2011</year>) <volume>108</volume>:<fpage>3047</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmid">21282636</pub-id></mixed-citation>
</ref>
<ref id="B303">
<label>303</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Ryan</surname><given-names>FJ</given-names></name><name><surname>Hoban</surname><given-names>AE</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Claesson</surname><given-names>MJ</given-names></name><etal></etal></person-group>
<article-title>Microbes &amp; neurodevelopment – absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>50</volume>:<fpage>209</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.07.009</pub-id><pub-id pub-id-type="pmid">26184083</pub-id></mixed-citation>
</ref>
<ref id="B304">
<label>304</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoban</surname><given-names>AE</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Moloney</surname><given-names>G</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>The microbiome regulates amygdala-dependent fear recall</article-title>. <source/>Mol Psychiatry (<year>2017</year>).<pub-id pub-id-type="doi">10.1038/mp.2017.100</pub-id><pub-id pub-id-type="pmid">28507320</pub-id></mixed-citation>
</ref>
<ref id="B305">
<label>305</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarr</surname><given-names>AJ</given-names></name><name><surname>Galley</surname><given-names>JD</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Chichlowski</surname><given-names>M</given-names></name><name><surname>Berg</surname><given-names>BM</given-names></name><name><surname>Bailey</surname><given-names>MT</given-names></name></person-group>. <article-title>The prebiotics 3’sialyllactose and 6’sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: evidence for effects on the gut-brain axis</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>50</volume>:<fpage>166</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.06.025</pub-id><pub-id pub-id-type="pmid">26144888</pub-id></mixed-citation>
</ref>
<ref id="B306">
<label>306</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burokas</surname><given-names>A</given-names></name><name><surname>Arboleya</surname><given-names>S</given-names></name><name><surname>Moloney</surname><given-names>RD</given-names></name><name><surname>Peterson</surname><given-names>VL</given-names></name><name><surname>Murphy</surname><given-names>K</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice</article-title>. <source/>Biol Psychiatry (<year>2017</year>) <volume>82</volume>(<issue>7</issue>):<fpage>472</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.12.031</pub-id><pub-id pub-id-type="pmid">28242013</pub-id></mixed-citation>
</ref>
<ref id="B307">
<label>307</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deiteren</surname><given-names>A</given-names></name><name><surname>Vermeulen</surname><given-names>W</given-names></name><name><surname>Moreels</surname><given-names>TG</given-names></name><name><surname>Pelckmans</surname><given-names>PA</given-names></name><name><surname>De Man</surname><given-names>JG</given-names></name><name><surname>De Winter</surname><given-names>BY</given-names></name></person-group>. <article-title>The effect of chemically induced colitis, psychological stress and their combination on visceral pain in female Wistar rats</article-title>. <source/>Stress (<year>2014</year>) <volume>17</volume>:<fpage>431</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.3109/10253890.2014.951034</pub-id><pub-id pub-id-type="pmid">25089934</pub-id></mixed-citation>
</ref>
<ref id="B308">
<label>308</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>SO</given-names></name></person-group>
<article-title>Stress and animal models of inflammatory bowel disease – an update on the role of the hypothalamo-pituitary-adrenal axis</article-title>. <source/>Psychoneuroendocrinology (<year>2012</year>) <volume>37</volume>:<fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.05.014</pub-id><pub-id pub-id-type="pmid">21741177</pub-id></mixed-citation>
</ref>
<ref id="B309">
<label>309</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>BG</given-names></name><name><surname>Lee</surname><given-names>KL</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name></person-group>. <article-title>Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice</article-title>. <source/>World J Gastroenterol (<year>2015</year>) <volume>21</volume>:<fpage>8580</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v21.i28.8580</pub-id><pub-id pub-id-type="pmid">26229400</pub-id></mixed-citation>
</ref>
<ref id="B310">
<label>310</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>EM</given-names></name><name><surname>Maharshak</surname><given-names>N</given-names></name><name><surname>Elloumi</surname><given-names>H</given-names></name><name><surname>Borst</surname><given-names>L</given-names></name><name><surname>Plevy</surname><given-names>SE</given-names></name><name><surname>Moeser</surname><given-names>AJ</given-names></name></person-group>. <article-title>Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10<sup>-/-</sup> mice</article-title>. <source/>Inflamm Bowel Dis (<year>2013</year>) <volume>19</volume>:<fpage>712</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/MIB.0b013e3182802a4e</pub-id><pub-id pub-id-type="pmid">23446335</pub-id></mixed-citation>
</ref>
<ref id="B311">
<label>311</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaser</surname><given-names>A</given-names></name><name><surname>Zeissig</surname><given-names>S</given-names></name><name><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?</article-title>
<source/>Dig Dis (<year>2010</year>) <volume>28</volume>:<fpage>395</fpage>–<lpage>405</lpage>.<pub-id pub-id-type="doi">10.1159/000320393</pub-id><pub-id pub-id-type="pmid">20926863</pub-id></mixed-citation>
</ref>
<ref id="B312">
<label>312</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hunt</surname><given-names>NH</given-names></name><name><surname>Bao</surname><given-names>S</given-names></name></person-group>. <article-title>The effect of restraint stress on experimental colitis is IFN-gamma independent</article-title>. <source/>J Neuroimmunol (<year>2008</year>) <volume>200</volume>:<fpage>53</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.06.008</pub-id><pub-id pub-id-type="pmid">18662832</pub-id></mixed-citation>
</ref>
<ref id="B313">
<label>313</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>H</given-names></name><name><surname>Hokari</surname><given-names>R</given-names></name><name><surname>Ueda</surname><given-names>T</given-names></name><name><surname>Kurihara</surname><given-names>C</given-names></name><name><surname>Hozumi</surname><given-names>H</given-names></name><name><surname>Higashiyama</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Physiological stress exacerbates murine colitis by enhancing proinflammatory cytokine expression that is dependent on IL-18</article-title>. <source/>Am J Physiol (<year>2011</year>) <volume>301</volume>:<fpage>G555</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00482.2010</pub-id><pub-id pub-id-type="pmid">21719737</pub-id></mixed-citation>
</ref>
<ref id="B314">
<label>314</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melgar</surname><given-names>S</given-names></name><name><surname>Engström</surname><given-names>K</given-names></name><name><surname>Jägervall</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>V</given-names></name></person-group>. <article-title>Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice</article-title>. <source/>Stress (<year>2008</year>) <volume>11</volume>:<fpage>348</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1080/10253890701820166</pub-id><pub-id pub-id-type="pmid">18666024</pub-id></mixed-citation>
</ref>
<ref id="B315">
<label>315</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>SO</given-names></name><name><surname>Obermeier</surname><given-names>F</given-names></name><name><surname>Straub</surname><given-names>RH</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice increases the severity of an acute DSS-induced colitis and impairs regeneration</article-title>. <source/>Endocrinology (<year>2006</year>) <volume>147</volume>:<fpage>4968</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1210/en.2006-0347</pub-id><pub-id pub-id-type="pmid">16794011</pub-id></mixed-citation>
</ref>
<ref id="B316">
<label>316</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SM</given-names></name><name><surname>McHugh</surname><given-names>K</given-names></name><name><surname>Jacobson</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>I</given-names></name><name><surname>Riddell</surname><given-names>R</given-names></name><name><surname>Murase</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Previous inflammation alters the response of the rat colon to stress</article-title>. <source/>Gastroenterology (<year>1996</year>) <volume>111</volume>:<fpage>1509</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/S0016-5085(96)70012-4</pub-id><pub-id pub-id-type="pmid">8942729</pub-id></mixed-citation>
</ref>
<ref id="B317">
<label>317</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gué</surname><given-names>M</given-names></name><name><surname>Bonbonne</surname><given-names>C</given-names></name><name><surname>Fioramonti</surname><given-names>J</given-names></name><name><surname>Moré</surname><given-names>J</given-names></name><name><surname>Del Rio-Lachèze</surname><given-names>C</given-names></name><name><surname>Coméra</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved</article-title>. <source/>Am J Physiol (<year>1997</year>) <volume>272</volume>:<fpage>G84</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">9038880</pub-id></mixed-citation>
</ref>
<ref id="B318">
<label>318</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetinel</surname><given-names>S</given-names></name><name><surname>Hancioğlu</surname><given-names>S</given-names></name><name><surname>Sener</surname><given-names>E</given-names></name><name><surname>Uner</surname><given-names>C</given-names></name><name><surname>Kiliç</surname><given-names>M</given-names></name><name><surname>Sener</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Oxytocin treatment alleviates stress-aggravated colitis by a receptor-dependent mechanism</article-title>. <source/>Regul Pept (<year>2010</year>) <volume>160</volume>:<fpage>146</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/j.regpep.2009.11.011</pub-id><pub-id pub-id-type="pmid">19931575</pub-id></mixed-citation>
</ref>
<ref id="B319">
<label>319</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentes</surname><given-names>IM</given-names></name><name><surname>Walker</surname><given-names>NK</given-names></name><name><surname>Pierce</surname><given-names>AN</given-names></name><name><surname>Holt</surname><given-names>BR</given-names></name><name><surname>Di Silvestro</surname><given-names>ER</given-names></name><name><surname>Christianson</surname><given-names>JA</given-names></name></person-group>. <article-title>Neonatal maternal separation increases susceptibility to experimental colitis and acute stress exposure in male mice</article-title>. <source/>IBRO Rep (<year>2016</year>) <volume>1</volume>:<fpage>10</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ibror.2016.07.001</pub-id><pub-id pub-id-type="pmid">28164167</pub-id></mixed-citation>
</ref>
<ref id="B320">
<label>320</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>MH</given-names></name><name><surname>Miketa</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>V</given-names></name></person-group>. <article-title>Lack of interaction between psychological stress and DSS-induced colitis affecting colonic sensitivity during colorectal distension in mice</article-title>. <source/>Stress (<year>2009</year>) <volume>12</volume>:<fpage>434</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1080/10253890802626603</pub-id><pub-id pub-id-type="pmid">19929445</pub-id></mixed-citation>
</ref>
<ref id="B321">
<label>321</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cakir</surname><given-names>B</given-names></name><name><surname>Bozkurt</surname><given-names>A</given-names></name><name><surname>Ercan</surname><given-names>F</given-names></name><name><surname>Yeğen</surname><given-names>BC</given-names></name></person-group>. <article-title>The anti-inflammatory effect of leptin on experimental colitis: involvement of endogenous glucocorticoids</article-title>. <source/>Peptides (<year>2004</year>) <volume>25</volume>:<fpage>95</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1016/j.peptides.2003.11.005</pub-id><pub-id pub-id-type="pmid">15003361</pub-id></mixed-citation>
</ref>
<ref id="B322">
<label>322</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gülpinar</surname><given-names>MA</given-names></name><name><surname>Ozbeyli</surname><given-names>D</given-names></name><name><surname>Arbak</surname><given-names>S</given-names></name><name><surname>Yeğen</surname><given-names>BC</given-names></name></person-group>. <article-title>Anti-inflammatory effect of acute stress on experimental colitis is mediated by cholecystokinin-B receptors</article-title>. <source/>Life Sci (<year>2004</year>) <volume>75</volume>:<fpage>77</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.lfs.2003.12.009</pub-id><pub-id pub-id-type="pmid">15102523</pub-id></mixed-citation>
</ref>
<ref id="B323">
<label>323</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>QJ</given-names></name><name><surname>Deng</surname><given-names>DJ</given-names></name><name><surname>Che</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>HR</given-names></name><name><surname>Yu</surname><given-names>JJ</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name></person-group>. <article-title>Hypothalamic paraventricular nucleus stimulation reduces intestinal injury in rats with ulcerative colitis</article-title>. <source/>World J Gastroenterol (<year>2016</year>) <volume>22</volume>:<fpage>3769</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v22.i14.3769</pub-id><pub-id pub-id-type="pmid">27076761</pub-id></mixed-citation>
</ref>
<ref id="B324">
<label>324</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>SO</given-names></name><name><surname>Birkeneder</surname><given-names>L</given-names></name><name><surname>Veenema</surname><given-names>AH</given-names></name><name><surname>Obermeier</surname><given-names>F</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>Straub</surname><given-names>RH</given-names></name><etal></etal></person-group>
<article-title>Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms</article-title>. <source/>Endocrinology (<year>2007</year>) <volume>148</volume>:<fpage>670</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1210/en.2006-0983</pub-id><pub-id pub-id-type="pmid">17110427</pub-id></mixed-citation>
</ref>
<ref id="B325">
<label>325</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>SO</given-names></name><name><surname>Peters</surname><given-names>S</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Hofmann</surname><given-names>C</given-names></name><name><surname>Schölmerich</surname><given-names>J</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><etal></etal></person-group>
<article-title>Mucosal immunosuppression and epithelial barrier defects are key events in murine psychosocial stress-induced colitis</article-title>. <source/>Brain Behav Immun (<year>2011</year>) <volume>25</volume>:<fpage>1153</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2011.03.004</pub-id><pub-id pub-id-type="pmid">21397685</pub-id></mixed-citation>
</ref>
<ref id="B326">
<label>326</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savignac</surname><given-names>HM</given-names></name><name><surname>Hyland</surname><given-names>NP</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>The effects of repeated social interaction stress on behavioural and physiological parameters in a stress-sensitive mouse strain</article-title>. <source/>Behav Brain Res (<year>2011</year>) <volume>216</volume>:<fpage>576</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2010.08.049</pub-id><pub-id pub-id-type="pmid">20826188</pub-id></mixed-citation>
</ref>
<ref id="B327">
<label>327</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heer</surname><given-names>M</given-names></name><name><surname>Repond</surname><given-names>F</given-names></name><name><surname>Hany</surname><given-names>A</given-names></name><name><surname>Sulser</surname><given-names>H</given-names></name><name><surname>Kehl</surname><given-names>O</given-names></name><name><surname>Jäger</surname><given-names>K</given-names></name></person-group>. <article-title>Acute ischaemic colitis in a female long distance runner</article-title>. <source/>Gut (<year>1987</year>) <volume>28</volume>:<fpage>896</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/gut.28.7.896</pub-id><pub-id pub-id-type="pmid">3498668</pub-id></mixed-citation>
</ref>
<ref id="B328">
<label>328</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>W</given-names></name><name><surname>Schroy</surname><given-names>PC</given-names></name></person-group>. <article-title>Reversible ischemic colitis in a high endurance athlete</article-title>. <source/>Am J Gastroenterol (<year>1998</year>) <volume>93</volume>:<fpage>2231</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1111/j.1572-0241.1998.00621.x</pub-id><pub-id pub-id-type="pmid">9820403</pub-id></mixed-citation>
</ref>
<ref id="B329">
<label>329</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>BS</given-names></name></person-group>. <article-title>Physiology and neurobiology of stress and adaptation: central role of the brain</article-title>. <source/>Physiol Rev (<year>2007</year>) <volume>87</volume>:<fpage>873</fpage>–<lpage>904</lpage>.<pub-id pub-id-type="doi">10.1152/physrev.00041.2006</pub-id><pub-id pub-id-type="pmid">17615391</pub-id></mixed-citation>
</ref>
<ref id="B330">
<label>330</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>DS</given-names></name><name><surname>Kopin</surname><given-names>IJ</given-names></name></person-group>. <article-title>Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis</article-title>. <source/>Endocr Regul (<year>2008</year>) <volume>42</volume>:<fpage>111</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18999898</pub-id></mixed-citation>
</ref>
<ref id="B331">
<label>331</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taché</surname><given-names>Y</given-names></name><name><surname>Million</surname><given-names>M</given-names></name></person-group>. <article-title>Role of corticotropin-releasing factor signaling in stress-related alterations of colonic motility and hyperalgesia</article-title>. <source/>J Neurogastroenterol Motil (<year>2015</year>) <volume>21</volume>:<fpage>8</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.5056/jnm14162</pub-id><pub-id pub-id-type="pmid">25611064</pub-id></mixed-citation>
</ref>
<ref id="B332">
<label>332</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvetnansky</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Ziegler</surname><given-names>MG</given-names></name></person-group>. <article-title>Stress-triggered changes in peripheral catecholaminergic systems</article-title>. <source/>Adv Pharmacol (<year>2013</year>) <volume>68</volume>:<fpage>359</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1016/B978-0-12-411512-5.00017-8</pub-id><pub-id pub-id-type="pmid">24054153</pub-id></mixed-citation>
</ref>
<ref id="B333">
<label>333</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>JW</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group>
<article-title>IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2008</year>) <volume>105</volume>:<fpage>751</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0708092105</pub-id><pub-id pub-id-type="pmid">18178625</pub-id></mixed-citation>
</ref>
<ref id="B334">
<label>334</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleshner</surname><given-names>M</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Maier</surname><given-names>SF</given-names></name></person-group>. <article-title>Danger signals and inflammasomes: stress-evoked sterile inflammation in mood disorders</article-title>. <source/>Neuropsychopharmacology (<year>2017</year>) <volume>42</volume>:<fpage>36</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/npp.2016.125</pub-id><pub-id pub-id-type="pmid">27412959</pub-id></mixed-citation>
</ref>
<ref id="B335">
<label>335</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodes</surname><given-names>GE</given-names></name><name><surname>Pfau</surname><given-names>ML</given-names></name><name><surname>Leboeuf</surname><given-names>M</given-names></name><name><surname>Golden</surname><given-names>SA</given-names></name><name><surname>Christoffel</surname><given-names>DJ</given-names></name><name><surname>Bregman</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2014</year>) <volume>111</volume>:<fpage>16136</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1415191111</pub-id><pub-id pub-id-type="pmid">25331895</pub-id></mixed-citation>
</ref>
<ref id="B336">
<label>336</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait-Belgnaoui</surname><given-names>A</given-names></name><name><surname>Durand</surname><given-names>H</given-names></name><name><surname>Cartier</surname><given-names>C</given-names></name><name><surname>Chaumaz</surname><given-names>G</given-names></name><name><surname>Eutamene</surname><given-names>H</given-names></name><name><surname>Ferrier</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats</article-title>. <source/>Psychoneuroendocrinology (<year>2012</year>) <volume>37</volume>:<fpage>1885</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.03.024</pub-id><pub-id pub-id-type="pmid">22541937</pub-id></mixed-citation>
</ref>
<ref id="B337">
<label>337</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzi</surname><given-names>A</given-names></name><name><surname>Reichmann</surname><given-names>F</given-names></name><name><surname>Holzer</surname><given-names>P</given-names></name></person-group>
<article-title>The homeostatic role of neuropeptide Y in immune function and its impact on mood and behavior</article-title>. <source/>Acta Physiol (Oxf) (<year>2015</year>) <volume>213</volume>:<fpage>603</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1111/apha.12445</pub-id><pub-id pub-id-type="pmid">25545642</pub-id></mixed-citation>
</ref>
<ref id="B338">
<label>338</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>SC</given-names></name><name><surname>Cox</surname><given-names>HM</given-names></name></person-group>
<article-title>Peptide YY, neuropeptide Y and corticotropin-releasing factor modulate gastrointestinal motility and food intake during acute stress</article-title>. <source/>Neurogastroenterol Motil (<year>2014</year>) <volume>26</volume>:<fpage>1605</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12428</pub-id><pub-id pub-id-type="pmid">25238483</pub-id></mixed-citation>
</ref>
<ref id="B339">
<label>339</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>S</given-names></name><name><surname>Herzog</surname><given-names>H</given-names></name><name><surname>Cox</surname><given-names>HM</given-names></name></person-group>. <article-title>A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress</article-title>. <source/>Br J Pharmacol (<year>2012</year>) <volume>166</volume>:<fpage>2307</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.01939.x</pub-id><pub-id pub-id-type="pmid">22404240</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>